<?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2 20190208//EN?>
<?DTDIdentifier.IdentifierType public?>
<?SourceDTD.DTDName JATS-journalpublishing1.dtd?>
<?SourceDTD.Version 1.2?>
<?ConverterInfo.XSLTName jats2jats3.xsl?>
<?ConverterInfo.Version 1?>
<?properties open_access?>
<processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats">
  <restricted-by>pmc</restricted-by>
</processing-meta>
<front>
  <journal-meta>
    <journal-id journal-id-type="nlm-ta">Bioinform Adv</journal-id>
    <journal-id journal-id-type="iso-abbrev">Bioinform Adv</journal-id>
    <journal-id journal-id-type="publisher-id">bioadv</journal-id>
    <journal-title-group>
      <journal-title>Bioinformatics Advances</journal-title>
    </journal-title-group>
    <issn pub-type="epub">2635-0041</issn>
    <publisher>
      <publisher-name>Oxford University Press</publisher-name>
    </publisher>
  </journal-meta>
  <article-meta>
    <article-id pub-id-type="pmcid">10438957</article-id>
    <article-id pub-id-type="doi">10.1093/bioadv/vbad104</article-id>
    <article-id pub-id-type="publisher-id">vbad104</article-id>
    <article-categories>
      <subj-group subj-group-type="heading">
        <subject>Original Article</subject>
        <subj-group subj-group-type="category-toc-heading">
          <subject>Genome Analysis</subject>
        </subj-group>
      </subj-group>
      <subj-group subj-group-type="category-taxonomy-collection">
        <subject>AcademicSubjects/SCI01060</subject>
      </subj-group>
    </article-categories>
    <title-group>
      <article-title>Cobind: quantitative analysis of the genomic overlaps</article-title>
    </title-group>
    <contrib-group>
      <contrib contrib-type="author">
        <name>
          <surname>Ma</surname>
          <given-names>Tao</given-names>
        </name>
        <role vocab="credit" vocab-identifier="http://credit.niso.org" vocab-term="Data curation" vocab-term-identifier="http://credit.niso.org/contributor-roles/data-curation" degree-contribution="lead">Data curation</role>
        <role vocab="credit" vocab-identifier="http://credit.niso.org" vocab-term="Formal analysis" vocab-term-identifier="http://credit.niso.org/contributor-roles/formal-analysis" degree-contribution="lead">Formal analysis</role>
        <role vocab="credit" vocab-identifier="http://credit.niso.org" vocab-term="Validation" vocab-term-identifier="http://credit.niso.org/contributor-roles/validation" degree-contribution="lead">Validation</role>
        <role vocab="credit" vocab-identifier="http://credit.niso.org" vocab-term="Visualization" vocab-term-identifier="http://credit.niso.org/contributor-roles/visualization" degree-contribution="equal">Visualization</role>
        <role vocab="credit" vocab-identifier="http://credit.niso.org" vocab-term="Writing - original draft" vocab-term-identifier="http://credit.niso.org/contributor-roles/writing-original-draft" degree-contribution="equal">Writing - original draft</role>
        <role vocab="credit" vocab-identifier="http://credit.niso.org" vocab-term="Writing - review &amp; editing" vocab-term-identifier="http://credit.niso.org/contributor-roles/writing-review-editing" degree-contribution="equal">Writing - review &amp; editing</role>
        <aff><institution>Division of Computational Biology, Mayo Clinic College of Medicine and Science</institution>, Rochester, MN 55905, <country country="US">United States</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Guo</surname>
          <given-names>Lingyun</given-names>
        </name>
        <role vocab="credit" vocab-identifier="http://credit.niso.org" vocab-term="Data curation" vocab-term-identifier="http://credit.niso.org/contributor-roles/data-curation" degree-contribution="supporting">Data curation</role>
        <role vocab="credit" vocab-identifier="http://credit.niso.org" vocab-term="Formal analysis" vocab-term-identifier="http://credit.niso.org/contributor-roles/formal-analysis" degree-contribution="supporting">Formal analysis</role>
        <aff><institution>Department of Computer Science and Engineering, University of Minnesota Twin Cities</institution>, Minneapolis, MN 55455, <country country="US">United States</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Yan</surname>
          <given-names>Huihuang</given-names>
        </name>
        <role vocab="credit" vocab-identifier="http://credit.niso.org" vocab-term="Writing - review &amp; editing" vocab-term-identifier="http://credit.niso.org/contributor-roles/writing-review-editing" degree-contribution="supporting">Writing - review &amp; editing</role>
        <aff><institution>Division of Computational Biology, Mayo Clinic College of Medicine and Science</institution>, Rochester, MN 55905, <country country="US">United States</country></aff>
      </contrib>
      <contrib contrib-type="author" corresp="yes">
        <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0003-2072-4826</contrib-id>
        <name>
          <surname>Wang</surname>
          <given-names>Liguo</given-names>
        </name>
        <role vocab="credit" vocab-identifier="http://credit.niso.org" vocab-term="Conceptualization" vocab-term-identifier="http://credit.niso.org/contributor-roles/conceptualization" degree-contribution="lead">Conceptualization</role>
        <role vocab="credit" vocab-identifier="http://credit.niso.org" vocab-term="Data curation" vocab-term-identifier="http://credit.niso.org/contributor-roles/data-curation" degree-contribution="lead">Data curation</role>
        <role vocab="credit" vocab-identifier="http://credit.niso.org" vocab-term="Formal analysis" vocab-term-identifier="http://credit.niso.org/contributor-roles/formal-analysis" degree-contribution="lead">Formal analysis</role>
        <role vocab="credit" vocab-identifier="http://credit.niso.org" vocab-term="Funding acquisition" vocab-term-identifier="http://credit.niso.org/contributor-roles/funding-acquisition" degree-contribution="lead">Funding acquisition</role>
        <role vocab="credit" vocab-identifier="http://credit.niso.org" vocab-term="Investigation" vocab-term-identifier="http://credit.niso.org/contributor-roles/investigation" degree-contribution="lead">Investigation</role>
        <role vocab="credit" vocab-identifier="http://credit.niso.org" vocab-term="Methodology" vocab-term-identifier="http://credit.niso.org/contributor-roles/methodology" degree-contribution="lead">Methodology</role>
        <role vocab="credit" vocab-identifier="http://credit.niso.org" vocab-term="Project administration" vocab-term-identifier="http://credit.niso.org/contributor-roles/project-administration" degree-contribution="lead">Project administration</role>
        <role vocab="credit" vocab-identifier="http://credit.niso.org" vocab-term="Software" vocab-term-identifier="http://credit.niso.org/contributor-roles/software" degree-contribution="lead">Software</role>
        <role vocab="credit" vocab-identifier="http://credit.niso.org" vocab-term="Supervision" vocab-term-identifier="http://credit.niso.org/contributor-roles/supervision" degree-contribution="lead">Supervision</role>
        <role vocab="credit" vocab-identifier="http://credit.niso.org" vocab-term="Validation" vocab-term-identifier="http://credit.niso.org/contributor-roles/validation" degree-contribution="lead">Validation</role>
        <role vocab="credit" vocab-identifier="http://credit.niso.org" vocab-term="Visualization" vocab-term-identifier="http://credit.niso.org/contributor-roles/visualization" degree-contribution="lead">Visualization</role>
        <role vocab="credit" vocab-identifier="http://credit.niso.org" vocab-term="Writing - original draft" vocab-term-identifier="http://credit.niso.org/contributor-roles/writing-original-draft" degree-contribution="lead">Writing - original draft</role>
        <role vocab="credit" vocab-identifier="http://credit.niso.org" vocab-term="Writing - review &amp; editing" vocab-term-identifier="http://credit.niso.org/contributor-roles/writing-review-editing" degree-contribution="lead">Writing - review &amp; editing</role>
        <aff><institution>Division of Computational Biology, Mayo Clinic College of Medicine and Science</institution>, Rochester, MN 55905, <country country="US">United States</country></aff>
        <aff><institution>Bioinformatics and Computational Biology Graduate Program, University of Minnesota Rochester</institution>, Rochester, MN 55904, <country country="US">United States</country></aff>
        <xref rid="vbad104-cor1" ref-type="corresp"/>
        <!--Wang.Liguo@mayo.edu-->
      </contrib>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name>
          <surname>Forslund</surname>
          <given-names>Sofia</given-names>
        </name>
        <role>Associate Editor</role>
      </contrib>
    </contrib-group>
    <author-notes>
      <corresp id="vbad104-cor1">Corresponding author. Division of Computational Biology, Mayo Clinic College of Medicine and Science, 200 1st St SW, Rochester, MN 55905, United States. E-mail: <email>Wang.Liguo@mayo.edu</email></corresp>
    </author-notes>
    <pub-date pub-type="collection">
      <year>2023</year>
    </pub-date>
    <pub-date pub-type="epub" iso-8601-date="2023-08-07">
      <day>07</day>
      <month>8</month>
      <year>2023</year>
    </pub-date>
    <pub-date pub-type="pmc-release">
      <day>07</day>
      <month>8</month>
      <year>2023</year>
    </pub-date>
    <volume>3</volume>
    <issue>1</issue>
    <elocation-id>vbad104</elocation-id>
    <history>
      <date date-type="received">
        <day>24</day>
        <month>5</month>
        <year>2023</year>
      </date>
      <date date-type="rev-recd">
        <day>17</day>
        <month>7</month>
        <year>2023</year>
      </date>
      <date date-type="editorial-decision">
        <day>20</day>
        <month>7</month>
        <year>2023</year>
      </date>
      <date date-type="accepted">
        <day>04</day>
        <month>8</month>
        <year>2023</year>
      </date>
      <date date-type="corrected-typeset">
        <day>18</day>
        <month>8</month>
        <year>2023</year>
      </date>
    </history>
    <permissions>
      <copyright-statement>© The Author(s) 2023. Published by Oxford University Press.</copyright-statement>
      <copyright-year>2023</copyright-year>
      <license>
        <ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
        <license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
      </license>
    </permissions>
    <self-uri xlink:href="vbad104.pdf"/>
    <abstract>
      <title>Abstract</title>
      <sec id="s1">
        <title>Motivation</title>
        <p>Analyzing the overlap between two sets of genomic intervals is a frequent task in the field of bioinformatics. Typically, this is accomplished by counting the number (or proportion) of overlapped regions, which applies an arbitrary threshold to determine if two genomic intervals are overlapped. By making binary calls but disregarding the magnitude of the overlap, such an approach often leads to biased, non-reproducible, and incomparable results.</p>
      </sec>
      <sec id="s2">
        <title>Results</title>
        <p>We developed the cobind package, which incorporates six statistical measures: the Jaccard coefficient, Sørensen–Dice coefficient, Szymkiewicz–Simpson coefficient, collocation coefficient, pointwise mutual information (PMI), and normalized PMI. These measures allow for a quantitative assessment of the collocation strength between two sets of genomic intervals. To demonstrate the effectiveness of these methods, we applied them to analyze CTCF’s binding sites identified from ChIP-seq, cancer-specific open-chromatin regions (OCRs) identified from ATAC-seq of 17 cancer types, and oligodendrocytes-specific OCRs identified from scATAC-seq. Our results indicated that these new approaches effectively re-discover CTCF’s cofactors, as well as cancer-specific and oligodendrocytes-specific master regulators implicated in disease and cell type development.</p>
      </sec>
      <sec id="s3">
        <title>Availability and implementation</title>
        <p>The cobind package is implemented in Python and freely available at <ext-link xlink:href="https://cobind.readthedocs.io/en/latest/" ext-link-type="uri">https://cobind.readthedocs.io/en/latest/</ext-link>.</p>
      </sec>
    </abstract>
    <funding-group>
      <award-group award-type="grant">
        <funding-source>
          <institution-wrap>
            <institution>US National Institute of Health</institution>
          </institution-wrap>
        </funding-source>
        <award-id>CA180882-07</award-id>
        <award-id>CA130908-12</award-id>
        <award-id>CA230712-4</award-id>
        <award-id>AA27179</award-id>
      </award-group>
    </funding-group>
    <counts>
      <page-count count="9"/>
    </counts>
  </article-meta>
</front>
<body>
  <sec>
    <title>1 Introduction</title>
    <p>Collocated genomic intervals indicate biological or functional connections. For example, a previous study found that over 50% of ERα-binding sites occur on FoxA1-occupied sites, and a further mechanistic study confirmed the direct collaboration between ERα and FoxA1 to control the transcription of estrogen-responsive genes (<xref rid="vbad104-B28" ref-type="bibr">Lupien <italic toggle="yes">et al.</italic> 2008</xref>). Therefore, investigating the collocation of two sets of genomic intervals is vital in identifying common biological pathways, revealing the underlying molecular mechanisms, and validating results obtained from different experiments.</p>
    <p>Despite its significance, the methodology for examining overlapping intervals, referred to as collocation analysis hereafter, has yet to receive extensive research attention. Currently, most researchers use an arbitrary threshold to determine if two intervals are overlapped. Based on the total number of overlaps between two interval sets, different statistical tests were employed to determine their statistical significance, such as Fisher’s exact test and odds ratio (<xref rid="vbad104-B38" ref-type="bibr">Sheffield and Bock 2016</xref>, <xref rid="vbad104-B25" ref-type="bibr">Layer <italic toggle="yes">et al.</italic> 2018</xref>) or permutation test (<xref rid="vbad104-B16" ref-type="bibr">Haiminen <italic toggle="yes">et al.</italic> 2008</xref>, <xref rid="vbad104-B12" ref-type="bibr">Ferre <italic toggle="yes">et al.</italic> 2020</xref>). This threshold-and-count approach inappropriately equates collocation analysis with co-occurrence analysis. Co-occurrence analysis is a statistical technique for measuring the joint appearance frequency of two zero-dimensional objects (e.g. gene symbols) in a dataset. The result of co-occurrence analysis can be visualized using a Venn diagram, formulated as a 2 × 2 contingency table, and the significance of co-occurrence can be evaluated using Fisher’s exact test or <italic toggle="yes">χ</italic><sup>2</sup> test. In contrast, collocation analysis deals with one-dimensional genomic intervals that have different sizes, and the magnitude of overlapping between two genomic intervals is a continuous variable. As a result, applying the co-occurrence analysis approach to genomic intervals can produce biased, non-reproducible, and incomparable results because it depends on a threshold and discards valuable information. To address these limitations, more rigorous, threshold-free approaches are needed to measure the strength of genomic collocations. To this end, we have developed the cobind package with six threshold-free metrics to objectively quantify the collocation of genomic intervals.</p>
  </sec>
  <sec>
    <title>2 Methods</title>
    <sec>
      <title>2.1 Data collection</title>
      <p>Curated binding sites of 1208 transcription factors (TFs) were downloaded from the ReMap 2022 database (<ext-link xlink:href="https://remap.univ-amu.fr/" ext-link-type="uri">https://remap.univ-amu.fr/</ext-link>) (<xref rid="vbad104-B17" ref-type="bibr">Hammal <italic toggle="yes">et al.</italic> 2022</xref>). ATAC-seq peaks of 17 TCGA common cancer types, including Bladder Urothelial Carcinoma (BLCA), Breast invasive carcinoma (BRCA), Cervical squamous cell carcinoma and endocervical adenocarcinoma (CESC), Colon adenocarcinoma (COAD), Esophageal carcinoma (ESCA), glioblastoma multiforme (GBM), Head and Neck squamous cell carcinoma (HNSC), Kidney renal clear cell carcinoma (KIRC), low-grade glioma (LGG), Liver hepatocellular carcinoma (LIHC), Lung adenocarcinoma (LUAD), Lung squamous cell carcinoma (LUSC), Prostate adenocarcinoma (PRAD), Skin Cutaneous Melanoma (SKCM), Stomach adenocarcinoma (STAD), Thyroid carcinoma (THCA), and Uterine Corpus Endometrial Carcinoma (UCEC), were downloaded from Genomics Data Commons (<ext-link xlink:href="https://gdc.cancer.gov/about-data/publications/ATACseq-AWG" ext-link-type="uri">https://gdc.cancer.gov/about-data/publications/ATACseq-AWG</ext-link>) (<xref rid="vbad104-B6" ref-type="bibr">Corces <italic toggle="yes">et al.</italic> 2018</xref>). Cancer type-specific open-chromatin regions (OCRs) were identified by comparing ATAC-seq peaks of one cancer type with the remaining cancer types using BEDTools (<xref rid="vbad104-B36" ref-type="bibr">Quinlan and Hall 2010</xref>). Single nucleus RNA-seq (snRNA-seq) data from adult humans’ motor cortex (M1) were generated by the Allen Institute for Brain Science (<ext-link xlink:href="https://portal.brain-map.org/" ext-link-type="uri">https://portal.brain-map.org/</ext-link>) using the 10× Chromium Single Cell 3' Reagent Kit v3. Gene expression of count per million values was quantified using the default 10× Cell Ranger v3 pipeline. The University of California, Santa Cruz (UCSC) genome browser track hub to visualize these data is available at <ext-link xlink:href="https://human-m1-rna-hub.s3-us-west-2.amazonaws.com/HumanM1RNAHub.html" ext-link-type="uri">https://human-m1-rna-hub.s3-us-west-2.amazonaws.com/HumanM1RNAHub.html</ext-link>. Oligodendrocyte-specific single-cell assay for transposase-accessible chromatin with sequencing (scATAC-seq) peaks were downloaded from this study (<xref rid="vbad104-B7" ref-type="bibr">Corces <italic toggle="yes">et al.</italic> 2020</xref>). Only distal peaks (<italic toggle="yes">n</italic> = 28 109) were used for collocation analysis to identify the master regulators since peaks identified from scATAC-seq are highly enriched in distal/intron regions but depleted in promoter regions.</p>
    </sec>
    <sec>
      <title>2.2 The six statistical metrics</title>
      <sec>
        <title>2.2.1 The collocation coefficient</title>
        <p><italic toggle="yes">A</italic> and <italic toggle="yes">B</italic> represent two sets of genomic intervals. |<italic toggle="yes">A</italic>| represents the cardinality of <italic toggle="yes">A</italic> (i.e. all the non-redundant bases covered by <italic toggle="yes">A</italic>). |<italic toggle="yes">B</italic>| represents the cardinality of <italic toggle="yes">B</italic>. |<italic toggle="yes">A</italic> ∩ <italic toggle="yes">B</italic>| represents all the non-redundant bases covered by both <italic toggle="yes">A</italic> and <italic toggle="yes">B</italic>. The collocation coefficient (<italic toggle="yes">C</italic>) is calculated as the size of the intersection divided by the geometric mean of the two sets. <italic toggle="yes">C</italic> is defined as 0 when either of |<italic toggle="yes">A</italic>| or |<italic toggle="yes">B</italic>| is 0.
</p>
        <disp-formula id="E1">
          <mml:math id="M1" display="block" overflow="scroll">
            <mml:mi>C</mml:mi>
            <mml:mfenced open="(" close=")" separators="|">
              <mml:mrow>
                <mml:mi>A</mml:mi>
                <mml:mo>,</mml:mo>
                <mml:mi>B</mml:mi>
              </mml:mrow>
            </mml:mfenced>
            <mml:mo>=</mml:mo>
            <mml:mrow>
              <mml:mfrac>
                <mml:mrow>
                  <mml:mfenced open="|" close="|" separators="|">
                    <mml:mrow>
                      <mml:mi>A</mml:mi>
                      <mml:mo>∩</mml:mo>
                      <mml:mi>B</mml:mi>
                    </mml:mrow>
                  </mml:mfenced>
                </mml:mrow>
                <mml:mrow>
                  <mml:msqrt>
                    <mml:mfenced open="|" close="|" separators="|">
                      <mml:mrow>
                        <mml:mi>A</mml:mi>
                      </mml:mrow>
                    </mml:mfenced>
                    <mml:mo>×</mml:mo>
                    <mml:mfenced open="|" close="|" separators="|">
                      <mml:mrow>
                        <mml:mi>B</mml:mi>
                      </mml:mrow>
                    </mml:mfenced>
                  </mml:msqrt>
                </mml:mrow>
              </mml:mfrac>
            </mml:mrow>
            <mml:mo>,</mml:mo>
            <mml:mi mathvariant="normal"> </mml:mi>
            <mml:mn>0</mml:mn>
            <mml:mi mathvariant="normal"> </mml:mi>
            <mml:mo>≤</mml:mo>
            <mml:mi>C</mml:mi>
            <mml:mfenced open="(" close=")" separators="|">
              <mml:mrow>
                <mml:mi>A</mml:mi>
                <mml:mo>,</mml:mo>
                <mml:mi>B</mml:mi>
              </mml:mrow>
            </mml:mfenced>
            <mml:mo>≤</mml:mo>
            <mml:mn>1.</mml:mn>
          </mml:math>
        </disp-formula>
      </sec>
      <sec>
        <title>2.2.2 The Jaccard coefficient</title>
        <p>The Jaccard coefficient is (<italic toggle="yes">J</italic>) calculated as the size of the intersection divided by the union of the two sets. <italic toggle="yes">J</italic> is defined as 0 when either of |<italic toggle="yes">A</italic>| or |<italic toggle="yes">B</italic>| is 0.
</p>
        <disp-formula id="E2">
          <mml:math id="M2" display="block" overflow="scroll">
            <mml:mi>J</mml:mi>
            <mml:mfenced open="(" close=")" separators="|">
              <mml:mrow>
                <mml:mi>A</mml:mi>
                <mml:mo>,</mml:mo>
                <mml:mi>B</mml:mi>
              </mml:mrow>
            </mml:mfenced>
            <mml:mo>=</mml:mo>
            <mml:mi mathvariant="normal"> </mml:mi>
            <mml:mrow>
              <mml:mfrac>
                <mml:mrow>
                  <mml:mfenced open="|" close="|" separators="|">
                    <mml:mrow>
                      <mml:mi>A</mml:mi>
                      <mml:mo>∩</mml:mo>
                      <mml:mi>B</mml:mi>
                    </mml:mrow>
                  </mml:mfenced>
                </mml:mrow>
                <mml:mrow>
                  <mml:mfenced open="|" close="|" separators="|">
                    <mml:mrow>
                      <mml:mi>A</mml:mi>
                      <mml:mo>∪</mml:mo>
                      <mml:mi>B</mml:mi>
                    </mml:mrow>
                  </mml:mfenced>
                </mml:mrow>
              </mml:mfrac>
            </mml:mrow>
            <mml:mo>=</mml:mo>
            <mml:mrow>
              <mml:mfrac>
                <mml:mrow>
                  <mml:mfenced open="|" close="|" separators="|">
                    <mml:mrow>
                      <mml:mi>A</mml:mi>
                      <mml:mo>∩</mml:mo>
                      <mml:mi>B</mml:mi>
                    </mml:mrow>
                  </mml:mfenced>
                </mml:mrow>
                <mml:mrow>
                  <mml:mfenced open="|" close="|" separators="|">
                    <mml:mrow>
                      <mml:mi>A</mml:mi>
                    </mml:mrow>
                  </mml:mfenced>
                  <mml:mo>+</mml:mo>
                  <mml:mfenced open="|" close="|" separators="|">
                    <mml:mrow>
                      <mml:mi>B</mml:mi>
                    </mml:mrow>
                  </mml:mfenced>
                  <mml:mo>-</mml:mo>
                  <mml:mfenced open="|" close="|" separators="|">
                    <mml:mrow>
                      <mml:mi>A</mml:mi>
                      <mml:mo>∩</mml:mo>
                      <mml:mi>B</mml:mi>
                    </mml:mrow>
                  </mml:mfenced>
                </mml:mrow>
              </mml:mfrac>
            </mml:mrow>
            <mml:mo>,</mml:mo>
            <mml:mi mathvariant="normal"> </mml:mi>
            <mml:mn>0</mml:mn>
            <mml:mi mathvariant="normal"> </mml:mi>
            <mml:mo>≤</mml:mo>
            <mml:mi>J</mml:mi>
            <mml:mfenced open="(" close=")" separators="|">
              <mml:mrow>
                <mml:mi>A</mml:mi>
                <mml:mo>,</mml:mo>
                <mml:mi>B</mml:mi>
              </mml:mrow>
            </mml:mfenced>
            <mml:mo>≤</mml:mo>
            <mml:mn>1.</mml:mn>
          </mml:math>
        </disp-formula>
      </sec>
      <sec>
        <title>2.2.3 The Sørensen–Dice coefficient</title>
        <p>The Sørensen–Dice (SD) coefficient is calculated as the size of the intersection divided by the arithmetic mean of the two sets. SD is defined as 0 when either of |<italic toggle="yes">A</italic>| or |<italic toggle="yes">B</italic>| is 0.
</p>
        <disp-formula id="E3">
          <mml:math id="M3" display="block" overflow="scroll">
            <mml:mi mathvariant="normal">SD</mml:mi>
            <mml:mfenced open="(" close=")" separators="|">
              <mml:mrow>
                <mml:mi>A</mml:mi>
                <mml:mo>,</mml:mo>
                <mml:mi>B</mml:mi>
              </mml:mrow>
            </mml:mfenced>
            <mml:mo>=</mml:mo>
            <mml:mi mathvariant="normal"> </mml:mi>
            <mml:mrow>
              <mml:mfrac>
                <mml:mrow>
                  <mml:mfenced open="|" close="|" separators="|">
                    <mml:mrow>
                      <mml:mi>A</mml:mi>
                      <mml:mo>∩</mml:mo>
                      <mml:mi>B</mml:mi>
                    </mml:mrow>
                  </mml:mfenced>
                </mml:mrow>
                <mml:mrow>
                  <mml:mrow>
                    <mml:mfrac>
                      <mml:mrow>
                        <mml:mfenced open="|" close="|" separators="|">
                          <mml:mrow>
                            <mml:mi>A</mml:mi>
                          </mml:mrow>
                        </mml:mfenced>
                        <mml:mo>+</mml:mo>
                        <mml:mfenced open="|" close="|" separators="|">
                          <mml:mrow>
                            <mml:mi>B</mml:mi>
                          </mml:mrow>
                        </mml:mfenced>
                      </mml:mrow>
                      <mml:mrow>
                        <mml:mn>2</mml:mn>
                      </mml:mrow>
                    </mml:mfrac>
                  </mml:mrow>
                </mml:mrow>
              </mml:mfrac>
            </mml:mrow>
            <mml:mo>,</mml:mo>
            <mml:mi mathvariant="normal"> </mml:mi>
            <mml:mn>0</mml:mn>
            <mml:mi mathvariant="normal"> </mml:mi>
            <mml:mo>≤</mml:mo>
            <mml:mi mathvariant="normal">SD</mml:mi>
            <mml:mfenced open="(" close=")" separators="|">
              <mml:mrow>
                <mml:mi>A</mml:mi>
                <mml:mo>,</mml:mo>
                <mml:mi>B</mml:mi>
              </mml:mrow>
            </mml:mfenced>
            <mml:mo>≤</mml:mo>
            <mml:mn>1.</mml:mn>
          </mml:math>
        </disp-formula>
        <p>The Jaccard coefficient (<italic toggle="yes">J</italic>) can be converted from SD with <italic toggle="yes">J</italic> = SD/(2−SD) and <italic toggle="yes">vice versa</italic> with SD<italic toggle="yes"> </italic>=<italic toggle="yes"> </italic>2<italic toggle="yes">J</italic>/(1+<italic toggle="yes">J</italic>).</p>
      </sec>
      <sec>
        <title>2.2.4 The Szymkiewicz–Simpson</title>
        <p>The Szymkiewicz–Simpson (SS) coefficient is defined as the size of the intersection divided by the smaller size of the two sets.
</p>
        <disp-formula id="E4">
          <mml:math id="M4" display="block" overflow="scroll">
            <mml:mi mathvariant="normal">SS</mml:mi>
            <mml:mfenced open="(" close=")" separators="|">
              <mml:mrow>
                <mml:mi>A</mml:mi>
                <mml:mo>,</mml:mo>
                <mml:mi>B</mml:mi>
              </mml:mrow>
            </mml:mfenced>
            <mml:mo>=</mml:mo>
            <mml:mi mathvariant="normal"> </mml:mi>
            <mml:mrow>
              <mml:mfrac>
                <mml:mrow>
                  <mml:mfenced open="|" close="|" separators="|">
                    <mml:mrow>
                      <mml:mi>A</mml:mi>
                      <mml:mo>∩</mml:mo>
                      <mml:mi>B</mml:mi>
                    </mml:mrow>
                  </mml:mfenced>
                </mml:mrow>
                <mml:mrow>
                  <mml:mrow>
                    <mml:mrow>
                      <mml:mi mathvariant="normal">min</mml:mi>
                    </mml:mrow>
                    <mml:mo>⁡</mml:mo>
                    <mml:mrow>
                      <mml:mo>(</mml:mo>
                      <mml:mrow>
                        <mml:mo>|</mml:mo>
                        <mml:mrow>
                          <mml:mi>A</mml:mi>
                          <mml:mrow>
                            <mml:mo>|</mml:mo>
                            <mml:mo>,</mml:mo>
                          </mml:mrow>
                          <mml:mo>|</mml:mo>
                          <mml:mi>B</mml:mi>
                        </mml:mrow>
                        <mml:mo>|</mml:mo>
                      </mml:mrow>
                      <mml:mo>)</mml:mo>
                    </mml:mrow>
                  </mml:mrow>
                </mml:mrow>
              </mml:mfrac>
            </mml:mrow>
            <mml:mo>,</mml:mo>
            <mml:mi mathvariant="normal"> </mml:mi>
            <mml:mn>0</mml:mn>
            <mml:mi mathvariant="normal"> </mml:mi>
            <mml:mo>≤</mml:mo>
            <mml:mi mathvariant="normal">SS</mml:mi>
            <mml:mfenced open="(" close=")" separators="|">
              <mml:mrow>
                <mml:mi>A</mml:mi>
                <mml:mo>,</mml:mo>
                <mml:mi>B</mml:mi>
              </mml:mrow>
            </mml:mfenced>
            <mml:mo>≤</mml:mo>
            <mml:mn>1.</mml:mn>
          </mml:math>
        </disp-formula>
      </sec>
      <sec>
        <title>2.2.5 Pointwise mutual information</title>
        <p><italic toggle="yes">G</italic> represents the size of the genome (<italic toggle="yes">A</italic> ⊂ <italic toggle="yes">G</italic> and <italic toggle="yes">B</italic> ⊂ <italic toggle="yes">G</italic>). Pointwise mutual information (PMI) is calculated as
</p>
        <disp-formula id="E5">
          <mml:math id="M5" display="block" overflow="scroll">
            <mml:mi mathvariant="normal">PMI</mml:mi>
            <mml:mfenced open="(" close=")" separators="|">
              <mml:mrow>
                <mml:mi>A</mml:mi>
                <mml:mo>∩</mml:mo>
                <mml:mi>B</mml:mi>
              </mml:mrow>
            </mml:mfenced>
            <mml:mo>≡</mml:mo>
            <mml:mi mathvariant="normal">log</mml:mi>
            <mml:mfenced open="(" close=")" separators="|">
              <mml:mrow>
                <mml:mrow>
                  <mml:mfrac>
                    <mml:mrow>
                      <mml:mi>p</mml:mi>
                      <mml:mfenced open="(" close=")" separators="|">
                        <mml:mrow>
                          <mml:mi>A</mml:mi>
                          <mml:mo>∩</mml:mo>
                          <mml:mi>B</mml:mi>
                        </mml:mrow>
                      </mml:mfenced>
                    </mml:mrow>
                    <mml:mrow>
                      <mml:mi>p</mml:mi>
                      <mml:mfenced open="(" close=")" separators="|">
                        <mml:mrow>
                          <mml:mi>A</mml:mi>
                        </mml:mrow>
                      </mml:mfenced>
                      <mml:mo>×</mml:mo>
                      <mml:mi>p</mml:mi>
                      <mml:mfenced open="(" close=")" separators="|">
                        <mml:mrow>
                          <mml:mi>B</mml:mi>
                        </mml:mrow>
                      </mml:mfenced>
                    </mml:mrow>
                  </mml:mfrac>
                </mml:mrow>
              </mml:mrow>
            </mml:mfenced>
          </mml:math>
        </disp-formula>
        <disp-formula id="E6">
          <mml:math id="M6" display="block" overflow="scroll">
            <mml:mo>-</mml:mo>
            <mml:mi mathvariant="normal">∞</mml:mi>
            <mml:mo>≤</mml:mo>
            <mml:mi mathvariant="normal">PMI</mml:mi>
            <mml:mo>(</mml:mo>
            <mml:mi>A</mml:mi>
            <mml:mo>∩</mml:mo>
            <mml:mi>B</mml:mi>
            <mml:mo>)</mml:mo>
            <mml:mo>≤</mml:mo>
            <mml:mi mathvariant="normal">min</mml:mi>
            <mml:mfenced open="(" close=")" separators="|">
              <mml:mrow>
                <mml:mo>-</mml:mo>
                <mml:mi mathvariant="normal">log</mml:mi>
                <mml:mo>⁡</mml:mo>
                <mml:mo>(</mml:mo>
                <mml:mi>p</mml:mi>
                <mml:mo>(</mml:mo>
                <mml:mi>A</mml:mi>
              </mml:mrow>
            </mml:mfenced>
            <mml:mo>)</mml:mo>
            <mml:mo>,</mml:mo>
            <mml:mi mathvariant="normal"> </mml:mi>
            <mml:mo>-</mml:mo>
            <mml:mi mathvariant="normal">log</mml:mi>
            <mml:mo>⁡</mml:mo>
            <mml:mo>(</mml:mo>
            <mml:mi>p</mml:mi>
            <mml:mo>(</mml:mo>
            <mml:mi>B</mml:mi>
            <mml:mo>)</mml:mo>
            <mml:mo>)</mml:mo>
            <mml:mo>)</mml:mo>
            <mml:mo>,</mml:mo>
          </mml:math>
        </disp-formula>
        <p>where <italic toggle="yes">p</italic>(<italic toggle="yes">A</italic>), <italic toggle="yes">p</italic>(<italic toggle="yes">B</italic>), and <italic toggle="yes">p</italic>(<italic toggle="yes">A∩B</italic>) are defined as
</p>
        <disp-formula id="E7">
          <mml:math id="M7" display="block" overflow="scroll">
            <mml:mi>p</mml:mi>
            <mml:mfenced open="(" close=")" separators="|">
              <mml:mrow>
                <mml:mi>A</mml:mi>
              </mml:mrow>
            </mml:mfenced>
            <mml:mo>=</mml:mo>
            <mml:mrow>
              <mml:mfrac>
                <mml:mrow>
                  <mml:mfenced open="|" close="|" separators="|">
                    <mml:mrow>
                      <mml:mi>A</mml:mi>
                    </mml:mrow>
                  </mml:mfenced>
                </mml:mrow>
                <mml:mrow>
                  <mml:mfenced open="|" close="|" separators="|">
                    <mml:mrow>
                      <mml:mi>G</mml:mi>
                    </mml:mrow>
                  </mml:mfenced>
                </mml:mrow>
              </mml:mfrac>
            </mml:mrow>
            <mml:mo>,</mml:mo>
            <mml:mo> </mml:mo>
            <mml:mi>p</mml:mi>
            <mml:mfenced open="(" close=")" separators="|">
              <mml:mrow>
                <mml:mi>B</mml:mi>
              </mml:mrow>
            </mml:mfenced>
            <mml:mo>=</mml:mo>
            <mml:mrow>
              <mml:mfrac>
                <mml:mrow>
                  <mml:mfenced open="|" close="|" separators="|">
                    <mml:mrow>
                      <mml:mi>B</mml:mi>
                    </mml:mrow>
                  </mml:mfenced>
                </mml:mrow>
                <mml:mrow>
                  <mml:mfenced open="|" close="|" separators="|">
                    <mml:mrow>
                      <mml:mi>G</mml:mi>
                    </mml:mrow>
                  </mml:mfenced>
                </mml:mrow>
              </mml:mfrac>
            </mml:mrow>
            <mml:mo>,</mml:mo>
            <mml:mi mathvariant="normal"> </mml:mi>
            <mml:mi>p</mml:mi>
            <mml:mfenced open="(" close=")" separators="|">
              <mml:mrow>
                <mml:mi>A</mml:mi>
                <mml:mo> </mml:mo>
                <mml:mo>∩</mml:mo>
                <mml:mo> </mml:mo>
                <mml:mi>B</mml:mi>
              </mml:mrow>
            </mml:mfenced>
            <mml:mo>=</mml:mo>
            <mml:mi mathvariant="normal"> </mml:mi>
            <mml:mrow>
              <mml:mfrac>
                <mml:mrow>
                  <mml:mfenced open="|" close="|" separators="|">
                    <mml:mrow>
                      <mml:mi>A</mml:mi>
                      <mml:mo>∩</mml:mo>
                      <mml:mi>B</mml:mi>
                    </mml:mrow>
                  </mml:mfenced>
                </mml:mrow>
                <mml:mrow>
                  <mml:mfenced open="|" close="|" separators="|">
                    <mml:mrow>
                      <mml:mi>G</mml:mi>
                    </mml:mrow>
                  </mml:mfenced>
                </mml:mrow>
              </mml:mfrac>
            </mml:mrow>
            <mml:mo>.</mml:mo>
          </mml:math>
        </disp-formula>
      </sec>
      <sec>
        <title>2.2.6 Normalized PMI</title>
        <p>When dividing PMI by −log(<italic toggle="yes">p</italic>(<italic toggle="yes">A ∩ B</italic>)), the lower bound and upper bound are normalized to −1 and 1, respectively. Normalized PMI (NPMI) is calculated as
</p>
        <disp-formula id="E8">
          <mml:math id="M8" display="block" overflow="scroll">
            <mml:mi mathvariant="normal">NPMI</mml:mi>
            <mml:mfenced open="(" close=")" separators="|">
              <mml:mrow>
                <mml:mi>A</mml:mi>
                <mml:mo>∩</mml:mo>
                <mml:mi>B</mml:mi>
              </mml:mrow>
            </mml:mfenced>
            <mml:mo>=</mml:mo>
            <mml:mrow>
              <mml:mfrac>
                <mml:mrow>
                  <mml:mi mathvariant="normal">PMI</mml:mi>
                  <mml:mfenced open="(" close=")" separators="|">
                    <mml:mrow>
                      <mml:mi>A</mml:mi>
                      <mml:mo>∩</mml:mo>
                      <mml:mi>B</mml:mi>
                    </mml:mrow>
                  </mml:mfenced>
                </mml:mrow>
                <mml:mrow>
                  <mml:mo>-</mml:mo>
                  <mml:mrow>
                    <mml:mrow>
                      <mml:mi mathvariant="normal">log</mml:mi>
                    </mml:mrow>
                    <mml:mo>⁡</mml:mo>
                    <mml:mrow>
                      <mml:mfenced open="(" close=")" separators="|">
                        <mml:mrow>
                          <mml:mi>p</mml:mi>
                          <mml:mfenced open="(" close=")" separators="|">
                            <mml:mrow>
                              <mml:mi>A</mml:mi>
                              <mml:mo>∩</mml:mo>
                              <mml:mo> </mml:mo>
                              <mml:mi>B</mml:mi>
                            </mml:mrow>
                          </mml:mfenced>
                        </mml:mrow>
                      </mml:mfenced>
                    </mml:mrow>
                  </mml:mrow>
                </mml:mrow>
              </mml:mfrac>
            </mml:mrow>
            <mml:mo>=</mml:mo>
            <mml:mrow>
              <mml:mfrac>
                <mml:mrow>
                  <mml:mi mathvariant="normal">log</mml:mi>
                  <mml:mfenced open="(" close=")" separators="|">
                    <mml:mrow>
                      <mml:mrow>
                        <mml:mfrac>
                          <mml:mrow>
                            <mml:mi>p</mml:mi>
                            <mml:mfenced open="(" close=")" separators="|">
                              <mml:mrow>
                                <mml:mi>A</mml:mi>
                                <mml:mo> </mml:mo>
                                <mml:mo>∩</mml:mo>
                                <mml:mo> </mml:mo>
                                <mml:mi>B</mml:mi>
                              </mml:mrow>
                            </mml:mfenced>
                          </mml:mrow>
                          <mml:mrow>
                            <mml:mi>p</mml:mi>
                            <mml:mfenced open="(" close=")" separators="|">
                              <mml:mrow>
                                <mml:mi>A</mml:mi>
                              </mml:mrow>
                            </mml:mfenced>
                            <mml:mo>×</mml:mo>
                            <mml:mi>p</mml:mi>
                            <mml:mfenced open="(" close=")" separators="|">
                              <mml:mrow>
                                <mml:mi>B</mml:mi>
                              </mml:mrow>
                            </mml:mfenced>
                          </mml:mrow>
                        </mml:mfrac>
                      </mml:mrow>
                    </mml:mrow>
                  </mml:mfenced>
                </mml:mrow>
                <mml:mrow>
                  <mml:mo>-</mml:mo>
                  <mml:mrow>
                    <mml:mrow>
                      <mml:mi mathvariant="normal">log</mml:mi>
                    </mml:mrow>
                    <mml:mo>⁡</mml:mo>
                    <mml:mrow>
                      <mml:mfenced open="(" close=")" separators="|">
                        <mml:mrow>
                          <mml:mi>p</mml:mi>
                          <mml:mfenced open="(" close=")" separators="|">
                            <mml:mrow>
                              <mml:mi>A</mml:mi>
                              <mml:mo>∩</mml:mo>
                              <mml:mi>B</mml:mi>
                            </mml:mrow>
                          </mml:mfenced>
                        </mml:mrow>
                      </mml:mfenced>
                    </mml:mrow>
                  </mml:mrow>
                </mml:mrow>
              </mml:mfrac>
            </mml:mrow>
            <mml:mo>=</mml:mo>
            <mml:mrow>
              <mml:mfrac>
                <mml:mrow>
                  <mml:mi mathvariant="normal">log</mml:mi>
                  <mml:mfenced open="(" close=")" separators="|">
                    <mml:mrow>
                      <mml:mi>p</mml:mi>
                      <mml:mfenced open="(" close=")" separators="|">
                        <mml:mrow>
                          <mml:mi>A</mml:mi>
                        </mml:mrow>
                      </mml:mfenced>
                      <mml:mo>×</mml:mo>
                      <mml:mi>p</mml:mi>
                      <mml:mfenced open="(" close=")" separators="|">
                        <mml:mrow>
                          <mml:mi>B</mml:mi>
                        </mml:mrow>
                      </mml:mfenced>
                    </mml:mrow>
                  </mml:mfenced>
                </mml:mrow>
                <mml:mrow>
                  <mml:mrow>
                    <mml:mrow>
                      <mml:mi mathvariant="normal">log</mml:mi>
                    </mml:mrow>
                    <mml:mo>⁡</mml:mo>
                    <mml:mrow>
                      <mml:mfenced open="(" close=")" separators="|">
                        <mml:mrow>
                          <mml:mi>p</mml:mi>
                          <mml:mfenced open="(" close=")" separators="|">
                            <mml:mrow>
                              <mml:mi>A</mml:mi>
                              <mml:mo>∩</mml:mo>
                              <mml:mi>B</mml:mi>
                            </mml:mrow>
                          </mml:mfenced>
                        </mml:mrow>
                      </mml:mfenced>
                    </mml:mrow>
                  </mml:mrow>
                </mml:mrow>
              </mml:mfrac>
            </mml:mrow>
            <mml:mo>-</mml:mo>
            <mml:mn>1</mml:mn>
          </mml:math>
        </disp-formula>
        <disp-formula id="E9">
          <mml:math id="M9" display="block" overflow="scroll">
            <mml:mo>-</mml:mo>
            <mml:mn>1</mml:mn>
            <mml:mo>≤</mml:mo>
            <mml:mi mathvariant="normal">NPMI</mml:mi>
            <mml:mfenced open="(" close=")" separators="|">
              <mml:mrow>
                <mml:mi>A</mml:mi>
                <mml:mo>∩</mml:mo>
                <mml:mi>B</mml:mi>
              </mml:mrow>
            </mml:mfenced>
            <mml:mo>≤</mml:mo>
            <mml:mn>1.</mml:mn>
          </mml:math>
        </disp-formula>
      </sec>
    </sec>
    <sec>
      <title>2.3 Estimate confidence interval with bootstrapping</title>
      <p>To estimate the variability and uncertainty associated with the six calculated statistical measures, we used the non-parametric bootstrapping method to estimate the 95% confidence interval. By default, 75% of input genomic intervals will be resampled and this resampling process will be repeated 20 times.</p>
    </sec>
    <sec>
      <title>2.4 Conventional threshold-and-count approach to measure genomic collocations between CTCF and other TFs</title>
      <p>Pre-analyzed, IDR (Irreproducible Discovery Rate) filtered CTCF (CCCTC-binding factor) ChIP-seq peaks (GRCh38) were downloaded from the ENCODE project (<ext-link xlink:href="https://www.encodeproject.org/files/ENCFF660GHM/" ext-link-type="uri">https://www.encodeproject.org/files/ENCFF660GHM/</ext-link>). ChIP-seq peaks from 1208 TFs were downloaded from the ReMap database (<ext-link xlink:href="https://remap.univ-amu.fr/" ext-link-type="uri">https://remap.univ-amu.fr/</ext-link>). The threshold-and-count approach consists of two steps: first, an arbitrary threshold (minimum number of nucleotides overlapped) was used to determine the overlapping of two peaks, and then each CTCF peak was labeled by “0” or “1”, representing non-overlap or overlap with peaks of the TF compared, respectively; second, the percentage of overlapped CTCF peaks was calculated as the measure of collocation strength. This approach was evaluated using six different thresholds: 1-nucleotide (the most relaxed), 10%, 30%, 50%, 80%, and 100% (the most stringent). Based on the percentage of overlapped CTCF peaks, the 1207 TFs (CTCF itself was excluded) were ranked in descending order under each criterion.</p>
    </sec>
    <sec>
      <title>2.5 Calculate the combined <italic toggle="yes">Z</italic>-score</title>
      <p>We used the Gene Set Variation Analysis package (<xref rid="vbad104-B19" ref-type="bibr">Hänzelmann <italic toggle="yes">et al.</italic> 2013</xref>) to calculate the combined <italic toggle="yes">Z</italic>-scores. Specifically, scores of the six metrics were converted into <italic toggle="yes">Z</italic>-scores by <italic toggle="yes">Z</italic><sub>i</sub> = (<italic toggle="yes">x</italic> − <italic toggle="yes">μ</italic>)/<italic toggle="yes">σ</italic>, where <italic toggle="yes">μ</italic> and <italic toggle="yes">σ</italic> are the average and standard deviation of the score, and <italic toggle="yes">i</italic> ∈ {<italic toggle="yes">C</italic>, <italic toggle="yes">J</italic>, SD, SS, PMI, NPMI}. The combined <italic toggle="yes">Z</italic>-score is defined as:
</p>
      <disp-formula id="E10">
        <mml:math id="M10" display="block" overflow="scroll">
          <mml:mi>Z</mml:mi>
          <mml:mo>=</mml:mo>
          <mml:mrow>
            <mml:mfrac>
              <mml:mrow>
                <mml:mrow>
                  <mml:mo stretchy="false">∑</mml:mo>
                  <mml:mrow>
                    <mml:mrow>
                      <mml:msub>
                        <mml:mrow>
                          <mml:mi>Z</mml:mi>
                        </mml:mrow>
                        <mml:mrow>
                          <mml:mi>i</mml:mi>
                        </mml:mrow>
                      </mml:msub>
                    </mml:mrow>
                  </mml:mrow>
                </mml:mrow>
              </mml:mrow>
              <mml:mrow>
                <mml:msqrt>
                  <mml:mn>6</mml:mn>
                </mml:msqrt>
              </mml:mrow>
            </mml:mfrac>
          </mml:mrow>
          <mml:mo>.</mml:mo>
        </mml:math>
      </disp-formula>
      <p>TFs with <italic toggle="yes">Z</italic>-scores that are more than 3 standard deviations away from the mean are considered outliers (i.e. potential master regulators).</p>
    </sec>
  </sec>
  <sec>
    <title>3 Results</title>
    <sec>
      <title>3.1 Overview of collocation metrics</title>
      <p>The collocation coefficient (<italic toggle="yes">C</italic>), the Jaccard coefficient (<italic toggle="yes">J</italic>), the Sørensen–Dice coefficient (SD), and the Szymkiewicz–Simpson coefficient (SS) are intersection-based metrics and conceptually similar: they normalize the size of the intersection between <italic toggle="yes">A</italic> and <italic toggle="yes">B</italic> by the “geometric mean,” “union,” “arithmetic mean,” and “min” of <italic toggle="yes">A</italic> and <italic toggle="yes">B</italic> (<italic toggle="yes">A</italic> and <italic toggle="yes">B</italic> represent two sets of genomic intervals), respectively. As can be seen from Section 2 and <xref rid="vbad104-T1" ref-type="table">Table 1</xref>, all the intersection-based coefficients are bounded by 0 (no collocation) and 1 (complete collocation), which facilitate cross-sample comparison and integration. In theory, <italic toggle="yes">J</italic> and SD scores are prone to be biased by the larger interval set due to their use of “union” and “arithmetic mean” as denominators, respectively. Conversely, SS is susceptible to the smaller interval set as it uses “min” as the denominator. However, the novel metric <italic toggle="yes">C</italic> developed in this study utilizes the geometric mean that is less sensitive to highly skewed data, thus could alleviate the observed bias in <italic toggle="yes">J</italic>, SD, and SS (<xref rid="sup1" ref-type="supplementary-material">Supplementary Fig. S1</xref>; Section 2).</p>
      <table-wrap position="float" id="vbad104-T1">
        <label>Table 1.</label>
        <caption>
          <p>The six collocation measurements and their lower and upper bounds.</p>
        </caption>
        <table frame="hsides" rules="groups">
          <colgroup span="1">
            <col valign="top" align="left" span="1"/>
            <col valign="top" align="center" span="1"/>
            <col valign="top" align="center" span="1"/>
            <col valign="top" align="center" span="1"/>
            <col valign="top" align="center" span="1"/>
          </colgroup>
          <thead>
            <tr>
              <th rowspan="1" colspan="1">Metrics</th>
              <th rowspan="1" colspan="1">Nominator</th>
              <th rowspan="1" colspan="1">Denominator</th>
              <th rowspan="1" colspan="1">Lower bound (when <italic toggle="yes">A</italic> ∩ <italic toggle="yes">B</italic> = 0)</th>
              <th rowspan="1" colspan="1">Upper bound (when <italic toggle="yes">A</italic> = <italic toggle="yes">B</italic>)</th>
            </tr>
          </thead>
          <tbody>
            <tr>
              <td rowspan="1" colspan="1">
                <italic toggle="yes">C</italic>
              </td>
              <td rowspan="1" colspan="1">
                <inline-formula id="IE1">
                  <mml:math id="IM1" display="inline" overflow="scroll">
                    <mml:mo>|</mml:mo>
                    <mml:mi>A</mml:mi>
                    <mml:mo>∩</mml:mo>
                    <mml:mi>B</mml:mi>
                    <mml:mo>|</mml:mo>
                  </mml:math>
                </inline-formula>
              </td>
              <td rowspan="1" colspan="1">
                <inline-formula id="IE2">
                  <mml:math id="IM2" display="inline" overflow="scroll">
                    <mml:msqrt>
                      <mml:mo>|</mml:mo>
                      <mml:mi>A</mml:mi>
                      <mml:mo>|</mml:mo>
                      <mml:mo>×</mml:mo>
                      <mml:mo>|</mml:mo>
                      <mml:mi>B</mml:mi>
                      <mml:mo>|</mml:mo>
                    </mml:msqrt>
                  </mml:math>
                </inline-formula>
              </td>
              <td rowspan="1" colspan="1">0</td>
              <td rowspan="1" colspan="1">1</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">
                <italic toggle="yes">J</italic>
              </td>
              <td rowspan="1" colspan="1">
                <inline-formula id="IE3">
                  <mml:math id="IM3" display="inline" overflow="scroll">
                    <mml:mo>|</mml:mo>
                    <mml:mi>A</mml:mi>
                    <mml:mo>∩</mml:mo>
                    <mml:mi>B</mml:mi>
                    <mml:mo>|</mml:mo>
                  </mml:math>
                </inline-formula>
              </td>
              <td rowspan="1" colspan="1">
                <inline-formula id="IE4">
                  <mml:math id="IM4" display="inline" overflow="scroll">
                    <mml:mo>|</mml:mo>
                    <mml:mi>A</mml:mi>
                    <mml:mo>∪</mml:mo>
                    <mml:mi>B</mml:mi>
                    <mml:mo>|</mml:mo>
                  </mml:math>
                </inline-formula>
              </td>
              <td rowspan="1" colspan="1">0</td>
              <td rowspan="1" colspan="1">1</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">SD</td>
              <td rowspan="1" colspan="1">
                <inline-formula id="IE5">
                  <mml:math id="IM5" display="inline" overflow="scroll">
                    <mml:mo>|</mml:mo>
                    <mml:mi>A</mml:mi>
                    <mml:mo>∩</mml:mo>
                    <mml:mi>B</mml:mi>
                    <mml:mo>|</mml:mo>
                  </mml:math>
                </inline-formula>
              </td>
              <td rowspan="1" colspan="1">
                <inline-formula id="IE6">
                  <mml:math id="IM6" display="inline" overflow="scroll">
                    <mml:mo>(</mml:mo>
                    <mml:mo>|</mml:mo>
                    <mml:mi>A</mml:mi>
                    <mml:mo>|</mml:mo>
                    <mml:mi mathvariant="normal"> </mml:mi>
                    <mml:mo>+</mml:mo>
                    <mml:mi mathvariant="normal"> </mml:mi>
                    <mml:mo>|</mml:mo>
                    <mml:mi>B</mml:mi>
                    <mml:mo>|</mml:mo>
                    <mml:mo>)</mml:mo>
                    <mml:mo>/</mml:mo>
                    <mml:mn>2</mml:mn>
                  </mml:math>
                </inline-formula>
              </td>
              <td rowspan="1" colspan="1">0</td>
              <td rowspan="1" colspan="1">1</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">SS</td>
              <td rowspan="1" colspan="1">
                <inline-formula id="IE7">
                  <mml:math id="IM7" display="inline" overflow="scroll">
                    <mml:mo>|</mml:mo>
                    <mml:mi>A</mml:mi>
                    <mml:mo>∩</mml:mo>
                    <mml:mi>B</mml:mi>
                    <mml:mo>|</mml:mo>
                  </mml:math>
                </inline-formula>
              </td>
              <td rowspan="1" colspan="1">
                <inline-formula id="IE8">
                  <mml:math id="IM8" display="inline" overflow="scroll">
                    <mml:mi mathvariant="normal">Min</mml:mi>
                    <mml:mo>(</mml:mo>
                    <mml:mfenced open="|" close="|" separators="|">
                      <mml:mrow>
                        <mml:mi>A</mml:mi>
                      </mml:mrow>
                    </mml:mfenced>
                    <mml:mo>,</mml:mo>
                    <mml:mi mathvariant="normal"> </mml:mi>
                    <mml:mfenced open="|" close="|" separators="|">
                      <mml:mrow>
                        <mml:mi mathvariant="normal">B</mml:mi>
                      </mml:mrow>
                    </mml:mfenced>
                    <mml:mo>)</mml:mo>
                  </mml:math>
                </inline-formula>
              </td>
              <td rowspan="1" colspan="1">0</td>
              <td rowspan="1" colspan="1">
                <list list-type="simple">
                  <list-item>
                    <p>1 (when <italic toggle="yes">A</italic> = <italic toggle="yes">B</italic>,</p>
                  </list-item>
                  <list-item>
                    <p><italic toggle="yes">A</italic> ∈ <italic toggle="yes">B</italic>, <italic toggle="yes">B</italic> ∈ <italic toggle="yes">A</italic>)</p>
                  </list-item>
                </list>
              </td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">PMI</td>
              <td colspan="2" rowspan="1">See Section 2</td>
              <td rowspan="1" colspan="1">−∞</td>
              <td rowspan="1" colspan="1">
                <list list-type="simple">
                  <list-item>
                    <p>min(−log(<italic toggle="yes">p</italic>(<italic toggle="yes">A</italic>)),</p>
                  </list-item>
                  <list-item>
                    <p>−log(<italic toggle="yes">p</italic>(<italic toggle="yes">B</italic>)))</p>
                  </list-item>
                </list>
              </td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">NPMI</td>
              <td colspan="2" rowspan="1">See Section 2</td>
              <td rowspan="1" colspan="1">−1</td>
              <td rowspan="1" colspan="1">1</td>
            </tr>
          </tbody>
        </table>
        <table-wrap-foot>
          <fn id="tblfn1">
            <p><italic toggle="yes">Notes</italic>: <italic toggle="yes">A</italic> and <italic toggle="yes">B</italic> represent two sets of genomic intervals. <italic toggle="yes">C</italic>, the collocation coefficient; <italic toggle="yes">J</italic>, the Jaccard coefficient; <italic toggle="yes">SD</italic>, the Sørensen–Dice coefficient; SS, the Szymkiewicz–Simpson coefficient.</p>
          </fn>
        </table-wrap-foot>
      </table-wrap>
      <p>In addition to these four intersection-based metrics, we also introduced two information-theory-based association measures: PMI and normalized PMI (NPMI). PMI measures how much the observed overlap differs from what we expected. PMI =<italic toggle="yes"> </italic>0 indicates that <italic toggle="yes">A</italic> and <italic toggle="yes">B</italic> are independent, whereas PMI &gt; 0 and PMI &lt; 0 indicate that the overlap between <italic toggle="yes">A</italic> and <italic toggle="yes">B</italic> is higher and lower than expected if <italic toggle="yes">A</italic> and <italic toggle="yes">B</italic> were independent, respectively. Although PMI is a standard measure to quantify overlapping or co-occurrence, the lack of a fixed upper bound compromises its use for cross-sample comparison. Instead, NPMI gives a fixed upper bound and lower bound with “−1” and “1,” indicating no collocation and complete collocation, respectively (<xref rid="vbad104-T1" ref-type="table">Table 1</xref>).</p>
    </sec>
    <sec>
      <title>3.2 Identify TFs co-localized with CTCF bindings</title>
      <p>CTCF is a TF that plays a critical role in chromatin organization. The interdependence between CTCF and the cohesin proteins (including RAD21, SMC1A, SMC3, STAG1, and STAG2) to regulate the 3D chromatin architecture is well-known and has been independently validated by numerous studies (<xref rid="vbad104-B18" ref-type="bibr">Hansen <italic toggle="yes">et al.</italic> 2017</xref>, <xref rid="vbad104-B4" ref-type="bibr">Cattoglio <italic toggle="yes">et al.</italic> 2019</xref>, <xref rid="vbad104-B26" ref-type="bibr">Li <italic toggle="yes">et al.</italic> 2020</xref>, <xref rid="vbad104-B35" ref-type="bibr">Pugacheva <italic toggle="yes">et al.</italic> 2020</xref>, <xref rid="vbad104-B15" ref-type="bibr">Gabriele <italic toggle="yes">et al.</italic> 2022</xref>, <xref rid="vbad104-B29" ref-type="bibr">Mach <italic toggle="yes">et al.</italic> 2022</xref>). Their collaborative relationship leads to collocated bindings. This allows us to evaluate the performance of the six collocation measurements implemented in the cobind package. We first calculated the scores of these metrics between CTCF’s binding sites (CBF) and those binding sites of other 1207 TFs curated in the ReMap database (<ext-link xlink:href="https://remap.univ-amu.fr/" ext-link-type="uri">https://remap.univ-amu.fr/</ext-link>). We also calculated <italic toggle="yes">Z</italic>-scores combining all six metrics as an overall measure (<xref rid="vbad104-F1" ref-type="fig">Fig. 1A</xref> and <xref rid="sup1" ref-type="supplementary-material">Supplementary Table S1</xref>; Section 2).</p>
      <fig position="float" id="vbad104-F1">
        <label>Figure 1.</label>
        <caption>
          <p>Evaluation of the collocation metrics implemented in cobind using CTCF binding sites. (A) The process of calculating the six collocation measurements (and the combined <italic toggle="yes">Z</italic>-score) of a query genomic interval with the database of TFBS. (B) Heatmap shows Pearson’s and Spearman’s pairwise correlations between six collocation metrics, including <italic toggle="yes">C</italic>, <italic toggle="yes">J</italic>, SD, NPMI, PMI, and SS. The collocation coefficients were calculated between CTCF binding sites and the binding sites of 1207 TFs. (C) Barplots show the top 20 TFs whose binding sites overlap with CTCF binding sites. Outliers (defined as TFs whose <italic toggle="yes">Z</italic>-score is at least three standard deviations from the mean) were filled in red, while other proteins were filled in blue. (D) Venn diagram shows the overlaps of the top 10 master regulators reported by <italic toggle="yes">C</italic>, <italic toggle="yes">J</italic>(SD), SS(PMI), and NPMI. <italic toggle="yes">J</italic> and SD, SS, and PMI were combined since the top 10 master regulators were the same. (E) The density plot shows the five cohesin proteins and TRIM22 were identified as outliers. <italic toggle="yes">C</italic>, collocation coefficient; <italic toggle="yes">J</italic>, the Jaccard coefficient; SD, the Sørensen–Dice coefficient; SS, the Szymkiewicz–Simpson coefficient; PMI, pointwise mutual information; NPMI, normalized pointwise mutual information.</p>
        </caption>
        <graphic xlink:href="vbad104f1" position="float"/>
      </fig>
      <p>The results indicated that the six metrics exhibited high pairwise concordance with Spearman’s correlation coefficient (<italic toggle="yes">ρ</italic>) ranging from 0.60 to 0.99 (mean = 0.83, median = 0.88) and Pearson’s <italic toggle="yes">r</italic> ranging from 0.57 to 0.99 (mean = 0.80, median = 0.78) (<xref rid="vbad104-F1" ref-type="fig">Fig. 1B</xref>). All six metrics successfully ranked the five cohesin proteins (RAD21, SMC1A, SMC3, STAG1, STAG2) and the TRIM22 protein in the top 10 (<xref rid="vbad104-F1" ref-type="fig">Fig. 1C and D</xref>). Considering data points with more than 3 standard deviations from the mean as outliers, these six proteins were the only outliers detected (<xref rid="vbad104-F1" ref-type="fig">Fig. 1E</xref>). This suggests that their collocations with CTCF are significantly higher than those of other proteins. Although the exact mechanism is unclear, multiple studies have identified TRIM22 as a critical regulator of chromatin structure. TRIM22 bindings are highly enriched at chromatin contact domain boundaries (<xref rid="vbad104-B42" ref-type="bibr">Weintraub <italic toggle="yes">et al.</italic> 2017</xref>, <xref rid="vbad104-B5" ref-type="bibr">Chen <italic toggle="yes">et al.</italic> 2018</xref>). TRIM22 is reported as one of the most informative proteins for predicting human chromosome structures (<xref rid="vbad104-B10" ref-type="bibr">Di Pierro <italic toggle="yes">et al.</italic> 2017</xref>). TRIM22 has also been identified as one of the loop-mediating proteins by a deep learning algorithm (RefHiC) using HiC data (<xref rid="vbad104-B49" ref-type="bibr">Zhang and Blanchette 2022</xref>). In summary, these algorithms could successfully nominate CTCF’s cofactors from other DNA-binding proteins and highlight the potential of collocation analysis in revealing meaningful biological associations.</p>
      <p>As a comparison, the conventional threshold-and-count approach missed the majority of cohesin proteins from the top 10 rankings, regardless of the thresholds applied (<xref rid="sup1" ref-type="supplementary-material">Supplementary Fig. S2</xref>). We found that only one cohesin protein (RAD21) was identified with relatively relaxed thresholds (i.e. from 1 nt overlap to 30% of CTCF peak overlap). When using the most stringent thresholds (&gt;50% of CTCF peak overlap), two to three cohesin proteins (RAD21, SMC1A, and SMC3) were detected (<xref rid="sup1" ref-type="supplementary-material">Supplementary Fig. S2</xref>). These results indicate that the threshold-and-count approach is influenced by the number of peaks and lacks the sensitivity to identify CTCF’s cofactors. For example, this method consistently ranked BRD4 and ESR1 at the top of the list. These two TFs are likely false positives; they are ranked the highest simply because BRD4 (1105211 peaks) and ESR1 (866869 peaks) have the largest and the second largest number of peaks, respectively.</p>
    </sec>
    <sec>
      <title>3.3 Identify the master regulators co-localized with cancer-specific OCRs</title>
      <p>OCRs refer to exposed DNA accessible to TFs and other regulatory proteins. Collocation analysis of TF binding sites (TFBS) with cancer-specific OCRs offers the opportunity to identify master regulators implicated in modulating cancer-specific transcription programs. To demonstrate the utility of our approach, we applied the algorithms implemented in the cobind package to analyze the collocation between the TFBS of 1208 TFs (<xref rid="sup1" ref-type="supplementary-material">Supplementary Table S1</xref>) and OCRs specific to 17 common cancers (<xref rid="sup1" ref-type="supplementary-material">Supplementary Table S2</xref>). The resulting collocation <italic toggle="yes">Z</italic>-scores are listed in <xref rid="sup1" ref-type="supplementary-material">Supplementary Table S3</xref>.</p>
      <p>Our collocation analyses revealed many well-known, cancer-specific master regulators (<xref rid="sup1" ref-type="supplementary-material">Supplementary Fig. S3</xref> and <xref rid="sup1" ref-type="supplementary-material">Supplementary Tables S3 and S4</xref>). For example, GATA3, ESR1, and TRPS1 were identified as the three leading master regulators in breast cancer (<xref rid="vbad104-F2" ref-type="fig">Fig. 2A</xref>). The implications of these TFs with breast cancer are reported by numerous studies (<xref rid="vbad104-B44" ref-type="bibr">Witwicki <italic toggle="yes">et al.</italic> 2018</xref>, <xref rid="vbad104-B11" ref-type="bibr">Dustin <italic toggle="yes">et al.</italic> 2019</xref>, <xref rid="vbad104-B2" ref-type="bibr">Brett <italic toggle="yes">et al.</italic> 2021</xref>, <xref rid="vbad104-B21" ref-type="bibr">Herzog and Fuqua 2022</xref>, <xref rid="vbad104-B32" ref-type="bibr">Parkinson <italic toggle="yes">et al.</italic> 2022</xref>, <xref rid="vbad104-B45" ref-type="bibr">Yoon <italic toggle="yes">et al.</italic> 2022</xref>). AR, HOXB13, and TLE3 were identified as the top three master regulators in prostate cancer (<xref rid="vbad104-F2" ref-type="fig">Fig. 2B</xref>), which is also in line with previous findings (<xref rid="vbad104-B20" ref-type="bibr">Heinlein and Chang 2004</xref>, <xref rid="vbad104-B31" ref-type="bibr">Palit <italic toggle="yes">et al.</italic> 2019</xref>, <xref rid="vbad104-B23" ref-type="bibr">Jamroze <italic toggle="yes">et al.</italic> 2021</xref>, <xref rid="vbad104-B9" ref-type="bibr">Darst <italic toggle="yes">et al.</italic> 2022</xref>, <xref rid="vbad104-B27" ref-type="bibr">Lu <italic toggle="yes">et al.</italic> 2022</xref>). SOX10, a key nuclear TF involved in differentiating neural crest progenitor cells into melanocytes, was recognized as the top master regulator in Skin Cutaneous Melanoma (SKCM) (<xref rid="vbad104-B37" ref-type="bibr">Rosenbaum <italic toggle="yes">et al.</italic> 2021</xref>, <xref rid="vbad104-B3" ref-type="bibr">Capparelli <italic toggle="yes">et al.</italic> 2022</xref>). CDX2, an intestine-specific TF that regulates intestinal development and oncogenesis, was found as the top master regulator in colon adenocarcinoma (COAD) (<xref rid="vbad104-B8" ref-type="bibr">Crissey <italic toggle="yes">et al.</italic> 2011</xref>, <xref rid="vbad104-B34" ref-type="bibr">Pilati <italic toggle="yes">et al.</italic> 2017</xref>, <xref rid="vbad104-B46" ref-type="bibr">Yu <italic toggle="yes">et al.</italic> 2019</xref>). Lung adenocarcinoma (LUAD) and lung squamous cell carcinoma (LUSC) are the most common subtypes of lung cancer. Although both LUAD and LUSC are classified as non-small cell lung cancer, they have drastically different biology, etiology, molecular characteristics, and clinical behavior. Our collocation analysis revealed that NKX2-1 (<xref rid="vbad104-B43" ref-type="bibr">Winslow <italic toggle="yes">et al.</italic> 2011</xref>, <xref rid="vbad104-B30" ref-type="bibr">Mollaoglu <italic toggle="yes">et al.</italic> 2018</xref>, <xref rid="vbad104-B33" ref-type="bibr">Phelps <italic toggle="yes">et al.</italic> 2018</xref>, <xref rid="vbad104-B22" ref-type="bibr">Ingram <italic toggle="yes">et al.</italic> 2022</xref>) and ASCL1 (<xref rid="vbad104-B24" ref-type="bibr">Kosari <italic toggle="yes">et al.</italic> 2014</xref>, <xref rid="vbad104-B1" ref-type="bibr">Baine <italic toggle="yes">et al.</italic> 2020</xref>) are the top regulators in LUAD, while TP63, TP73, SOX2, and TP53 are the top regulators in LUSC. In fact, we only observed one common TF, IRF4, which regulates transcription programs in immune cells, out of the 10 and 11 master regulators in LUAD and LUSC, respectively (<xref rid="vbad104-F2" ref-type="fig">Fig. 2C and D</xref>). LGG and GBM are two common brain tumor types. LGG is slow growing, has a better prognosis and response to treatment, and tends to recur less frequently. GBM, on the other hand, is more aggressive, has a poorer prognosis with a shorter overall survival rate and a higher recurrence rate. Our collocation analyses revealed 19 master regulators in LGG and 18 master regulators in GBM, of which 11 (NEUROG2, OLIG2, RARA, SOX2, SOX3, SOX8, SOX21, CHD7, MYOG, MYF5, FOXO1-PAX3) are shared (<xref rid="vbad104-F2" ref-type="fig">Fig. 2E and F</xref>). Of note, BMI1 was identified as one of the top master regulators in GBM but not in LGG, and numerous studies have revealed that BMI1 plays a significant role in promoting cell proliferation, inhibiting cell death, sustaining stem cell renewal, and activating signaling pathways, all of which contribute to the development, progression, and aggressiveness of GBMs (<xref rid="vbad104-B40" ref-type="bibr">Venugopal <italic toggle="yes">et al.</italic> 2012</xref>, <xref rid="vbad104-B41" ref-type="bibr">Vora <italic toggle="yes">et al.</italic> 2019</xref>, <xref rid="vbad104-B13" ref-type="bibr">Flamier <italic toggle="yes">et al.</italic> 2020</xref>, <xref rid="vbad104-B14" ref-type="bibr">Freire-Benéitez <italic toggle="yes">et al.</italic> 2021</xref>). In summary, our analyses suggested that collocation analyses of cancer-specific OCRs with TFBS can provide valuable information for understanding the molecular mechanisms that drive cancer development and identify biomarkers for cancer diagnosis, prognosis, and treatment.</p>
      <fig position="float" id="vbad104-F2">
        <label>Figure 2.</label>
        <caption>
          <p>Evaluation of the collocation metrics implemented in cobind using cancer-specific OCRs identified from ATAC-seq data. (A) Candidate master regulators identified from breast cancer-specific OCRs. (B) Candidate master regulators identified from prostate cancer-specific OCRs. (C) Candidate master regulators identified from LUAD- and LUSC-specific OCRs. (D) Venn diagram shows the overlap of master regulators identified from LUAD and LUSC. (E) Candidate master regulators identified from LGG and GBM. (F) Venn diagram shows the overlap of master regulators identified in LGG and GBM.</p>
        </caption>
        <graphic xlink:href="vbad104f2" position="float"/>
      </fig>
    </sec>
    <sec>
      <title>3.4 Identify the master regulators co-localized with oligodendrocyte-specific open chromatin</title>
      <p>In a study profiling the chromatin accessibility of more than 70 000 human adult brain cells, <xref rid="vbad104-B7" ref-type="bibr">Corces <italic toggle="yes">et al.</italic> (2020)</xref> discovered six major cell types, including oligodendrocytes, excitatory neurons, inhibitory neurons, microglia, astrocytes, and oligodendrocyte progenitor cells, of which oligodendrocytes is the largest cell population. To identify putative master regulators responsible for establishing and maintaining cell type-specific regulatory programs, the authors performed DNA motif enrichment analyses on scATAC-seq peak regions specific to oligodendrocytes. They found that SOX9, SOX10, and FOXN2 DNA motifs were significantly enriched in the oligodendrocytes OCRs (<xref rid="vbad104-B7" ref-type="bibr">Corces <italic toggle="yes">et al.</italic> 2020</xref>).</p>
      <p>Aiming to identify the master regulators in oligodendrocytes, we used the cobind package to conduct the collocation analysis between oligodendrocyte-specific OCRs and the binding sites of 1208 TFs (<xref rid="sup1" ref-type="supplementary-material">Supplementary Table S5</xref>). Our methods revealed seven TFs (SOX10, OLIG2, SOX8, SOX2, ZNF654, ZBTB2, and SOX21) that were significantly collocated with oligodendrocyte-specific <italic toggle="yes">cis</italic>-regulatory regions (<xref rid="vbad104-F3" ref-type="fig">Fig. 3A</xref> and <xref rid="sup1" ref-type="supplementary-material">Supplementary Fig. S4</xref>), among which SOX10 and oligodendrocyte TF 2 (OLIG2) had the highest <italic toggle="yes">Z</italic>-scores (<xref rid="vbad104-F3" ref-type="fig">Fig. 3B</xref>), suggesting that they are master regulators of oligodendrocytes. To independently validate these results, we examined the snRNA-seq expression data generated from the human cortex and primary motor cortex region (M1) by the Allen Brain Map project (<ext-link xlink:href="https://portal.brain-map.org/" ext-link-type="uri">https://portal.brain-map.org/</ext-link>). Indeed, we observed that SOX10 and OLIG2 were expressed specifically in oligodendrocytes (<xref rid="vbad104-F3" ref-type="fig">Fig. 3C and D</xref>).</p>
      <fig position="float" id="vbad104-F3">
        <label>Figure 3.</label>
        <caption>
          <p>Evaluation of the collocation metrics implemented in cobind using oligodendrocytes-specific OCRs identified from scATAC-seq data. (A) Venn diagram shows the overlaps of the top 10 master regulators reported by <italic toggle="yes">C</italic>, <italic toggle="yes">J</italic>(SD), SS(PMI), and NPMI. <italic toggle="yes">J</italic> and SD, SS, and PMI were combined since the top 10 master regulators were the same. (B) Barplot shows the <italic toggle="yes">Z</italic>-scores of the seven master regulators reported by all six metrics. Venn diagram shows the overlap between the top three TFs identified by motif analysis (green circle) and the top two TFs identified by collocation analysis (red circle). (C) t-distributed stochastic neighbor embedding (tSNE)-based cell map shows that <italic toggle="yes">SOX10</italic> is specifically expressed in oligodendrocytes. Upper: <italic toggle="yes">SOX10</italic> expression in human primary motor cortex region (M1). Lower: <italic toggle="yes">SOX10</italic> expression in human cortex brain region. (D) tSNE-based cell map shows that <italic toggle="yes">OLIG2</italic> is specifically expressed in oligodendrocytes. Upper: <italic toggle="yes">OLIG2</italic> expression in the human primary motor cortex (M1) region. Lower: <italic toggle="yes">OLIG2</italic> expression in the human cortex brain region. UMI, unique molecular identifiers.</p>
        </caption>
        <graphic xlink:href="vbad104f3" position="float"/>
      </fig>
      <p>Among the three TFs (SOX10, SOX9, and FOXN2) reported by <xref rid="vbad104-B7" ref-type="bibr">Corces <italic toggle="yes">et al.</italic> (2020)</xref> using the motif enrichment method, two (SOX9 and FOXN2) were not detected by our collocation analysis approach; SOX9 was ranked 89th by <italic toggle="yes">Z</italic>-score, while FOXN2 was not included in the ReMap database (<xref rid="sup1" ref-type="supplementary-material">Supplementary Table S5</xref>). snRNA-seq data show that SOX9 and FOXN2 genes were not explicitly expressed in oligodendrocytes, suggesting these two TFs are less likely to be master regulators (<xref rid="sup1" ref-type="supplementary-material">Supplementary Fig. S5</xref>). In contrast, OLIG2, which was missed by the motif enrichment analysis method, is explicitly expressed in both oligodendrocytes and oligodendrocyte progenitor cells (<xref rid="vbad104-F3" ref-type="fig">Fig. 3B and D</xref>) and has proven to play an imperative role in promoting oligodendrocyte differentiation (<xref rid="vbad104-B39" ref-type="bibr">Takebayashi <italic toggle="yes">et al.</italic> 2000</xref>, <xref rid="vbad104-B50" ref-type="bibr">Zhou <italic toggle="yes">et al.</italic> 2001</xref>, <xref rid="vbad104-B47" ref-type="bibr">Yu <italic toggle="yes">et al.</italic> 2013</xref>). These results highlighted that collocation analysis is a more robust approach to revealing key TFs that might be missed by motif analysis.</p>
    </sec>
  </sec>
  <sec>
    <title>4 Summary and discussion</title>
    <p>The metrics implemented in the cobind package (except the collocation coefficient) have been widely utilized in the Natural Language Processing field to determine if two words occur more frequently than expected by chance. However, in the genomics field, only the Jaccard coefficient has been adopted by BEDTools to measure the overlaps between two BED files. It is worth noting that there is a slight difference in the calculation of the Jaccard coefficient between cobind and BEDTools. Cobind considers every input genomic interval, regardless of overlap, while BEDTools only consider intervals that exhibit overlap.</p>
    <p>Motif analysis, a computational approach to identify overrepresented short-nucleotide patterns, has been extensively applied to identify common regulators from a given set of genomic intervals. Although DNA motif analysis can provide valuable insights, it is prone to false positives and false negatives since most TFs only bind less than a few percent of their consensus target sites in the genome (<xref rid="vbad104-B48" ref-type="bibr">Zaret and Carroll 2011</xref>). In our study, we demonstrated that collocation analysis successfully identified a known master regulator in oligodendrocytes, OLIG2, which was not detected by motif analysis. This result highlights the collocation analysis’s potential as a more effective alternative to motif analysis. However, collocation analysis necessitates a comprehensive list of well-annotated <italic toggle="yes">cis</italic>-regulatory sites. Fortunately, public consortia such as ENCODE, modENCODE, Roadmap, and functional genomic repositories like GEO (<ext-link xlink:href="https://www.ncbi.nlm.nih.gov/geo/" ext-link-type="uri">https://www.ncbi.nlm.nih.gov/geo/</ext-link>) offer rich resources encompassing a wide range of TFs from numerous tissues and cell lines.</p>
    <p>The cobind package is the first bioinformatics tool specifically designed for quantitative collocation analysis of genomic intervals. It is efficient in terms of speed and memory usage (<xref rid="sup1" ref-type="supplementary-material">Supplementary Table S6</xref>). This study demonstrated the significant potential of cobind in characterizing the functionalities of noncoding genomic regions, integrating multi-omics data, and gaining new biological insights. This potential is particularly relevant in the context of functional genomics assays such as scATAC-seq, which can reveal cell type-specific regulatory elements.</p>
  </sec>
  <sec sec-type="supplementary-material">
    <title>Supplementary Material</title>
    <supplementary-material id="sup1" position="float" content-type="local-data">
      <label>vbad104_Supplementary_Data</label>
      <media xlink:href="vbad104_supplementary_data.zip">
        <caption>
          <p>Click here for additional data file.</p>
        </caption>
      </media>
    </supplementary-material>
  </sec>
</body>
<back>
  <sec>
    <title>Author contributions</title>
    <p>Tao Ma (Data curation [lead], Formal analysis [lead], Validation [lead], Visualization [equal], Writing—original draft [equal], Writing—review &amp; editing [equal]), Lingyun Guo (Data curation [supporting], Formal analysis [supporting]), HuiHuang Yan (Writing—review &amp; editing [supporting]), and Liguo Wang (Conceptualization [lead], Data curation [lead], Formal analysis [lead], Funding acquisition [lead], Investigation [lead], Methodology [lead], Project administration [lead], Software [lead], Supervision [lead], Validation [lead], Visualization [lead], Writing—original draft [lead], Writing—review &amp; editing [lead])</p>
  </sec>
  <sec>
    <title>Supplementary data</title>
    <p><xref rid="sup1" ref-type="supplementary-material">Supplementary data</xref> are available at <italic toggle="yes">Bioinformatics Advances</italic> online.</p>
  </sec>
  <sec sec-type="COI-statement">
    <title>Conflict of interest</title>
    <p>None declared.</p>
  </sec>
  <sec>
    <title>Funding</title>
    <p>This work is partially supported by the US National Institute of Health [CA180882-07, CA130908-12, CA230712-4, and AA27179] and the epigenomics program of the Center for Individualized Medicine of Mayo Clinic.</p>
  </sec>
  <sec sec-type="data-availability">
    <title>Data availability</title>
    <p>The data underlying this article are available in the article and in its online <xref rid="sup1" ref-type="supplementary-material">supplementary material</xref>.</p>
  </sec>
  <ref-list id="ref1">
    <title>References</title>
    <ref id="vbad104-B1">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Baine</surname><given-names>MK</given-names></string-name>, <string-name><surname>Hsieh</surname><given-names>M-S</given-names></string-name>, <string-name><surname>Lai</surname><given-names>WV</given-names></string-name></person-group><etal>et al</etal><article-title>SCLC subtypes defined by ASCL1, NEUROD1, POU2F3, and YAP1: a comprehensive immunohistochemical and histopathologic characterization</article-title>. <source>J Thorac Oncol</source><year>2020</year>;<volume>15</volume>:<fpage>1823</fpage>–<lpage>35</lpage>.<pub-id pub-id-type="pmid">33011388</pub-id></mixed-citation>
    </ref>
    <ref id="vbad104-B2">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Brett</surname><given-names>JO</given-names></string-name>, <string-name><surname>Spring</surname><given-names>LM</given-names></string-name>, <string-name><surname>Bardia</surname><given-names>A</given-names></string-name></person-group><etal>et al</etal><article-title>ESR1 mutation as an emerging clinical biomarker in metastatic hormone receptor-positive breast cancer</article-title>. <source>Breast Cancer Res</source><year>2021</year>;<volume>23</volume>:<fpage>85</fpage>.<pub-id pub-id-type="pmid">34392831</pub-id></mixed-citation>
    </ref>
    <ref id="vbad104-B3">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Capparelli</surname><given-names>C</given-names></string-name>, <string-name><surname>Purwin</surname><given-names>TJ</given-names></string-name>, <string-name><surname>Glasheen</surname><given-names>M</given-names></string-name></person-group><etal>et al</etal><article-title>Targeting SOX10-deficient cells to reduce the dormant-invasive phenotype state in melanoma</article-title>. <source>Nat Commun</source><year>2022</year>;<volume>13</volume>:<fpage>1381</fpage>.<pub-id pub-id-type="pmid">35296667</pub-id></mixed-citation>
    </ref>
    <ref id="vbad104-B4">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Cattoglio</surname><given-names>C</given-names></string-name>, <string-name><surname>Pustova</surname><given-names>I</given-names></string-name>, <string-name><surname>Walther</surname><given-names>N</given-names></string-name></person-group><etal>et al</etal><article-title>Determining cellular CTCF and cohesin abundances to constrain 3D genome models</article-title>. <source>Elife</source><year>2019</year>;<volume>8</volume>:e40164.</mixed-citation>
    </ref>
    <ref id="vbad104-B5">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Chen</surname><given-names>F</given-names></string-name>, <string-name><surname>Li</surname><given-names>G</given-names></string-name>, <string-name><surname>Zhang</surname><given-names>MQ</given-names></string-name></person-group><etal>et al</etal><article-title>HiCDB: a sensitive and robust method for detecting contact domain boundaries</article-title>. <source>Nucleic Acids Res</source><year>2018</year>;<volume>46</volume>:<fpage>11239</fpage>–<lpage>50</lpage>.<pub-id pub-id-type="pmid">30184171</pub-id></mixed-citation>
    </ref>
    <ref id="vbad104-B6">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Corces</surname><given-names>MR</given-names></string-name>, <string-name><surname>Granja</surname><given-names>JM</given-names></string-name>, <string-name><surname>Shams</surname><given-names>S</given-names></string-name></person-group><etal>et al</etal>; <collab>Cancer Genome Atlas Analysis Network</collab>. <article-title>The chromatin accessibility landscape of primary human cancers</article-title>. <source>Science</source><year>2018</year>;<volume>362</volume>:<fpage>6413</fpage>.</mixed-citation>
    </ref>
    <ref id="vbad104-B7">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Corces</surname><given-names>MR</given-names></string-name>, <string-name><surname>Shcherbina</surname><given-names>A</given-names></string-name>, <string-name><surname>Kundu</surname><given-names>S</given-names></string-name></person-group><etal>et al</etal><article-title>Single-cell epigenomic analyses implicate candidate causal variants at inherited risk loci for Alzheimer’s and Parkinson’s diseases</article-title>. <source>Nat Genet</source><year>2020</year>;<volume>52</volume>:<fpage>1158</fpage>–<lpage>68</lpage>.<pub-id pub-id-type="pmid">33106633</pub-id></mixed-citation>
    </ref>
    <ref id="vbad104-B8">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Crissey</surname><given-names>MAS</given-names></string-name>, <string-name><surname>Guo</surname><given-names>R-J</given-names></string-name>, <string-name><surname>Funakoshi</surname><given-names>S</given-names></string-name></person-group><etal>et al</etal><article-title>Cdx2 levels modulate intestinal epithelium maturity and Paneth cell development</article-title>. <source>Gastroenterology</source><year>2011</year>;<volume>140</volume>:<fpage>517</fpage>–<lpage>28 e518</lpage>.<pub-id pub-id-type="pmid">21081128</pub-id></mixed-citation>
    </ref>
    <ref id="vbad104-B9">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Darst</surname><given-names>BF</given-names></string-name>, <string-name><surname>Hughley</surname><given-names>R</given-names></string-name>, <string-name><surname>Pfennig</surname><given-names>A</given-names></string-name></person-group><etal>et al</etal><article-title>A rare germline HOXB13 variant contributes to risk of prostate cancer in men of African ancestry</article-title>. <source>Eur Urol</source><year>2022</year>;<volume>81</volume>:<fpage>458</fpage>–<lpage>62</lpage>.<pub-id pub-id-type="pmid">35031163</pub-id></mixed-citation>
    </ref>
    <ref id="vbad104-B10">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Di Pierro</surname><given-names>M</given-names></string-name>, <string-name><surname>Cheng</surname><given-names>RR</given-names></string-name>, <string-name><surname>Lieberman Aiden</surname><given-names>E</given-names></string-name></person-group><etal>et al</etal><article-title>De novo prediction of human chromosome structures: epigenetic marking patterns encode genome architecture</article-title>. <source>Proc Natl Acad Sci USA</source><year>2017</year>;<volume>114</volume>:<fpage>12126</fpage>–<lpage>31</lpage>.<pub-id pub-id-type="pmid">29087948</pub-id></mixed-citation>
    </ref>
    <ref id="vbad104-B11">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Dustin</surname><given-names>D</given-names></string-name>, <string-name><surname>Gu</surname><given-names>G</given-names></string-name>, <string-name><surname>Fuqua</surname><given-names>SAW</given-names></string-name></person-group><etal>et al</etal><article-title>ESR1 mutations in breast cancer</article-title>. <source>Cancer</source><year>2019</year>;<volume>125</volume>:<fpage>3714</fpage>–<lpage>28</lpage>.<pub-id pub-id-type="pmid">31318440</pub-id></mixed-citation>
    </ref>
    <ref id="vbad104-B12">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Ferré</surname><given-names>Q</given-names></string-name>, <string-name><surname>Charbonnier</surname><given-names>G</given-names></string-name>, <string-name><surname>Sadouni</surname><given-names>N</given-names></string-name></person-group><etal>et al</etal><article-title>OLOGRAM: determining significance of total overlap length between genomic regions sets</article-title>. <source>Bioinformatics</source><year>2020</year>;<volume>36</volume>:<fpage>1920</fpage>–<lpage>2</lpage>.</mixed-citation>
    </ref>
    <ref id="vbad104-B13">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Flamier</surname><given-names>A</given-names></string-name>, <string-name><surname>Abdouh</surname><given-names>M</given-names></string-name>, <string-name><surname>Hamam</surname><given-names>R</given-names></string-name></person-group><etal>et al</etal><article-title>Off-target effect of the BMI1 inhibitor PTC596 drives epithelial-mesenchymal transition in glioblastoma multiforme</article-title>. <source>NPJ Precis Oncol</source><year>2020</year>;<volume>4</volume>:<fpage>1</fpage>.<pub-id pub-id-type="pmid">31934644</pub-id></mixed-citation>
    </ref>
    <ref id="vbad104-B14">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Freire-Benéitez</surname><given-names>V</given-names></string-name>, <string-name><surname>Pomella</surname><given-names>N</given-names></string-name>, <string-name><surname>Millner</surname><given-names>TO</given-names></string-name></person-group><etal>et al</etal><article-title>Elucidation of the BMI1 interactome identifies novel regulatory roles in glioblastoma</article-title>. <source>NAR Cancer</source><year>2021</year>;<volume>3</volume>:zcab009.</mixed-citation>
    </ref>
    <ref id="vbad104-B15">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Gabriele</surname><given-names>M</given-names></string-name>, <string-name><surname>Brandão</surname><given-names>HB</given-names></string-name>, <string-name><surname>Grosse-Holz</surname><given-names>S</given-names></string-name></person-group><etal>et al</etal><article-title>Dynamics of CTCF- and cohesin-mediated chromatin looping revealed by live-cell imaging</article-title>. <source>Science</source><year>2022</year>;<volume>376</volume>:<fpage>496</fpage>–<lpage>501</lpage>.<pub-id pub-id-type="pmid">35420890</pub-id></mixed-citation>
    </ref>
    <ref id="vbad104-B16">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Haiminen</surname><given-names>N</given-names></string-name>, <string-name><surname>Mannila</surname><given-names>H</given-names></string-name>, <string-name><surname>Terzi</surname><given-names>E</given-names></string-name></person-group><etal>et al</etal><article-title>Determining significance of pairwise co-occurrences of events in bursty sequences</article-title>. <source>BMC Bioinformatics</source><year>2008</year>;<volume>9</volume>:<fpage>336</fpage>.<pub-id pub-id-type="pmid">18691400</pub-id></mixed-citation>
    </ref>
    <ref id="vbad104-B17">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Hammal</surname><given-names>F</given-names></string-name>, <string-name><surname>de Langen</surname><given-names>P</given-names></string-name>, <string-name><surname>Bergon</surname><given-names>A</given-names></string-name></person-group><etal>et al</etal><article-title>ReMap 2022: a database of human, mouse, drosophila and Arabidopsis regulatory regions from an integrative analysis of DNA-binding sequencing experiments</article-title>. <source>Nucleic Acids Res</source><year>2022</year>;<volume>50</volume>:<fpage>D316</fpage>–<lpage>25</lpage>.<pub-id pub-id-type="pmid">34751401</pub-id></mixed-citation>
    </ref>
    <ref id="vbad104-B18">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Hansen</surname><given-names>AS</given-names></string-name>, <string-name><surname>Pustova</surname><given-names>I</given-names></string-name>, <string-name><surname>Cattoglio</surname><given-names>C</given-names></string-name></person-group><etal>et al</etal><article-title>CTCF and cohesin regulate chromatin loop stability with distinct dynamics</article-title>. <source>Elife</source><year>2017</year>;<volume>6</volume>:<fpage>e25776</fpage>.<pub-id pub-id-type="pmid">28467304</pub-id></mixed-citation>
    </ref>
    <ref id="vbad104-B19">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Hänzelmann</surname><given-names>S</given-names></string-name>, <string-name><surname>Castelo</surname><given-names>R</given-names></string-name>, <string-name><surname>Guinney</surname><given-names>J</given-names></string-name></person-group><etal>et al</etal><article-title>GSVA: gene set variation analysis for microarray and RNA-seq data</article-title>. <source>BMC Bioinformatics</source><year>2013</year>;<volume>14</volume>:<fpage>7</fpage>.<pub-id pub-id-type="pmid">23323831</pub-id></mixed-citation>
    </ref>
    <ref id="vbad104-B20">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Heinlein</surname><given-names>CA</given-names></string-name>, <string-name><surname>Chang</surname><given-names>C.</given-names></string-name></person-group><article-title>Androgen receptor in prostate cancer</article-title>. <source>Endocr Rev</source><year>2004</year>;<volume>25</volume>:<fpage>276</fpage>–<lpage>308</lpage>.<pub-id pub-id-type="pmid">15082523</pub-id></mixed-citation>
    </ref>
    <ref id="vbad104-B21">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Herzog</surname><given-names>SK</given-names></string-name>, <string-name><surname>Fuqua</surname><given-names>SAW.</given-names></string-name></person-group><article-title>ESR1 mutations and therapeutic resistance in metastatic breast cancer: progress and remaining challenges</article-title>. <source>Br J Cancer</source><year>2022</year>;<volume>126</volume>:<fpage>174</fpage>–<lpage>86</lpage>.<pub-id pub-id-type="pmid">34621045</pub-id></mixed-citation>
    </ref>
    <ref id="vbad104-B22">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Ingram</surname><given-names>K</given-names></string-name>, <string-name><surname>Samson</surname><given-names>SC</given-names></string-name>, <string-name><surname>Zewdu</surname><given-names>R</given-names></string-name></person-group><etal>et al</etal><article-title>NKX2-1 controls lung cancer progression by inducing DUSP6 to dampen ERK activity</article-title>. <source>Oncogene</source><year>2022</year>;<volume>41</volume>:<fpage>293</fpage>–<lpage>300</lpage>.<pub-id pub-id-type="pmid">34689179</pub-id></mixed-citation>
    </ref>
    <ref id="vbad104-B23">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Jamroze</surname><given-names>A</given-names></string-name>, <string-name><surname>Chatta</surname><given-names>G</given-names></string-name>, <string-name><surname>Tang</surname><given-names>DG</given-names></string-name></person-group><etal>et al</etal><article-title>Androgen receptor (AR) heterogeneity in prostate cancer and therapy resistance</article-title>. <source>Cancer Lett</source><year>2021</year>;<volume>518</volume>:<fpage>1</fpage>–<lpage>9</lpage>.<pub-id pub-id-type="pmid">34118355</pub-id></mixed-citation>
    </ref>
    <ref id="vbad104-B24">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Kosari</surname><given-names>F</given-names></string-name>, <string-name><surname>Ida</surname><given-names>CM</given-names></string-name>, <string-name><surname>Aubry</surname><given-names>M-C</given-names></string-name></person-group><etal>et al</etal><article-title>ASCL1 and RET expression defines a clinically relevant subgroup of lung adenocarcinoma characterized by neuroendocrine differentiation</article-title>. <source>Oncogene</source><year>2014</year>;<volume>33</volume>:<fpage>3776</fpage>–<lpage>83</lpage>.<pub-id pub-id-type="pmid">24037524</pub-id></mixed-citation>
    </ref>
    <ref id="vbad104-B25">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Layer</surname><given-names>RM</given-names></string-name>, <string-name><surname>Pedersen</surname><given-names>BS</given-names></string-name>, <string-name><surname>DiSera</surname><given-names>T</given-names></string-name></person-group><etal>et al</etal><article-title>GIGGLE: a search engine for large-scale integrated genome analysis</article-title>. <source>Nat Methods</source><year>2018</year>;<volume>15</volume>:<fpage>123</fpage>–<lpage>6</lpage>.<pub-id pub-id-type="pmid">29309061</pub-id></mixed-citation>
    </ref>
    <ref id="vbad104-B26">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Li</surname><given-names>Y</given-names></string-name>, <string-name><surname>Haarhuis</surname><given-names>JHI</given-names></string-name>, <string-name><surname>Sedeño Cacciatore</surname><given-names>Á</given-names></string-name></person-group><etal>et al</etal><article-title>The structural basis for cohesin-CTCF-anchored loops</article-title>. <source>Nature</source><year>2020</year>;<volume>578</volume>:<fpage>472</fpage>–<lpage>6</lpage>.<pub-id pub-id-type="pmid">31905366</pub-id></mixed-citation>
    </ref>
    <ref id="vbad104-B27">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Lu</surname><given-names>X</given-names></string-name>, <string-name><surname>Fong</surname><given-names>K-W</given-names></string-name>, <string-name><surname>Gritsina</surname><given-names>G</given-names></string-name></person-group><etal>et al</etal><article-title>HOXB13 suppresses de novo lipogenesis through HDAC3-mediated epigenetic reprogramming in prostate cancer</article-title>. <source>Nat Genet</source><year>2022</year>;<volume>54</volume>:<fpage>670</fpage>–<lpage>83</lpage>.<pub-id pub-id-type="pmid">35468964</pub-id></mixed-citation>
    </ref>
    <ref id="vbad104-B28">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Lupien</surname><given-names>M</given-names></string-name>, <string-name><surname>Eeckhoute</surname><given-names>J</given-names></string-name>, <string-name><surname>Meyer</surname><given-names>CA</given-names></string-name></person-group><etal>et al</etal><article-title>FoxA1 translates epigenetic signatures into enhancer-driven lineage-specific transcription</article-title>. <source>Cell</source><year>2008</year>;<volume>132</volume>:<fpage>958</fpage>–<lpage>70</lpage>.<pub-id pub-id-type="pmid">18358809</pub-id></mixed-citation>
    </ref>
    <ref id="vbad104-B29">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Mach</surname><given-names>P</given-names></string-name>, <string-name><surname>Kos</surname><given-names>PI</given-names></string-name>, <string-name><surname>Zhan</surname><given-names>Y</given-names></string-name></person-group><etal>et al</etal><article-title>Cohesin and CTCF control the dynamics of chromosome folding</article-title>. <source>Nat Genet</source><year>2022</year>;<volume>54</volume>:<fpage>1907</fpage>–<lpage>18</lpage>.<pub-id pub-id-type="pmid">36471076</pub-id></mixed-citation>
    </ref>
    <ref id="vbad104-B30">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Mollaoglu</surname><given-names>G</given-names></string-name>, <string-name><surname>Jones</surname><given-names>A</given-names></string-name>, <string-name><surname>Wait</surname><given-names>SJ</given-names></string-name></person-group><etal>et al</etal><article-title>The lineage-defining transcription factors SOX2 and NKX2-1 determine lung cancer cell fate and shape the tumor immune microenvironment</article-title>. <source>Immunity</source><year>2018</year>;<volume>49</volume>:<fpage>764</fpage>–<lpage>79</lpage> e769.<pub-id pub-id-type="pmid">30332632</pub-id></mixed-citation>
    </ref>
    <ref id="vbad104-B31">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Palit</surname><given-names>SA</given-names></string-name>, <string-name><surname>Vis</surname><given-names>D</given-names></string-name>, <string-name><surname>Stelloo</surname><given-names>S</given-names></string-name></person-group><etal>et al</etal><article-title>TLE3 loss confers AR inhibitor resistance by facilitating GR-mediated human prostate cancer cell growth</article-title>. <source>Elife</source><year>2019</year>;<volume>8</volume>:e47430.</mixed-citation>
    </ref>
    <ref id="vbad104-B32">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Parkinson</surname><given-names>B</given-names></string-name>, <string-name><surname>Chen</surname><given-names>W</given-names></string-name>, <string-name><surname>Shen</surname><given-names>T</given-names></string-name></person-group><etal>et al</etal><article-title>TRPS1 expression in breast carcinomas: focusing on metaplastic breast carcinomas</article-title>. <source>Am J Surg Pathol</source><year>2022</year>;<volume>46</volume>:<fpage>415</fpage>–<lpage>23</lpage>.<pub-id pub-id-type="pmid">35175968</pub-id></mixed-citation>
    </ref>
    <ref id="vbad104-B33">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Phelps</surname><given-names>CA</given-names></string-name>, <string-name><surname>Lai</surname><given-names>SC</given-names></string-name>, <string-name><surname>Mu</surname><given-names>D</given-names></string-name></person-group><etal>et al</etal><article-title>Roles of thyroid transcription factor 1 in lung cancer biology</article-title>. <source>Vitam Horm</source><year>2018</year>;<volume>106</volume>:<fpage>517</fpage>–<lpage>44</lpage>.<pub-id pub-id-type="pmid">29407447</pub-id></mixed-citation>
    </ref>
    <ref id="vbad104-B34">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Pilati</surname><given-names>C</given-names></string-name>, <string-name><surname>Taieb</surname><given-names>J</given-names></string-name>, <string-name><surname>Balogoun</surname><given-names>R</given-names></string-name></person-group><etal>et al</etal><article-title>CDX2 prognostic value in stage II/III resected Colon cancer is related to CMS classification</article-title>. <source>Ann Oncol</source><year>2017</year>;<volume>28</volume>:<fpage>1032</fpage>–<lpage>5</lpage>.<pub-id pub-id-type="pmid">28328000</pub-id></mixed-citation>
    </ref>
    <ref id="vbad104-B35">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Pugacheva</surname><given-names>EM</given-names></string-name>, <string-name><surname>Kubo</surname><given-names>N</given-names></string-name>, <string-name><surname>Loukinov</surname><given-names>D</given-names></string-name></person-group><etal>et al</etal><article-title>CTCF mediates chromatin looping via N-terminal domain-dependent cohesin retention</article-title>. <source>Proc Natl Acad Sci USA</source><year>2020</year>;<volume>117</volume>:<fpage>2020</fpage>–<lpage>31</lpage>.<pub-id pub-id-type="pmid">31937660</pub-id></mixed-citation>
    </ref>
    <ref id="vbad104-B36">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Quinlan</surname><given-names>AR</given-names></string-name>, <string-name><surname>Hall</surname><given-names>IM.</given-names></string-name></person-group><article-title>BEDTools: a flexible suite of utilities for comparing genomic features</article-title>. <source>Bioinformatics</source><year>2010</year>;<volume>26</volume>:<fpage>841</fpage>–<lpage>2</lpage>.<pub-id pub-id-type="pmid">20110278</pub-id></mixed-citation>
    </ref>
    <ref id="vbad104-B37">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Rosenbaum</surname><given-names>SR</given-names></string-name>, <string-name><surname>Tiago</surname><given-names>M</given-names></string-name>, <string-name><surname>Caksa</surname><given-names>S</given-names></string-name></person-group><etal>et al</etal><article-title>SOX10 requirement for melanoma tumor growth is due, in part, to immune-mediated effects</article-title>. <source>Cell Rep</source><year>2021</year>;<volume>37</volume>:<fpage>110085</fpage>.<pub-id pub-id-type="pmid">34879275</pub-id></mixed-citation>
    </ref>
    <ref id="vbad104-B38">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Sheffield</surname><given-names>NC</given-names></string-name>, <string-name><surname>Bock</surname><given-names>C.</given-names></string-name></person-group><article-title>LOLA: enrichment analysis for genomic region sets and regulatory elements in R and bioconductor</article-title>. <source>Bioinformatics</source><year>2016</year>;<volume>32</volume>:<fpage>587</fpage>–<lpage>9</lpage>.<pub-id pub-id-type="pmid">26508757</pub-id></mixed-citation>
    </ref>
    <ref id="vbad104-B39">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Takebayashi</surname><given-names>H</given-names></string-name>, <string-name><surname>Yoshida</surname><given-names>S</given-names></string-name>, <string-name><surname>Sugimori</surname><given-names>M</given-names></string-name></person-group><etal>et al</etal><article-title>Dynamic expression of basic helix–loop–helix olig family members: implication of Olig2 in neuron and oligodendrocyte differentiation and identification of a new member, Olig3</article-title>. <source>Mech Dev</source><year>2000</year>;<volume>99</volume>:<fpage>143</fpage>–<lpage>8</lpage>.<pub-id pub-id-type="pmid">11091082</pub-id></mixed-citation>
    </ref>
    <ref id="vbad104-B40">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Venugopal</surname><given-names>C</given-names></string-name>, <string-name><surname>Li</surname><given-names>N</given-names></string-name>, <string-name><surname>Wang</surname><given-names>X</given-names></string-name></person-group><etal>et al</etal><article-title>Bmi1 marks intermediate precursors during differentiation of human brain tumor initiating cells</article-title>. <source>Stem Cell Res</source><year>2012</year>;<volume>8</volume>:<fpage>141</fpage>–<lpage>53</lpage>.<pub-id pub-id-type="pmid">22265735</pub-id></mixed-citation>
    </ref>
    <ref id="vbad104-B41">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Vora</surname><given-names>P</given-names></string-name>, <string-name><surname>Seyfrid</surname><given-names>M</given-names></string-name>, <string-name><surname>Venugopal</surname><given-names>C</given-names></string-name></person-group><etal>et al</etal><article-title>Bmi1 regulates human glioblastoma stem cells through activation of differential gene networks in CD133+ brain tumor initiating cells</article-title>. <source>J Neurooncol</source><year>2019</year>;<volume>143</volume>:<fpage>417</fpage>–<lpage>28</lpage>.<pub-id pub-id-type="pmid">31115870</pub-id></mixed-citation>
    </ref>
    <ref id="vbad104-B42">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Weintraub</surname><given-names>AS</given-names></string-name>, <string-name><surname>Li</surname><given-names>CH</given-names></string-name>, <string-name><surname>Zamudio</surname><given-names>AV</given-names></string-name></person-group><etal>et al</etal><article-title>YY1 is a structural regulator of enhancer-promoter loops</article-title>. <source>Cell</source><year>2017</year>;<volume>171</volume>:<fpage>1573</fpage>–<lpage>88 e1528</lpage>.<pub-id pub-id-type="pmid">29224777</pub-id></mixed-citation>
    </ref>
    <ref id="vbad104-B43">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Winslow</surname><given-names>MM</given-names></string-name>, <string-name><surname>Dayton</surname><given-names>TL</given-names></string-name>, <string-name><surname>Verhaak</surname><given-names>RGW</given-names></string-name></person-group><etal>et al</etal><article-title>Suppression of lung adenocarcinoma progression by Nkx2-1</article-title>. <source>Nature</source><year>2011</year>;<volume>473</volume>:<fpage>101</fpage>–<lpage>4</lpage>.<pub-id pub-id-type="pmid">21471965</pub-id></mixed-citation>
    </ref>
    <ref id="vbad104-B44">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Witwicki</surname><given-names>RM</given-names></string-name>, <string-name><surname>Ekram</surname><given-names>MB</given-names></string-name>, <string-name><surname>Qiu</surname><given-names>X</given-names></string-name></person-group><etal>et al</etal><article-title>TRPS1 is a lineage-specific transcriptional dependency in breast cancer</article-title>. <source>Cell Rep</source><year>2018</year>;<volume>25</volume>:<fpage>1255</fpage>–<lpage>67 e1255</lpage>.<pub-id pub-id-type="pmid">30380416</pub-id></mixed-citation>
    </ref>
    <ref id="vbad104-B45">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Yoon</surname><given-names>EC</given-names></string-name>, <string-name><surname>Wang</surname><given-names>G</given-names></string-name>, <string-name><surname>Parkinson</surname><given-names>B</given-names></string-name></person-group><etal>et al</etal><article-title>TRPS1, GATA3, and SOX10 expression in triple-negative breast carcinoma</article-title>. <source>Hum Pathol</source><year>2022</year>;<volume>125</volume>:<fpage>97</fpage>–<lpage>107</lpage>.<pub-id pub-id-type="pmid">35413381</pub-id></mixed-citation>
    </ref>
    <ref id="vbad104-B46">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Yu</surname><given-names>J</given-names></string-name>, <string-name><surname>Liu</surname><given-names>D</given-names></string-name>, <string-name><surname>Sun</surname><given-names>X</given-names></string-name></person-group><etal>et al</etal><article-title>CDX2 inhibits the proliferation and tumor formation of Colon cancer cells by suppressing wnt/beta-catenin signaling via transactivation of GSK-3beta and Axin2 expression</article-title>. <source>Cell Death Dis</source><year>2019</year>;<volume>10</volume>:<fpage>26</fpage>.<pub-id pub-id-type="pmid">30631044</pub-id></mixed-citation>
    </ref>
    <ref id="vbad104-B47">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Yu</surname><given-names>Y</given-names></string-name>, <string-name><surname>Chen</surname><given-names>Y</given-names></string-name>, <string-name><surname>Kim</surname><given-names>B</given-names></string-name></person-group><etal>et al</etal><article-title>Olig2 targets chromatin remodelers to enhancers to initiate oligodendrocyte differentiation</article-title>. <source>Cell</source><year>2013</year>;<volume>152</volume>:<fpage>248</fpage>–<lpage>61</lpage>.<pub-id pub-id-type="pmid">23332759</pub-id></mixed-citation>
    </ref>
    <ref id="vbad104-B48">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Zaret</surname><given-names>KS</given-names></string-name>, <string-name><surname>Carroll</surname><given-names>JS.</given-names></string-name></person-group><article-title>Pioneer transcription factors: establishing competence for gene expression</article-title>. <source>Genes Dev</source><year>2011</year>;<volume>25</volume>:<fpage>2227</fpage>–<lpage>41</lpage>.<pub-id pub-id-type="pmid">22056668</pub-id></mixed-citation>
    </ref>
    <ref id="vbad104-B49">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Zhang</surname><given-names>Y</given-names></string-name>, <string-name><surname>Blanchette</surname><given-names>M.</given-names></string-name></person-group><article-title>Reference panel guided topological structure annotation of Hi-C data</article-title>. <source>Nat Commun</source><year>2022</year>;<volume>13</volume>:<fpage>7426</fpage>.<pub-id pub-id-type="pmid">36460680</pub-id></mixed-citation>
    </ref>
    <ref id="vbad104-B50">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Zhou</surname><given-names>Q</given-names></string-name>, <string-name><surname>Choi</surname><given-names>G</given-names></string-name>, <string-name><surname>Anderson</surname><given-names>DJ</given-names></string-name></person-group><etal>et al</etal><article-title>The bHLH transcription factor Olig2 promotes oligodendrocyte differentiation in collaboration with Nkx2.2</article-title>. <source>Neuron</source><year>2001</year>;<volume>31</volume>:<fpage>791</fpage>–<lpage>807</lpage>.<pub-id pub-id-type="pmid">11567617</pub-id></mixed-citation>
    </ref>
  </ref-list>
</back>
<?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2 20190208//EN?>
<?DTDIdentifier.IdentifierType public?>
<?SourceDTD.DTDName JATS-journalpublishing1.dtd?>
<?SourceDTD.Version 1.2?>
<?ConverterInfo.XSLTName jats2jats3.xsl?>
<?ConverterInfo.Version 1?>
<?properties open_access?>
<processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats">
  <restricted-by>pmc</restricted-by>
</processing-meta>
<front>
  <journal-meta>
    <journal-id journal-id-type="nlm-ta">Bioinform Adv</journal-id>
    <journal-id journal-id-type="iso-abbrev">Bioinform Adv</journal-id>
    <journal-id journal-id-type="publisher-id">bioadv</journal-id>
    <journal-title-group>
      <journal-title>Bioinformatics Advances</journal-title>
    </journal-title-group>
    <issn pub-type="epub">2635-0041</issn>
    <publisher>
      <publisher-name>Oxford University Press</publisher-name>
    </publisher>
  </journal-meta>
  <article-meta>
    <article-id pub-id-type="pmcid">10438957</article-id>
    <article-id pub-id-type="doi">10.1093/bioadv/vbad104</article-id>
    <article-id pub-id-type="publisher-id">vbad104</article-id>
    <article-categories>
      <subj-group subj-group-type="heading">
        <subject>Original Article</subject>
        <subj-group subj-group-type="category-toc-heading">
          <subject>Genome Analysis</subject>
        </subj-group>
      </subj-group>
      <subj-group subj-group-type="category-taxonomy-collection">
        <subject>AcademicSubjects/SCI01060</subject>
      </subj-group>
    </article-categories>
    <title-group>
      <article-title>Cobind: quantitative analysis of the genomic overlaps</article-title>
    </title-group>
    <contrib-group>
      <contrib contrib-type="author">
        <name>
          <surname>Ma</surname>
          <given-names>Tao</given-names>
        </name>
        <role vocab="credit" vocab-identifier="http://credit.niso.org" vocab-term="Data curation" vocab-term-identifier="http://credit.niso.org/contributor-roles/data-curation" degree-contribution="lead">Data curation</role>
        <role vocab="credit" vocab-identifier="http://credit.niso.org" vocab-term="Formal analysis" vocab-term-identifier="http://credit.niso.org/contributor-roles/formal-analysis" degree-contribution="lead">Formal analysis</role>
        <role vocab="credit" vocab-identifier="http://credit.niso.org" vocab-term="Validation" vocab-term-identifier="http://credit.niso.org/contributor-roles/validation" degree-contribution="lead">Validation</role>
        <role vocab="credit" vocab-identifier="http://credit.niso.org" vocab-term="Visualization" vocab-term-identifier="http://credit.niso.org/contributor-roles/visualization" degree-contribution="equal">Visualization</role>
        <role vocab="credit" vocab-identifier="http://credit.niso.org" vocab-term="Writing - original draft" vocab-term-identifier="http://credit.niso.org/contributor-roles/writing-original-draft" degree-contribution="equal">Writing - original draft</role>
        <role vocab="credit" vocab-identifier="http://credit.niso.org" vocab-term="Writing - review &amp; editing" vocab-term-identifier="http://credit.niso.org/contributor-roles/writing-review-editing" degree-contribution="equal">Writing - review &amp; editing</role>
        <aff><institution>Division of Computational Biology, Mayo Clinic College of Medicine and Science</institution>, Rochester, MN 55905, <country country="US">United States</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Guo</surname>
          <given-names>Lingyun</given-names>
        </name>
        <role vocab="credit" vocab-identifier="http://credit.niso.org" vocab-term="Data curation" vocab-term-identifier="http://credit.niso.org/contributor-roles/data-curation" degree-contribution="supporting">Data curation</role>
        <role vocab="credit" vocab-identifier="http://credit.niso.org" vocab-term="Formal analysis" vocab-term-identifier="http://credit.niso.org/contributor-roles/formal-analysis" degree-contribution="supporting">Formal analysis</role>
        <aff><institution>Department of Computer Science and Engineering, University of Minnesota Twin Cities</institution>, Minneapolis, MN 55455, <country country="US">United States</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Yan</surname>
          <given-names>Huihuang</given-names>
        </name>
        <role vocab="credit" vocab-identifier="http://credit.niso.org" vocab-term="Writing - review &amp; editing" vocab-term-identifier="http://credit.niso.org/contributor-roles/writing-review-editing" degree-contribution="supporting">Writing - review &amp; editing</role>
        <aff><institution>Division of Computational Biology, Mayo Clinic College of Medicine and Science</institution>, Rochester, MN 55905, <country country="US">United States</country></aff>
      </contrib>
      <contrib contrib-type="author" corresp="yes">
        <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0003-2072-4826</contrib-id>
        <name>
          <surname>Wang</surname>
          <given-names>Liguo</given-names>
        </name>
        <role vocab="credit" vocab-identifier="http://credit.niso.org" vocab-term="Conceptualization" vocab-term-identifier="http://credit.niso.org/contributor-roles/conceptualization" degree-contribution="lead">Conceptualization</role>
        <role vocab="credit" vocab-identifier="http://credit.niso.org" vocab-term="Data curation" vocab-term-identifier="http://credit.niso.org/contributor-roles/data-curation" degree-contribution="lead">Data curation</role>
        <role vocab="credit" vocab-identifier="http://credit.niso.org" vocab-term="Formal analysis" vocab-term-identifier="http://credit.niso.org/contributor-roles/formal-analysis" degree-contribution="lead">Formal analysis</role>
        <role vocab="credit" vocab-identifier="http://credit.niso.org" vocab-term="Funding acquisition" vocab-term-identifier="http://credit.niso.org/contributor-roles/funding-acquisition" degree-contribution="lead">Funding acquisition</role>
        <role vocab="credit" vocab-identifier="http://credit.niso.org" vocab-term="Investigation" vocab-term-identifier="http://credit.niso.org/contributor-roles/investigation" degree-contribution="lead">Investigation</role>
        <role vocab="credit" vocab-identifier="http://credit.niso.org" vocab-term="Methodology" vocab-term-identifier="http://credit.niso.org/contributor-roles/methodology" degree-contribution="lead">Methodology</role>
        <role vocab="credit" vocab-identifier="http://credit.niso.org" vocab-term="Project administration" vocab-term-identifier="http://credit.niso.org/contributor-roles/project-administration" degree-contribution="lead">Project administration</role>
        <role vocab="credit" vocab-identifier="http://credit.niso.org" vocab-term="Software" vocab-term-identifier="http://credit.niso.org/contributor-roles/software" degree-contribution="lead">Software</role>
        <role vocab="credit" vocab-identifier="http://credit.niso.org" vocab-term="Supervision" vocab-term-identifier="http://credit.niso.org/contributor-roles/supervision" degree-contribution="lead">Supervision</role>
        <role vocab="credit" vocab-identifier="http://credit.niso.org" vocab-term="Validation" vocab-term-identifier="http://credit.niso.org/contributor-roles/validation" degree-contribution="lead">Validation</role>
        <role vocab="credit" vocab-identifier="http://credit.niso.org" vocab-term="Visualization" vocab-term-identifier="http://credit.niso.org/contributor-roles/visualization" degree-contribution="lead">Visualization</role>
        <role vocab="credit" vocab-identifier="http://credit.niso.org" vocab-term="Writing - original draft" vocab-term-identifier="http://credit.niso.org/contributor-roles/writing-original-draft" degree-contribution="lead">Writing - original draft</role>
        <role vocab="credit" vocab-identifier="http://credit.niso.org" vocab-term="Writing - review &amp; editing" vocab-term-identifier="http://credit.niso.org/contributor-roles/writing-review-editing" degree-contribution="lead">Writing - review &amp; editing</role>
        <aff><institution>Division of Computational Biology, Mayo Clinic College of Medicine and Science</institution>, Rochester, MN 55905, <country country="US">United States</country></aff>
        <aff><institution>Bioinformatics and Computational Biology Graduate Program, University of Minnesota Rochester</institution>, Rochester, MN 55904, <country country="US">United States</country></aff>
        <xref rid="vbad104-cor1" ref-type="corresp"/>
        <!--Wang.Liguo@mayo.edu-->
      </contrib>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name>
          <surname>Forslund</surname>
          <given-names>Sofia</given-names>
        </name>
        <role>Associate Editor</role>
      </contrib>
    </contrib-group>
    <author-notes>
      <corresp id="vbad104-cor1">Corresponding author. Division of Computational Biology, Mayo Clinic College of Medicine and Science, 200 1st St SW, Rochester, MN 55905, United States. E-mail: <email>Wang.Liguo@mayo.edu</email></corresp>
    </author-notes>
    <pub-date pub-type="collection">
      <year>2023</year>
    </pub-date>
    <pub-date pub-type="epub" iso-8601-date="2023-08-07">
      <day>07</day>
      <month>8</month>
      <year>2023</year>
    </pub-date>
    <pub-date pub-type="pmc-release">
      <day>07</day>
      <month>8</month>
      <year>2023</year>
    </pub-date>
    <volume>3</volume>
    <issue>1</issue>
    <elocation-id>vbad104</elocation-id>
    <history>
      <date date-type="received">
        <day>24</day>
        <month>5</month>
        <year>2023</year>
      </date>
      <date date-type="rev-recd">
        <day>17</day>
        <month>7</month>
        <year>2023</year>
      </date>
      <date date-type="editorial-decision">
        <day>20</day>
        <month>7</month>
        <year>2023</year>
      </date>
      <date date-type="accepted">
        <day>04</day>
        <month>8</month>
        <year>2023</year>
      </date>
      <date date-type="corrected-typeset">
        <day>18</day>
        <month>8</month>
        <year>2023</year>
      </date>
    </history>
    <permissions>
      <copyright-statement>© The Author(s) 2023. Published by Oxford University Press.</copyright-statement>
      <copyright-year>2023</copyright-year>
      <license>
        <ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
        <license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
      </license>
    </permissions>
    <self-uri xlink:href="vbad104.pdf"/>
    <abstract>
      <title>Abstract</title>
      <sec id="s1">
        <title>Motivation</title>
        <p>Analyzing the overlap between two sets of genomic intervals is a frequent task in the field of bioinformatics. Typically, this is accomplished by counting the number (or proportion) of overlapped regions, which applies an arbitrary threshold to determine if two genomic intervals are overlapped. By making binary calls but disregarding the magnitude of the overlap, such an approach often leads to biased, non-reproducible, and incomparable results.</p>
      </sec>
      <sec id="s2">
        <title>Results</title>
        <p>We developed the cobind package, which incorporates six statistical measures: the Jaccard coefficient, Sørensen–Dice coefficient, Szymkiewicz–Simpson coefficient, collocation coefficient, pointwise mutual information (PMI), and normalized PMI. These measures allow for a quantitative assessment of the collocation strength between two sets of genomic intervals. To demonstrate the effectiveness of these methods, we applied them to analyze CTCF’s binding sites identified from ChIP-seq, cancer-specific open-chromatin regions (OCRs) identified from ATAC-seq of 17 cancer types, and oligodendrocytes-specific OCRs identified from scATAC-seq. Our results indicated that these new approaches effectively re-discover CTCF’s cofactors, as well as cancer-specific and oligodendrocytes-specific master regulators implicated in disease and cell type development.</p>
      </sec>
      <sec id="s3">
        <title>Availability and implementation</title>
        <p>The cobind package is implemented in Python and freely available at <ext-link xlink:href="https://cobind.readthedocs.io/en/latest/" ext-link-type="uri">https://cobind.readthedocs.io/en/latest/</ext-link>.</p>
      </sec>
    </abstract>
    <funding-group>
      <award-group award-type="grant">
        <funding-source>
          <institution-wrap>
            <institution>US National Institute of Health</institution>
          </institution-wrap>
        </funding-source>
        <award-id>CA180882-07</award-id>
        <award-id>CA130908-12</award-id>
        <award-id>CA230712-4</award-id>
        <award-id>AA27179</award-id>
      </award-group>
    </funding-group>
    <counts>
      <page-count count="9"/>
    </counts>
  </article-meta>
</front>
<body>
  <sec>
    <title>1 Introduction</title>
    <p>Collocated genomic intervals indicate biological or functional connections. For example, a previous study found that over 50% of ERα-binding sites occur on FoxA1-occupied sites, and a further mechanistic study confirmed the direct collaboration between ERα and FoxA1 to control the transcription of estrogen-responsive genes (<xref rid="vbad104-B28" ref-type="bibr">Lupien <italic toggle="yes">et al.</italic> 2008</xref>). Therefore, investigating the collocation of two sets of genomic intervals is vital in identifying common biological pathways, revealing the underlying molecular mechanisms, and validating results obtained from different experiments.</p>
    <p>Despite its significance, the methodology for examining overlapping intervals, referred to as collocation analysis hereafter, has yet to receive extensive research attention. Currently, most researchers use an arbitrary threshold to determine if two intervals are overlapped. Based on the total number of overlaps between two interval sets, different statistical tests were employed to determine their statistical significance, such as Fisher’s exact test and odds ratio (<xref rid="vbad104-B38" ref-type="bibr">Sheffield and Bock 2016</xref>, <xref rid="vbad104-B25" ref-type="bibr">Layer <italic toggle="yes">et al.</italic> 2018</xref>) or permutation test (<xref rid="vbad104-B16" ref-type="bibr">Haiminen <italic toggle="yes">et al.</italic> 2008</xref>, <xref rid="vbad104-B12" ref-type="bibr">Ferre <italic toggle="yes">et al.</italic> 2020</xref>). This threshold-and-count approach inappropriately equates collocation analysis with co-occurrence analysis. Co-occurrence analysis is a statistical technique for measuring the joint appearance frequency of two zero-dimensional objects (e.g. gene symbols) in a dataset. The result of co-occurrence analysis can be visualized using a Venn diagram, formulated as a 2 × 2 contingency table, and the significance of co-occurrence can be evaluated using Fisher’s exact test or <italic toggle="yes">χ</italic><sup>2</sup> test. In contrast, collocation analysis deals with one-dimensional genomic intervals that have different sizes, and the magnitude of overlapping between two genomic intervals is a continuous variable. As a result, applying the co-occurrence analysis approach to genomic intervals can produce biased, non-reproducible, and incomparable results because it depends on a threshold and discards valuable information. To address these limitations, more rigorous, threshold-free approaches are needed to measure the strength of genomic collocations. To this end, we have developed the cobind package with six threshold-free metrics to objectively quantify the collocation of genomic intervals.</p>
  </sec>
  <sec>
    <title>2 Methods</title>
    <sec>
      <title>2.1 Data collection</title>
      <p>Curated binding sites of 1208 transcription factors (TFs) were downloaded from the ReMap 2022 database (<ext-link xlink:href="https://remap.univ-amu.fr/" ext-link-type="uri">https://remap.univ-amu.fr/</ext-link>) (<xref rid="vbad104-B17" ref-type="bibr">Hammal <italic toggle="yes">et al.</italic> 2022</xref>). ATAC-seq peaks of 17 TCGA common cancer types, including Bladder Urothelial Carcinoma (BLCA), Breast invasive carcinoma (BRCA), Cervical squamous cell carcinoma and endocervical adenocarcinoma (CESC), Colon adenocarcinoma (COAD), Esophageal carcinoma (ESCA), glioblastoma multiforme (GBM), Head and Neck squamous cell carcinoma (HNSC), Kidney renal clear cell carcinoma (KIRC), low-grade glioma (LGG), Liver hepatocellular carcinoma (LIHC), Lung adenocarcinoma (LUAD), Lung squamous cell carcinoma (LUSC), Prostate adenocarcinoma (PRAD), Skin Cutaneous Melanoma (SKCM), Stomach adenocarcinoma (STAD), Thyroid carcinoma (THCA), and Uterine Corpus Endometrial Carcinoma (UCEC), were downloaded from Genomics Data Commons (<ext-link xlink:href="https://gdc.cancer.gov/about-data/publications/ATACseq-AWG" ext-link-type="uri">https://gdc.cancer.gov/about-data/publications/ATACseq-AWG</ext-link>) (<xref rid="vbad104-B6" ref-type="bibr">Corces <italic toggle="yes">et al.</italic> 2018</xref>). Cancer type-specific open-chromatin regions (OCRs) were identified by comparing ATAC-seq peaks of one cancer type with the remaining cancer types using BEDTools (<xref rid="vbad104-B36" ref-type="bibr">Quinlan and Hall 2010</xref>). Single nucleus RNA-seq (snRNA-seq) data from adult humans’ motor cortex (M1) were generated by the Allen Institute for Brain Science (<ext-link xlink:href="https://portal.brain-map.org/" ext-link-type="uri">https://portal.brain-map.org/</ext-link>) using the 10× Chromium Single Cell 3' Reagent Kit v3. Gene expression of count per million values was quantified using the default 10× Cell Ranger v3 pipeline. The University of California, Santa Cruz (UCSC) genome browser track hub to visualize these data is available at <ext-link xlink:href="https://human-m1-rna-hub.s3-us-west-2.amazonaws.com/HumanM1RNAHub.html" ext-link-type="uri">https://human-m1-rna-hub.s3-us-west-2.amazonaws.com/HumanM1RNAHub.html</ext-link>. Oligodendrocyte-specific single-cell assay for transposase-accessible chromatin with sequencing (scATAC-seq) peaks were downloaded from this study (<xref rid="vbad104-B7" ref-type="bibr">Corces <italic toggle="yes">et al.</italic> 2020</xref>). Only distal peaks (<italic toggle="yes">n</italic> = 28 109) were used for collocation analysis to identify the master regulators since peaks identified from scATAC-seq are highly enriched in distal/intron regions but depleted in promoter regions.</p>
    </sec>
    <sec>
      <title>2.2 The six statistical metrics</title>
      <sec>
        <title>2.2.1 The collocation coefficient</title>
        <p><italic toggle="yes">A</italic> and <italic toggle="yes">B</italic> represent two sets of genomic intervals. |<italic toggle="yes">A</italic>| represents the cardinality of <italic toggle="yes">A</italic> (i.e. all the non-redundant bases covered by <italic toggle="yes">A</italic>). |<italic toggle="yes">B</italic>| represents the cardinality of <italic toggle="yes">B</italic>. |<italic toggle="yes">A</italic> ∩ <italic toggle="yes">B</italic>| represents all the non-redundant bases covered by both <italic toggle="yes">A</italic> and <italic toggle="yes">B</italic>. The collocation coefficient (<italic toggle="yes">C</italic>) is calculated as the size of the intersection divided by the geometric mean of the two sets. <italic toggle="yes">C</italic> is defined as 0 when either of |<italic toggle="yes">A</italic>| or |<italic toggle="yes">B</italic>| is 0.
</p>
        <disp-formula id="E1">
          <mml:math id="M1" display="block" overflow="scroll">
            <mml:mi>C</mml:mi>
            <mml:mfenced open="(" close=")" separators="|">
              <mml:mrow>
                <mml:mi>A</mml:mi>
                <mml:mo>,</mml:mo>
                <mml:mi>B</mml:mi>
              </mml:mrow>
            </mml:mfenced>
            <mml:mo>=</mml:mo>
            <mml:mrow>
              <mml:mfrac>
                <mml:mrow>
                  <mml:mfenced open="|" close="|" separators="|">
                    <mml:mrow>
                      <mml:mi>A</mml:mi>
                      <mml:mo>∩</mml:mo>
                      <mml:mi>B</mml:mi>
                    </mml:mrow>
                  </mml:mfenced>
                </mml:mrow>
                <mml:mrow>
                  <mml:msqrt>
                    <mml:mfenced open="|" close="|" separators="|">
                      <mml:mrow>
                        <mml:mi>A</mml:mi>
                      </mml:mrow>
                    </mml:mfenced>
                    <mml:mo>×</mml:mo>
                    <mml:mfenced open="|" close="|" separators="|">
                      <mml:mrow>
                        <mml:mi>B</mml:mi>
                      </mml:mrow>
                    </mml:mfenced>
                  </mml:msqrt>
                </mml:mrow>
              </mml:mfrac>
            </mml:mrow>
            <mml:mo>,</mml:mo>
            <mml:mi mathvariant="normal"> </mml:mi>
            <mml:mn>0</mml:mn>
            <mml:mi mathvariant="normal"> </mml:mi>
            <mml:mo>≤</mml:mo>
            <mml:mi>C</mml:mi>
            <mml:mfenced open="(" close=")" separators="|">
              <mml:mrow>
                <mml:mi>A</mml:mi>
                <mml:mo>,</mml:mo>
                <mml:mi>B</mml:mi>
              </mml:mrow>
            </mml:mfenced>
            <mml:mo>≤</mml:mo>
            <mml:mn>1.</mml:mn>
          </mml:math>
        </disp-formula>
      </sec>
      <sec>
        <title>2.2.2 The Jaccard coefficient</title>
        <p>The Jaccard coefficient is (<italic toggle="yes">J</italic>) calculated as the size of the intersection divided by the union of the two sets. <italic toggle="yes">J</italic> is defined as 0 when either of |<italic toggle="yes">A</italic>| or |<italic toggle="yes">B</italic>| is 0.
</p>
        <disp-formula id="E2">
          <mml:math id="M2" display="block" overflow="scroll">
            <mml:mi>J</mml:mi>
            <mml:mfenced open="(" close=")" separators="|">
              <mml:mrow>
                <mml:mi>A</mml:mi>
                <mml:mo>,</mml:mo>
                <mml:mi>B</mml:mi>
              </mml:mrow>
            </mml:mfenced>
            <mml:mo>=</mml:mo>
            <mml:mi mathvariant="normal"> </mml:mi>
            <mml:mrow>
              <mml:mfrac>
                <mml:mrow>
                  <mml:mfenced open="|" close="|" separators="|">
                    <mml:mrow>
                      <mml:mi>A</mml:mi>
                      <mml:mo>∩</mml:mo>
                      <mml:mi>B</mml:mi>
                    </mml:mrow>
                  </mml:mfenced>
                </mml:mrow>
                <mml:mrow>
                  <mml:mfenced open="|" close="|" separators="|">
                    <mml:mrow>
                      <mml:mi>A</mml:mi>
                      <mml:mo>∪</mml:mo>
                      <mml:mi>B</mml:mi>
                    </mml:mrow>
                  </mml:mfenced>
                </mml:mrow>
              </mml:mfrac>
            </mml:mrow>
            <mml:mo>=</mml:mo>
            <mml:mrow>
              <mml:mfrac>
                <mml:mrow>
                  <mml:mfenced open="|" close="|" separators="|">
                    <mml:mrow>
                      <mml:mi>A</mml:mi>
                      <mml:mo>∩</mml:mo>
                      <mml:mi>B</mml:mi>
                    </mml:mrow>
                  </mml:mfenced>
                </mml:mrow>
                <mml:mrow>
                  <mml:mfenced open="|" close="|" separators="|">
                    <mml:mrow>
                      <mml:mi>A</mml:mi>
                    </mml:mrow>
                  </mml:mfenced>
                  <mml:mo>+</mml:mo>
                  <mml:mfenced open="|" close="|" separators="|">
                    <mml:mrow>
                      <mml:mi>B</mml:mi>
                    </mml:mrow>
                  </mml:mfenced>
                  <mml:mo>-</mml:mo>
                  <mml:mfenced open="|" close="|" separators="|">
                    <mml:mrow>
                      <mml:mi>A</mml:mi>
                      <mml:mo>∩</mml:mo>
                      <mml:mi>B</mml:mi>
                    </mml:mrow>
                  </mml:mfenced>
                </mml:mrow>
              </mml:mfrac>
            </mml:mrow>
            <mml:mo>,</mml:mo>
            <mml:mi mathvariant="normal"> </mml:mi>
            <mml:mn>0</mml:mn>
            <mml:mi mathvariant="normal"> </mml:mi>
            <mml:mo>≤</mml:mo>
            <mml:mi>J</mml:mi>
            <mml:mfenced open="(" close=")" separators="|">
              <mml:mrow>
                <mml:mi>A</mml:mi>
                <mml:mo>,</mml:mo>
                <mml:mi>B</mml:mi>
              </mml:mrow>
            </mml:mfenced>
            <mml:mo>≤</mml:mo>
            <mml:mn>1.</mml:mn>
          </mml:math>
        </disp-formula>
      </sec>
      <sec>
        <title>2.2.3 The Sørensen–Dice coefficient</title>
        <p>The Sørensen–Dice (SD) coefficient is calculated as the size of the intersection divided by the arithmetic mean of the two sets. SD is defined as 0 when either of |<italic toggle="yes">A</italic>| or |<italic toggle="yes">B</italic>| is 0.
</p>
        <disp-formula id="E3">
          <mml:math id="M3" display="block" overflow="scroll">
            <mml:mi mathvariant="normal">SD</mml:mi>
            <mml:mfenced open="(" close=")" separators="|">
              <mml:mrow>
                <mml:mi>A</mml:mi>
                <mml:mo>,</mml:mo>
                <mml:mi>B</mml:mi>
              </mml:mrow>
            </mml:mfenced>
            <mml:mo>=</mml:mo>
            <mml:mi mathvariant="normal"> </mml:mi>
            <mml:mrow>
              <mml:mfrac>
                <mml:mrow>
                  <mml:mfenced open="|" close="|" separators="|">
                    <mml:mrow>
                      <mml:mi>A</mml:mi>
                      <mml:mo>∩</mml:mo>
                      <mml:mi>B</mml:mi>
                    </mml:mrow>
                  </mml:mfenced>
                </mml:mrow>
                <mml:mrow>
                  <mml:mrow>
                    <mml:mfrac>
                      <mml:mrow>
                        <mml:mfenced open="|" close="|" separators="|">
                          <mml:mrow>
                            <mml:mi>A</mml:mi>
                          </mml:mrow>
                        </mml:mfenced>
                        <mml:mo>+</mml:mo>
                        <mml:mfenced open="|" close="|" separators="|">
                          <mml:mrow>
                            <mml:mi>B</mml:mi>
                          </mml:mrow>
                        </mml:mfenced>
                      </mml:mrow>
                      <mml:mrow>
                        <mml:mn>2</mml:mn>
                      </mml:mrow>
                    </mml:mfrac>
                  </mml:mrow>
                </mml:mrow>
              </mml:mfrac>
            </mml:mrow>
            <mml:mo>,</mml:mo>
            <mml:mi mathvariant="normal"> </mml:mi>
            <mml:mn>0</mml:mn>
            <mml:mi mathvariant="normal"> </mml:mi>
            <mml:mo>≤</mml:mo>
            <mml:mi mathvariant="normal">SD</mml:mi>
            <mml:mfenced open="(" close=")" separators="|">
              <mml:mrow>
                <mml:mi>A</mml:mi>
                <mml:mo>,</mml:mo>
                <mml:mi>B</mml:mi>
              </mml:mrow>
            </mml:mfenced>
            <mml:mo>≤</mml:mo>
            <mml:mn>1.</mml:mn>
          </mml:math>
        </disp-formula>
        <p>The Jaccard coefficient (<italic toggle="yes">J</italic>) can be converted from SD with <italic toggle="yes">J</italic> = SD/(2−SD) and <italic toggle="yes">vice versa</italic> with SD<italic toggle="yes"> </italic>=<italic toggle="yes"> </italic>2<italic toggle="yes">J</italic>/(1+<italic toggle="yes">J</italic>).</p>
      </sec>
      <sec>
        <title>2.2.4 The Szymkiewicz–Simpson</title>
        <p>The Szymkiewicz–Simpson (SS) coefficient is defined as the size of the intersection divided by the smaller size of the two sets.
</p>
        <disp-formula id="E4">
          <mml:math id="M4" display="block" overflow="scroll">
            <mml:mi mathvariant="normal">SS</mml:mi>
            <mml:mfenced open="(" close=")" separators="|">
              <mml:mrow>
                <mml:mi>A</mml:mi>
                <mml:mo>,</mml:mo>
                <mml:mi>B</mml:mi>
              </mml:mrow>
            </mml:mfenced>
            <mml:mo>=</mml:mo>
            <mml:mi mathvariant="normal"> </mml:mi>
            <mml:mrow>
              <mml:mfrac>
                <mml:mrow>
                  <mml:mfenced open="|" close="|" separators="|">
                    <mml:mrow>
                      <mml:mi>A</mml:mi>
                      <mml:mo>∩</mml:mo>
                      <mml:mi>B</mml:mi>
                    </mml:mrow>
                  </mml:mfenced>
                </mml:mrow>
                <mml:mrow>
                  <mml:mrow>
                    <mml:mrow>
                      <mml:mi mathvariant="normal">min</mml:mi>
                    </mml:mrow>
                    <mml:mo>⁡</mml:mo>
                    <mml:mrow>
                      <mml:mo>(</mml:mo>
                      <mml:mrow>
                        <mml:mo>|</mml:mo>
                        <mml:mrow>
                          <mml:mi>A</mml:mi>
                          <mml:mrow>
                            <mml:mo>|</mml:mo>
                            <mml:mo>,</mml:mo>
                          </mml:mrow>
                          <mml:mo>|</mml:mo>
                          <mml:mi>B</mml:mi>
                        </mml:mrow>
                        <mml:mo>|</mml:mo>
                      </mml:mrow>
                      <mml:mo>)</mml:mo>
                    </mml:mrow>
                  </mml:mrow>
                </mml:mrow>
              </mml:mfrac>
            </mml:mrow>
            <mml:mo>,</mml:mo>
            <mml:mi mathvariant="normal"> </mml:mi>
            <mml:mn>0</mml:mn>
            <mml:mi mathvariant="normal"> </mml:mi>
            <mml:mo>≤</mml:mo>
            <mml:mi mathvariant="normal">SS</mml:mi>
            <mml:mfenced open="(" close=")" separators="|">
              <mml:mrow>
                <mml:mi>A</mml:mi>
                <mml:mo>,</mml:mo>
                <mml:mi>B</mml:mi>
              </mml:mrow>
            </mml:mfenced>
            <mml:mo>≤</mml:mo>
            <mml:mn>1.</mml:mn>
          </mml:math>
        </disp-formula>
      </sec>
      <sec>
        <title>2.2.5 Pointwise mutual information</title>
        <p><italic toggle="yes">G</italic> represents the size of the genome (<italic toggle="yes">A</italic> ⊂ <italic toggle="yes">G</italic> and <italic toggle="yes">B</italic> ⊂ <italic toggle="yes">G</italic>). Pointwise mutual information (PMI) is calculated as
</p>
        <disp-formula id="E5">
          <mml:math id="M5" display="block" overflow="scroll">
            <mml:mi mathvariant="normal">PMI</mml:mi>
            <mml:mfenced open="(" close=")" separators="|">
              <mml:mrow>
                <mml:mi>A</mml:mi>
                <mml:mo>∩</mml:mo>
                <mml:mi>B</mml:mi>
              </mml:mrow>
            </mml:mfenced>
            <mml:mo>≡</mml:mo>
            <mml:mi mathvariant="normal">log</mml:mi>
            <mml:mfenced open="(" close=")" separators="|">
              <mml:mrow>
                <mml:mrow>
                  <mml:mfrac>
                    <mml:mrow>
                      <mml:mi>p</mml:mi>
                      <mml:mfenced open="(" close=")" separators="|">
                        <mml:mrow>
                          <mml:mi>A</mml:mi>
                          <mml:mo>∩</mml:mo>
                          <mml:mi>B</mml:mi>
                        </mml:mrow>
                      </mml:mfenced>
                    </mml:mrow>
                    <mml:mrow>
                      <mml:mi>p</mml:mi>
                      <mml:mfenced open="(" close=")" separators="|">
                        <mml:mrow>
                          <mml:mi>A</mml:mi>
                        </mml:mrow>
                      </mml:mfenced>
                      <mml:mo>×</mml:mo>
                      <mml:mi>p</mml:mi>
                      <mml:mfenced open="(" close=")" separators="|">
                        <mml:mrow>
                          <mml:mi>B</mml:mi>
                        </mml:mrow>
                      </mml:mfenced>
                    </mml:mrow>
                  </mml:mfrac>
                </mml:mrow>
              </mml:mrow>
            </mml:mfenced>
          </mml:math>
        </disp-formula>
        <disp-formula id="E6">
          <mml:math id="M6" display="block" overflow="scroll">
            <mml:mo>-</mml:mo>
            <mml:mi mathvariant="normal">∞</mml:mi>
            <mml:mo>≤</mml:mo>
            <mml:mi mathvariant="normal">PMI</mml:mi>
            <mml:mo>(</mml:mo>
            <mml:mi>A</mml:mi>
            <mml:mo>∩</mml:mo>
            <mml:mi>B</mml:mi>
            <mml:mo>)</mml:mo>
            <mml:mo>≤</mml:mo>
            <mml:mi mathvariant="normal">min</mml:mi>
            <mml:mfenced open="(" close=")" separators="|">
              <mml:mrow>
                <mml:mo>-</mml:mo>
                <mml:mi mathvariant="normal">log</mml:mi>
                <mml:mo>⁡</mml:mo>
                <mml:mo>(</mml:mo>
                <mml:mi>p</mml:mi>
                <mml:mo>(</mml:mo>
                <mml:mi>A</mml:mi>
              </mml:mrow>
            </mml:mfenced>
            <mml:mo>)</mml:mo>
            <mml:mo>,</mml:mo>
            <mml:mi mathvariant="normal"> </mml:mi>
            <mml:mo>-</mml:mo>
            <mml:mi mathvariant="normal">log</mml:mi>
            <mml:mo>⁡</mml:mo>
            <mml:mo>(</mml:mo>
            <mml:mi>p</mml:mi>
            <mml:mo>(</mml:mo>
            <mml:mi>B</mml:mi>
            <mml:mo>)</mml:mo>
            <mml:mo>)</mml:mo>
            <mml:mo>)</mml:mo>
            <mml:mo>,</mml:mo>
          </mml:math>
        </disp-formula>
        <p>where <italic toggle="yes">p</italic>(<italic toggle="yes">A</italic>), <italic toggle="yes">p</italic>(<italic toggle="yes">B</italic>), and <italic toggle="yes">p</italic>(<italic toggle="yes">A∩B</italic>) are defined as
</p>
        <disp-formula id="E7">
          <mml:math id="M7" display="block" overflow="scroll">
            <mml:mi>p</mml:mi>
            <mml:mfenced open="(" close=")" separators="|">
              <mml:mrow>
                <mml:mi>A</mml:mi>
              </mml:mrow>
            </mml:mfenced>
            <mml:mo>=</mml:mo>
            <mml:mrow>
              <mml:mfrac>
                <mml:mrow>
                  <mml:mfenced open="|" close="|" separators="|">
                    <mml:mrow>
                      <mml:mi>A</mml:mi>
                    </mml:mrow>
                  </mml:mfenced>
                </mml:mrow>
                <mml:mrow>
                  <mml:mfenced open="|" close="|" separators="|">
                    <mml:mrow>
                      <mml:mi>G</mml:mi>
                    </mml:mrow>
                  </mml:mfenced>
                </mml:mrow>
              </mml:mfrac>
            </mml:mrow>
            <mml:mo>,</mml:mo>
            <mml:mo> </mml:mo>
            <mml:mi>p</mml:mi>
            <mml:mfenced open="(" close=")" separators="|">
              <mml:mrow>
                <mml:mi>B</mml:mi>
              </mml:mrow>
            </mml:mfenced>
            <mml:mo>=</mml:mo>
            <mml:mrow>
              <mml:mfrac>
                <mml:mrow>
                  <mml:mfenced open="|" close="|" separators="|">
                    <mml:mrow>
                      <mml:mi>B</mml:mi>
                    </mml:mrow>
                  </mml:mfenced>
                </mml:mrow>
                <mml:mrow>
                  <mml:mfenced open="|" close="|" separators="|">
                    <mml:mrow>
                      <mml:mi>G</mml:mi>
                    </mml:mrow>
                  </mml:mfenced>
                </mml:mrow>
              </mml:mfrac>
            </mml:mrow>
            <mml:mo>,</mml:mo>
            <mml:mi mathvariant="normal"> </mml:mi>
            <mml:mi>p</mml:mi>
            <mml:mfenced open="(" close=")" separators="|">
              <mml:mrow>
                <mml:mi>A</mml:mi>
                <mml:mo> </mml:mo>
                <mml:mo>∩</mml:mo>
                <mml:mo> </mml:mo>
                <mml:mi>B</mml:mi>
              </mml:mrow>
            </mml:mfenced>
            <mml:mo>=</mml:mo>
            <mml:mi mathvariant="normal"> </mml:mi>
            <mml:mrow>
              <mml:mfrac>
                <mml:mrow>
                  <mml:mfenced open="|" close="|" separators="|">
                    <mml:mrow>
                      <mml:mi>A</mml:mi>
                      <mml:mo>∩</mml:mo>
                      <mml:mi>B</mml:mi>
                    </mml:mrow>
                  </mml:mfenced>
                </mml:mrow>
                <mml:mrow>
                  <mml:mfenced open="|" close="|" separators="|">
                    <mml:mrow>
                      <mml:mi>G</mml:mi>
                    </mml:mrow>
                  </mml:mfenced>
                </mml:mrow>
              </mml:mfrac>
            </mml:mrow>
            <mml:mo>.</mml:mo>
          </mml:math>
        </disp-formula>
      </sec>
      <sec>
        <title>2.2.6 Normalized PMI</title>
        <p>When dividing PMI by −log(<italic toggle="yes">p</italic>(<italic toggle="yes">A ∩ B</italic>)), the lower bound and upper bound are normalized to −1 and 1, respectively. Normalized PMI (NPMI) is calculated as
</p>
        <disp-formula id="E8">
          <mml:math id="M8" display="block" overflow="scroll">
            <mml:mi mathvariant="normal">NPMI</mml:mi>
            <mml:mfenced open="(" close=")" separators="|">
              <mml:mrow>
                <mml:mi>A</mml:mi>
                <mml:mo>∩</mml:mo>
                <mml:mi>B</mml:mi>
              </mml:mrow>
            </mml:mfenced>
            <mml:mo>=</mml:mo>
            <mml:mrow>
              <mml:mfrac>
                <mml:mrow>
                  <mml:mi mathvariant="normal">PMI</mml:mi>
                  <mml:mfenced open="(" close=")" separators="|">
                    <mml:mrow>
                      <mml:mi>A</mml:mi>
                      <mml:mo>∩</mml:mo>
                      <mml:mi>B</mml:mi>
                    </mml:mrow>
                  </mml:mfenced>
                </mml:mrow>
                <mml:mrow>
                  <mml:mo>-</mml:mo>
                  <mml:mrow>
                    <mml:mrow>
                      <mml:mi mathvariant="normal">log</mml:mi>
                    </mml:mrow>
                    <mml:mo>⁡</mml:mo>
                    <mml:mrow>
                      <mml:mfenced open="(" close=")" separators="|">
                        <mml:mrow>
                          <mml:mi>p</mml:mi>
                          <mml:mfenced open="(" close=")" separators="|">
                            <mml:mrow>
                              <mml:mi>A</mml:mi>
                              <mml:mo>∩</mml:mo>
                              <mml:mo> </mml:mo>
                              <mml:mi>B</mml:mi>
                            </mml:mrow>
                          </mml:mfenced>
                        </mml:mrow>
                      </mml:mfenced>
                    </mml:mrow>
                  </mml:mrow>
                </mml:mrow>
              </mml:mfrac>
            </mml:mrow>
            <mml:mo>=</mml:mo>
            <mml:mrow>
              <mml:mfrac>
                <mml:mrow>
                  <mml:mi mathvariant="normal">log</mml:mi>
                  <mml:mfenced open="(" close=")" separators="|">
                    <mml:mrow>
                      <mml:mrow>
                        <mml:mfrac>
                          <mml:mrow>
                            <mml:mi>p</mml:mi>
                            <mml:mfenced open="(" close=")" separators="|">
                              <mml:mrow>
                                <mml:mi>A</mml:mi>
                                <mml:mo> </mml:mo>
                                <mml:mo>∩</mml:mo>
                                <mml:mo> </mml:mo>
                                <mml:mi>B</mml:mi>
                              </mml:mrow>
                            </mml:mfenced>
                          </mml:mrow>
                          <mml:mrow>
                            <mml:mi>p</mml:mi>
                            <mml:mfenced open="(" close=")" separators="|">
                              <mml:mrow>
                                <mml:mi>A</mml:mi>
                              </mml:mrow>
                            </mml:mfenced>
                            <mml:mo>×</mml:mo>
                            <mml:mi>p</mml:mi>
                            <mml:mfenced open="(" close=")" separators="|">
                              <mml:mrow>
                                <mml:mi>B</mml:mi>
                              </mml:mrow>
                            </mml:mfenced>
                          </mml:mrow>
                        </mml:mfrac>
                      </mml:mrow>
                    </mml:mrow>
                  </mml:mfenced>
                </mml:mrow>
                <mml:mrow>
                  <mml:mo>-</mml:mo>
                  <mml:mrow>
                    <mml:mrow>
                      <mml:mi mathvariant="normal">log</mml:mi>
                    </mml:mrow>
                    <mml:mo>⁡</mml:mo>
                    <mml:mrow>
                      <mml:mfenced open="(" close=")" separators="|">
                        <mml:mrow>
                          <mml:mi>p</mml:mi>
                          <mml:mfenced open="(" close=")" separators="|">
                            <mml:mrow>
                              <mml:mi>A</mml:mi>
                              <mml:mo>∩</mml:mo>
                              <mml:mi>B</mml:mi>
                            </mml:mrow>
                          </mml:mfenced>
                        </mml:mrow>
                      </mml:mfenced>
                    </mml:mrow>
                  </mml:mrow>
                </mml:mrow>
              </mml:mfrac>
            </mml:mrow>
            <mml:mo>=</mml:mo>
            <mml:mrow>
              <mml:mfrac>
                <mml:mrow>
                  <mml:mi mathvariant="normal">log</mml:mi>
                  <mml:mfenced open="(" close=")" separators="|">
                    <mml:mrow>
                      <mml:mi>p</mml:mi>
                      <mml:mfenced open="(" close=")" separators="|">
                        <mml:mrow>
                          <mml:mi>A</mml:mi>
                        </mml:mrow>
                      </mml:mfenced>
                      <mml:mo>×</mml:mo>
                      <mml:mi>p</mml:mi>
                      <mml:mfenced open="(" close=")" separators="|">
                        <mml:mrow>
                          <mml:mi>B</mml:mi>
                        </mml:mrow>
                      </mml:mfenced>
                    </mml:mrow>
                  </mml:mfenced>
                </mml:mrow>
                <mml:mrow>
                  <mml:mrow>
                    <mml:mrow>
                      <mml:mi mathvariant="normal">log</mml:mi>
                    </mml:mrow>
                    <mml:mo>⁡</mml:mo>
                    <mml:mrow>
                      <mml:mfenced open="(" close=")" separators="|">
                        <mml:mrow>
                          <mml:mi>p</mml:mi>
                          <mml:mfenced open="(" close=")" separators="|">
                            <mml:mrow>
                              <mml:mi>A</mml:mi>
                              <mml:mo>∩</mml:mo>
                              <mml:mi>B</mml:mi>
                            </mml:mrow>
                          </mml:mfenced>
                        </mml:mrow>
                      </mml:mfenced>
                    </mml:mrow>
                  </mml:mrow>
                </mml:mrow>
              </mml:mfrac>
            </mml:mrow>
            <mml:mo>-</mml:mo>
            <mml:mn>1</mml:mn>
          </mml:math>
        </disp-formula>
        <disp-formula id="E9">
          <mml:math id="M9" display="block" overflow="scroll">
            <mml:mo>-</mml:mo>
            <mml:mn>1</mml:mn>
            <mml:mo>≤</mml:mo>
            <mml:mi mathvariant="normal">NPMI</mml:mi>
            <mml:mfenced open="(" close=")" separators="|">
              <mml:mrow>
                <mml:mi>A</mml:mi>
                <mml:mo>∩</mml:mo>
                <mml:mi>B</mml:mi>
              </mml:mrow>
            </mml:mfenced>
            <mml:mo>≤</mml:mo>
            <mml:mn>1.</mml:mn>
          </mml:math>
        </disp-formula>
      </sec>
    </sec>
    <sec>
      <title>2.3 Estimate confidence interval with bootstrapping</title>
      <p>To estimate the variability and uncertainty associated with the six calculated statistical measures, we used the non-parametric bootstrapping method to estimate the 95% confidence interval. By default, 75% of input genomic intervals will be resampled and this resampling process will be repeated 20 times.</p>
    </sec>
    <sec>
      <title>2.4 Conventional threshold-and-count approach to measure genomic collocations between CTCF and other TFs</title>
      <p>Pre-analyzed, IDR (Irreproducible Discovery Rate) filtered CTCF (CCCTC-binding factor) ChIP-seq peaks (GRCh38) were downloaded from the ENCODE project (<ext-link xlink:href="https://www.encodeproject.org/files/ENCFF660GHM/" ext-link-type="uri">https://www.encodeproject.org/files/ENCFF660GHM/</ext-link>). ChIP-seq peaks from 1208 TFs were downloaded from the ReMap database (<ext-link xlink:href="https://remap.univ-amu.fr/" ext-link-type="uri">https://remap.univ-amu.fr/</ext-link>). The threshold-and-count approach consists of two steps: first, an arbitrary threshold (minimum number of nucleotides overlapped) was used to determine the overlapping of two peaks, and then each CTCF peak was labeled by “0” or “1”, representing non-overlap or overlap with peaks of the TF compared, respectively; second, the percentage of overlapped CTCF peaks was calculated as the measure of collocation strength. This approach was evaluated using six different thresholds: 1-nucleotide (the most relaxed), 10%, 30%, 50%, 80%, and 100% (the most stringent). Based on the percentage of overlapped CTCF peaks, the 1207 TFs (CTCF itself was excluded) were ranked in descending order under each criterion.</p>
    </sec>
    <sec>
      <title>2.5 Calculate the combined <italic toggle="yes">Z</italic>-score</title>
      <p>We used the Gene Set Variation Analysis package (<xref rid="vbad104-B19" ref-type="bibr">Hänzelmann <italic toggle="yes">et al.</italic> 2013</xref>) to calculate the combined <italic toggle="yes">Z</italic>-scores. Specifically, scores of the six metrics were converted into <italic toggle="yes">Z</italic>-scores by <italic toggle="yes">Z</italic><sub>i</sub> = (<italic toggle="yes">x</italic> − <italic toggle="yes">μ</italic>)/<italic toggle="yes">σ</italic>, where <italic toggle="yes">μ</italic> and <italic toggle="yes">σ</italic> are the average and standard deviation of the score, and <italic toggle="yes">i</italic> ∈ {<italic toggle="yes">C</italic>, <italic toggle="yes">J</italic>, SD, SS, PMI, NPMI}. The combined <italic toggle="yes">Z</italic>-score is defined as:
</p>
      <disp-formula id="E10">
        <mml:math id="M10" display="block" overflow="scroll">
          <mml:mi>Z</mml:mi>
          <mml:mo>=</mml:mo>
          <mml:mrow>
            <mml:mfrac>
              <mml:mrow>
                <mml:mrow>
                  <mml:mo stretchy="false">∑</mml:mo>
                  <mml:mrow>
                    <mml:mrow>
                      <mml:msub>
                        <mml:mrow>
                          <mml:mi>Z</mml:mi>
                        </mml:mrow>
                        <mml:mrow>
                          <mml:mi>i</mml:mi>
                        </mml:mrow>
                      </mml:msub>
                    </mml:mrow>
                  </mml:mrow>
                </mml:mrow>
              </mml:mrow>
              <mml:mrow>
                <mml:msqrt>
                  <mml:mn>6</mml:mn>
                </mml:msqrt>
              </mml:mrow>
            </mml:mfrac>
          </mml:mrow>
          <mml:mo>.</mml:mo>
        </mml:math>
      </disp-formula>
      <p>TFs with <italic toggle="yes">Z</italic>-scores that are more than 3 standard deviations away from the mean are considered outliers (i.e. potential master regulators).</p>
    </sec>
  </sec>
  <sec>
    <title>3 Results</title>
    <sec>
      <title>3.1 Overview of collocation metrics</title>
      <p>The collocation coefficient (<italic toggle="yes">C</italic>), the Jaccard coefficient (<italic toggle="yes">J</italic>), the Sørensen–Dice coefficient (SD), and the Szymkiewicz–Simpson coefficient (SS) are intersection-based metrics and conceptually similar: they normalize the size of the intersection between <italic toggle="yes">A</italic> and <italic toggle="yes">B</italic> by the “geometric mean,” “union,” “arithmetic mean,” and “min” of <italic toggle="yes">A</italic> and <italic toggle="yes">B</italic> (<italic toggle="yes">A</italic> and <italic toggle="yes">B</italic> represent two sets of genomic intervals), respectively. As can be seen from Section 2 and <xref rid="vbad104-T1" ref-type="table">Table 1</xref>, all the intersection-based coefficients are bounded by 0 (no collocation) and 1 (complete collocation), which facilitate cross-sample comparison and integration. In theory, <italic toggle="yes">J</italic> and SD scores are prone to be biased by the larger interval set due to their use of “union” and “arithmetic mean” as denominators, respectively. Conversely, SS is susceptible to the smaller interval set as it uses “min” as the denominator. However, the novel metric <italic toggle="yes">C</italic> developed in this study utilizes the geometric mean that is less sensitive to highly skewed data, thus could alleviate the observed bias in <italic toggle="yes">J</italic>, SD, and SS (<xref rid="sup1" ref-type="supplementary-material">Supplementary Fig. S1</xref>; Section 2).</p>
      <table-wrap position="float" id="vbad104-T1">
        <label>Table 1.</label>
        <caption>
          <p>The six collocation measurements and their lower and upper bounds.</p>
        </caption>
        <table frame="hsides" rules="groups">
          <colgroup span="1">
            <col valign="top" align="left" span="1"/>
            <col valign="top" align="center" span="1"/>
            <col valign="top" align="center" span="1"/>
            <col valign="top" align="center" span="1"/>
            <col valign="top" align="center" span="1"/>
          </colgroup>
          <thead>
            <tr>
              <th rowspan="1" colspan="1">Metrics</th>
              <th rowspan="1" colspan="1">Nominator</th>
              <th rowspan="1" colspan="1">Denominator</th>
              <th rowspan="1" colspan="1">Lower bound (when <italic toggle="yes">A</italic> ∩ <italic toggle="yes">B</italic> = 0)</th>
              <th rowspan="1" colspan="1">Upper bound (when <italic toggle="yes">A</italic> = <italic toggle="yes">B</italic>)</th>
            </tr>
          </thead>
          <tbody>
            <tr>
              <td rowspan="1" colspan="1">
                <italic toggle="yes">C</italic>
              </td>
              <td rowspan="1" colspan="1">
                <inline-formula id="IE1">
                  <mml:math id="IM1" display="inline" overflow="scroll">
                    <mml:mo>|</mml:mo>
                    <mml:mi>A</mml:mi>
                    <mml:mo>∩</mml:mo>
                    <mml:mi>B</mml:mi>
                    <mml:mo>|</mml:mo>
                  </mml:math>
                </inline-formula>
              </td>
              <td rowspan="1" colspan="1">
                <inline-formula id="IE2">
                  <mml:math id="IM2" display="inline" overflow="scroll">
                    <mml:msqrt>
                      <mml:mo>|</mml:mo>
                      <mml:mi>A</mml:mi>
                      <mml:mo>|</mml:mo>
                      <mml:mo>×</mml:mo>
                      <mml:mo>|</mml:mo>
                      <mml:mi>B</mml:mi>
                      <mml:mo>|</mml:mo>
                    </mml:msqrt>
                  </mml:math>
                </inline-formula>
              </td>
              <td rowspan="1" colspan="1">0</td>
              <td rowspan="1" colspan="1">1</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">
                <italic toggle="yes">J</italic>
              </td>
              <td rowspan="1" colspan="1">
                <inline-formula id="IE3">
                  <mml:math id="IM3" display="inline" overflow="scroll">
                    <mml:mo>|</mml:mo>
                    <mml:mi>A</mml:mi>
                    <mml:mo>∩</mml:mo>
                    <mml:mi>B</mml:mi>
                    <mml:mo>|</mml:mo>
                  </mml:math>
                </inline-formula>
              </td>
              <td rowspan="1" colspan="1">
                <inline-formula id="IE4">
                  <mml:math id="IM4" display="inline" overflow="scroll">
                    <mml:mo>|</mml:mo>
                    <mml:mi>A</mml:mi>
                    <mml:mo>∪</mml:mo>
                    <mml:mi>B</mml:mi>
                    <mml:mo>|</mml:mo>
                  </mml:math>
                </inline-formula>
              </td>
              <td rowspan="1" colspan="1">0</td>
              <td rowspan="1" colspan="1">1</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">SD</td>
              <td rowspan="1" colspan="1">
                <inline-formula id="IE5">
                  <mml:math id="IM5" display="inline" overflow="scroll">
                    <mml:mo>|</mml:mo>
                    <mml:mi>A</mml:mi>
                    <mml:mo>∩</mml:mo>
                    <mml:mi>B</mml:mi>
                    <mml:mo>|</mml:mo>
                  </mml:math>
                </inline-formula>
              </td>
              <td rowspan="1" colspan="1">
                <inline-formula id="IE6">
                  <mml:math id="IM6" display="inline" overflow="scroll">
                    <mml:mo>(</mml:mo>
                    <mml:mo>|</mml:mo>
                    <mml:mi>A</mml:mi>
                    <mml:mo>|</mml:mo>
                    <mml:mi mathvariant="normal"> </mml:mi>
                    <mml:mo>+</mml:mo>
                    <mml:mi mathvariant="normal"> </mml:mi>
                    <mml:mo>|</mml:mo>
                    <mml:mi>B</mml:mi>
                    <mml:mo>|</mml:mo>
                    <mml:mo>)</mml:mo>
                    <mml:mo>/</mml:mo>
                    <mml:mn>2</mml:mn>
                  </mml:math>
                </inline-formula>
              </td>
              <td rowspan="1" colspan="1">0</td>
              <td rowspan="1" colspan="1">1</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">SS</td>
              <td rowspan="1" colspan="1">
                <inline-formula id="IE7">
                  <mml:math id="IM7" display="inline" overflow="scroll">
                    <mml:mo>|</mml:mo>
                    <mml:mi>A</mml:mi>
                    <mml:mo>∩</mml:mo>
                    <mml:mi>B</mml:mi>
                    <mml:mo>|</mml:mo>
                  </mml:math>
                </inline-formula>
              </td>
              <td rowspan="1" colspan="1">
                <inline-formula id="IE8">
                  <mml:math id="IM8" display="inline" overflow="scroll">
                    <mml:mi mathvariant="normal">Min</mml:mi>
                    <mml:mo>(</mml:mo>
                    <mml:mfenced open="|" close="|" separators="|">
                      <mml:mrow>
                        <mml:mi>A</mml:mi>
                      </mml:mrow>
                    </mml:mfenced>
                    <mml:mo>,</mml:mo>
                    <mml:mi mathvariant="normal"> </mml:mi>
                    <mml:mfenced open="|" close="|" separators="|">
                      <mml:mrow>
                        <mml:mi mathvariant="normal">B</mml:mi>
                      </mml:mrow>
                    </mml:mfenced>
                    <mml:mo>)</mml:mo>
                  </mml:math>
                </inline-formula>
              </td>
              <td rowspan="1" colspan="1">0</td>
              <td rowspan="1" colspan="1">
                <list list-type="simple">
                  <list-item>
                    <p>1 (when <italic toggle="yes">A</italic> = <italic toggle="yes">B</italic>,</p>
                  </list-item>
                  <list-item>
                    <p><italic toggle="yes">A</italic> ∈ <italic toggle="yes">B</italic>, <italic toggle="yes">B</italic> ∈ <italic toggle="yes">A</italic>)</p>
                  </list-item>
                </list>
              </td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">PMI</td>
              <td colspan="2" rowspan="1">See Section 2</td>
              <td rowspan="1" colspan="1">−∞</td>
              <td rowspan="1" colspan="1">
                <list list-type="simple">
                  <list-item>
                    <p>min(−log(<italic toggle="yes">p</italic>(<italic toggle="yes">A</italic>)),</p>
                  </list-item>
                  <list-item>
                    <p>−log(<italic toggle="yes">p</italic>(<italic toggle="yes">B</italic>)))</p>
                  </list-item>
                </list>
              </td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">NPMI</td>
              <td colspan="2" rowspan="1">See Section 2</td>
              <td rowspan="1" colspan="1">−1</td>
              <td rowspan="1" colspan="1">1</td>
            </tr>
          </tbody>
        </table>
        <table-wrap-foot>
          <fn id="tblfn1">
            <p><italic toggle="yes">Notes</italic>: <italic toggle="yes">A</italic> and <italic toggle="yes">B</italic> represent two sets of genomic intervals. <italic toggle="yes">C</italic>, the collocation coefficient; <italic toggle="yes">J</italic>, the Jaccard coefficient; <italic toggle="yes">SD</italic>, the Sørensen–Dice coefficient; SS, the Szymkiewicz–Simpson coefficient.</p>
          </fn>
        </table-wrap-foot>
      </table-wrap>
      <p>In addition to these four intersection-based metrics, we also introduced two information-theory-based association measures: PMI and normalized PMI (NPMI). PMI measures how much the observed overlap differs from what we expected. PMI =<italic toggle="yes"> </italic>0 indicates that <italic toggle="yes">A</italic> and <italic toggle="yes">B</italic> are independent, whereas PMI &gt; 0 and PMI &lt; 0 indicate that the overlap between <italic toggle="yes">A</italic> and <italic toggle="yes">B</italic> is higher and lower than expected if <italic toggle="yes">A</italic> and <italic toggle="yes">B</italic> were independent, respectively. Although PMI is a standard measure to quantify overlapping or co-occurrence, the lack of a fixed upper bound compromises its use for cross-sample comparison. Instead, NPMI gives a fixed upper bound and lower bound with “−1” and “1,” indicating no collocation and complete collocation, respectively (<xref rid="vbad104-T1" ref-type="table">Table 1</xref>).</p>
    </sec>
    <sec>
      <title>3.2 Identify TFs co-localized with CTCF bindings</title>
      <p>CTCF is a TF that plays a critical role in chromatin organization. The interdependence between CTCF and the cohesin proteins (including RAD21, SMC1A, SMC3, STAG1, and STAG2) to regulate the 3D chromatin architecture is well-known and has been independently validated by numerous studies (<xref rid="vbad104-B18" ref-type="bibr">Hansen <italic toggle="yes">et al.</italic> 2017</xref>, <xref rid="vbad104-B4" ref-type="bibr">Cattoglio <italic toggle="yes">et al.</italic> 2019</xref>, <xref rid="vbad104-B26" ref-type="bibr">Li <italic toggle="yes">et al.</italic> 2020</xref>, <xref rid="vbad104-B35" ref-type="bibr">Pugacheva <italic toggle="yes">et al.</italic> 2020</xref>, <xref rid="vbad104-B15" ref-type="bibr">Gabriele <italic toggle="yes">et al.</italic> 2022</xref>, <xref rid="vbad104-B29" ref-type="bibr">Mach <italic toggle="yes">et al.</italic> 2022</xref>). Their collaborative relationship leads to collocated bindings. This allows us to evaluate the performance of the six collocation measurements implemented in the cobind package. We first calculated the scores of these metrics between CTCF’s binding sites (CBF) and those binding sites of other 1207 TFs curated in the ReMap database (<ext-link xlink:href="https://remap.univ-amu.fr/" ext-link-type="uri">https://remap.univ-amu.fr/</ext-link>). We also calculated <italic toggle="yes">Z</italic>-scores combining all six metrics as an overall measure (<xref rid="vbad104-F1" ref-type="fig">Fig. 1A</xref> and <xref rid="sup1" ref-type="supplementary-material">Supplementary Table S1</xref>; Section 2).</p>
      <fig position="float" id="vbad104-F1">
        <label>Figure 1.</label>
        <caption>
          <p>Evaluation of the collocation metrics implemented in cobind using CTCF binding sites. (A) The process of calculating the six collocation measurements (and the combined <italic toggle="yes">Z</italic>-score) of a query genomic interval with the database of TFBS. (B) Heatmap shows Pearson’s and Spearman’s pairwise correlations between six collocation metrics, including <italic toggle="yes">C</italic>, <italic toggle="yes">J</italic>, SD, NPMI, PMI, and SS. The collocation coefficients were calculated between CTCF binding sites and the binding sites of 1207 TFs. (C) Barplots show the top 20 TFs whose binding sites overlap with CTCF binding sites. Outliers (defined as TFs whose <italic toggle="yes">Z</italic>-score is at least three standard deviations from the mean) were filled in red, while other proteins were filled in blue. (D) Venn diagram shows the overlaps of the top 10 master regulators reported by <italic toggle="yes">C</italic>, <italic toggle="yes">J</italic>(SD), SS(PMI), and NPMI. <italic toggle="yes">J</italic> and SD, SS, and PMI were combined since the top 10 master regulators were the same. (E) The density plot shows the five cohesin proteins and TRIM22 were identified as outliers. <italic toggle="yes">C</italic>, collocation coefficient; <italic toggle="yes">J</italic>, the Jaccard coefficient; SD, the Sørensen–Dice coefficient; SS, the Szymkiewicz–Simpson coefficient; PMI, pointwise mutual information; NPMI, normalized pointwise mutual information.</p>
        </caption>
        <graphic xlink:href="vbad104f1" position="float"/>
      </fig>
      <p>The results indicated that the six metrics exhibited high pairwise concordance with Spearman’s correlation coefficient (<italic toggle="yes">ρ</italic>) ranging from 0.60 to 0.99 (mean = 0.83, median = 0.88) and Pearson’s <italic toggle="yes">r</italic> ranging from 0.57 to 0.99 (mean = 0.80, median = 0.78) (<xref rid="vbad104-F1" ref-type="fig">Fig. 1B</xref>). All six metrics successfully ranked the five cohesin proteins (RAD21, SMC1A, SMC3, STAG1, STAG2) and the TRIM22 protein in the top 10 (<xref rid="vbad104-F1" ref-type="fig">Fig. 1C and D</xref>). Considering data points with more than 3 standard deviations from the mean as outliers, these six proteins were the only outliers detected (<xref rid="vbad104-F1" ref-type="fig">Fig. 1E</xref>). This suggests that their collocations with CTCF are significantly higher than those of other proteins. Although the exact mechanism is unclear, multiple studies have identified TRIM22 as a critical regulator of chromatin structure. TRIM22 bindings are highly enriched at chromatin contact domain boundaries (<xref rid="vbad104-B42" ref-type="bibr">Weintraub <italic toggle="yes">et al.</italic> 2017</xref>, <xref rid="vbad104-B5" ref-type="bibr">Chen <italic toggle="yes">et al.</italic> 2018</xref>). TRIM22 is reported as one of the most informative proteins for predicting human chromosome structures (<xref rid="vbad104-B10" ref-type="bibr">Di Pierro <italic toggle="yes">et al.</italic> 2017</xref>). TRIM22 has also been identified as one of the loop-mediating proteins by a deep learning algorithm (RefHiC) using HiC data (<xref rid="vbad104-B49" ref-type="bibr">Zhang and Blanchette 2022</xref>). In summary, these algorithms could successfully nominate CTCF’s cofactors from other DNA-binding proteins and highlight the potential of collocation analysis in revealing meaningful biological associations.</p>
      <p>As a comparison, the conventional threshold-and-count approach missed the majority of cohesin proteins from the top 10 rankings, regardless of the thresholds applied (<xref rid="sup1" ref-type="supplementary-material">Supplementary Fig. S2</xref>). We found that only one cohesin protein (RAD21) was identified with relatively relaxed thresholds (i.e. from 1 nt overlap to 30% of CTCF peak overlap). When using the most stringent thresholds (&gt;50% of CTCF peak overlap), two to three cohesin proteins (RAD21, SMC1A, and SMC3) were detected (<xref rid="sup1" ref-type="supplementary-material">Supplementary Fig. S2</xref>). These results indicate that the threshold-and-count approach is influenced by the number of peaks and lacks the sensitivity to identify CTCF’s cofactors. For example, this method consistently ranked BRD4 and ESR1 at the top of the list. These two TFs are likely false positives; they are ranked the highest simply because BRD4 (1105211 peaks) and ESR1 (866869 peaks) have the largest and the second largest number of peaks, respectively.</p>
    </sec>
    <sec>
      <title>3.3 Identify the master regulators co-localized with cancer-specific OCRs</title>
      <p>OCRs refer to exposed DNA accessible to TFs and other regulatory proteins. Collocation analysis of TF binding sites (TFBS) with cancer-specific OCRs offers the opportunity to identify master regulators implicated in modulating cancer-specific transcription programs. To demonstrate the utility of our approach, we applied the algorithms implemented in the cobind package to analyze the collocation between the TFBS of 1208 TFs (<xref rid="sup1" ref-type="supplementary-material">Supplementary Table S1</xref>) and OCRs specific to 17 common cancers (<xref rid="sup1" ref-type="supplementary-material">Supplementary Table S2</xref>). The resulting collocation <italic toggle="yes">Z</italic>-scores are listed in <xref rid="sup1" ref-type="supplementary-material">Supplementary Table S3</xref>.</p>
      <p>Our collocation analyses revealed many well-known, cancer-specific master regulators (<xref rid="sup1" ref-type="supplementary-material">Supplementary Fig. S3</xref> and <xref rid="sup1" ref-type="supplementary-material">Supplementary Tables S3 and S4</xref>). For example, GATA3, ESR1, and TRPS1 were identified as the three leading master regulators in breast cancer (<xref rid="vbad104-F2" ref-type="fig">Fig. 2A</xref>). The implications of these TFs with breast cancer are reported by numerous studies (<xref rid="vbad104-B44" ref-type="bibr">Witwicki <italic toggle="yes">et al.</italic> 2018</xref>, <xref rid="vbad104-B11" ref-type="bibr">Dustin <italic toggle="yes">et al.</italic> 2019</xref>, <xref rid="vbad104-B2" ref-type="bibr">Brett <italic toggle="yes">et al.</italic> 2021</xref>, <xref rid="vbad104-B21" ref-type="bibr">Herzog and Fuqua 2022</xref>, <xref rid="vbad104-B32" ref-type="bibr">Parkinson <italic toggle="yes">et al.</italic> 2022</xref>, <xref rid="vbad104-B45" ref-type="bibr">Yoon <italic toggle="yes">et al.</italic> 2022</xref>). AR, HOXB13, and TLE3 were identified as the top three master regulators in prostate cancer (<xref rid="vbad104-F2" ref-type="fig">Fig. 2B</xref>), which is also in line with previous findings (<xref rid="vbad104-B20" ref-type="bibr">Heinlein and Chang 2004</xref>, <xref rid="vbad104-B31" ref-type="bibr">Palit <italic toggle="yes">et al.</italic> 2019</xref>, <xref rid="vbad104-B23" ref-type="bibr">Jamroze <italic toggle="yes">et al.</italic> 2021</xref>, <xref rid="vbad104-B9" ref-type="bibr">Darst <italic toggle="yes">et al.</italic> 2022</xref>, <xref rid="vbad104-B27" ref-type="bibr">Lu <italic toggle="yes">et al.</italic> 2022</xref>). SOX10, a key nuclear TF involved in differentiating neural crest progenitor cells into melanocytes, was recognized as the top master regulator in Skin Cutaneous Melanoma (SKCM) (<xref rid="vbad104-B37" ref-type="bibr">Rosenbaum <italic toggle="yes">et al.</italic> 2021</xref>, <xref rid="vbad104-B3" ref-type="bibr">Capparelli <italic toggle="yes">et al.</italic> 2022</xref>). CDX2, an intestine-specific TF that regulates intestinal development and oncogenesis, was found as the top master regulator in colon adenocarcinoma (COAD) (<xref rid="vbad104-B8" ref-type="bibr">Crissey <italic toggle="yes">et al.</italic> 2011</xref>, <xref rid="vbad104-B34" ref-type="bibr">Pilati <italic toggle="yes">et al.</italic> 2017</xref>, <xref rid="vbad104-B46" ref-type="bibr">Yu <italic toggle="yes">et al.</italic> 2019</xref>). Lung adenocarcinoma (LUAD) and lung squamous cell carcinoma (LUSC) are the most common subtypes of lung cancer. Although both LUAD and LUSC are classified as non-small cell lung cancer, they have drastically different biology, etiology, molecular characteristics, and clinical behavior. Our collocation analysis revealed that NKX2-1 (<xref rid="vbad104-B43" ref-type="bibr">Winslow <italic toggle="yes">et al.</italic> 2011</xref>, <xref rid="vbad104-B30" ref-type="bibr">Mollaoglu <italic toggle="yes">et al.</italic> 2018</xref>, <xref rid="vbad104-B33" ref-type="bibr">Phelps <italic toggle="yes">et al.</italic> 2018</xref>, <xref rid="vbad104-B22" ref-type="bibr">Ingram <italic toggle="yes">et al.</italic> 2022</xref>) and ASCL1 (<xref rid="vbad104-B24" ref-type="bibr">Kosari <italic toggle="yes">et al.</italic> 2014</xref>, <xref rid="vbad104-B1" ref-type="bibr">Baine <italic toggle="yes">et al.</italic> 2020</xref>) are the top regulators in LUAD, while TP63, TP73, SOX2, and TP53 are the top regulators in LUSC. In fact, we only observed one common TF, IRF4, which regulates transcription programs in immune cells, out of the 10 and 11 master regulators in LUAD and LUSC, respectively (<xref rid="vbad104-F2" ref-type="fig">Fig. 2C and D</xref>). LGG and GBM are two common brain tumor types. LGG is slow growing, has a better prognosis and response to treatment, and tends to recur less frequently. GBM, on the other hand, is more aggressive, has a poorer prognosis with a shorter overall survival rate and a higher recurrence rate. Our collocation analyses revealed 19 master regulators in LGG and 18 master regulators in GBM, of which 11 (NEUROG2, OLIG2, RARA, SOX2, SOX3, SOX8, SOX21, CHD7, MYOG, MYF5, FOXO1-PAX3) are shared (<xref rid="vbad104-F2" ref-type="fig">Fig. 2E and F</xref>). Of note, BMI1 was identified as one of the top master regulators in GBM but not in LGG, and numerous studies have revealed that BMI1 plays a significant role in promoting cell proliferation, inhibiting cell death, sustaining stem cell renewal, and activating signaling pathways, all of which contribute to the development, progression, and aggressiveness of GBMs (<xref rid="vbad104-B40" ref-type="bibr">Venugopal <italic toggle="yes">et al.</italic> 2012</xref>, <xref rid="vbad104-B41" ref-type="bibr">Vora <italic toggle="yes">et al.</italic> 2019</xref>, <xref rid="vbad104-B13" ref-type="bibr">Flamier <italic toggle="yes">et al.</italic> 2020</xref>, <xref rid="vbad104-B14" ref-type="bibr">Freire-Benéitez <italic toggle="yes">et al.</italic> 2021</xref>). In summary, our analyses suggested that collocation analyses of cancer-specific OCRs with TFBS can provide valuable information for understanding the molecular mechanisms that drive cancer development and identify biomarkers for cancer diagnosis, prognosis, and treatment.</p>
      <fig position="float" id="vbad104-F2">
        <label>Figure 2.</label>
        <caption>
          <p>Evaluation of the collocation metrics implemented in cobind using cancer-specific OCRs identified from ATAC-seq data. (A) Candidate master regulators identified from breast cancer-specific OCRs. (B) Candidate master regulators identified from prostate cancer-specific OCRs. (C) Candidate master regulators identified from LUAD- and LUSC-specific OCRs. (D) Venn diagram shows the overlap of master regulators identified from LUAD and LUSC. (E) Candidate master regulators identified from LGG and GBM. (F) Venn diagram shows the overlap of master regulators identified in LGG and GBM.</p>
        </caption>
        <graphic xlink:href="vbad104f2" position="float"/>
      </fig>
    </sec>
    <sec>
      <title>3.4 Identify the master regulators co-localized with oligodendrocyte-specific open chromatin</title>
      <p>In a study profiling the chromatin accessibility of more than 70 000 human adult brain cells, <xref rid="vbad104-B7" ref-type="bibr">Corces <italic toggle="yes">et al.</italic> (2020)</xref> discovered six major cell types, including oligodendrocytes, excitatory neurons, inhibitory neurons, microglia, astrocytes, and oligodendrocyte progenitor cells, of which oligodendrocytes is the largest cell population. To identify putative master regulators responsible for establishing and maintaining cell type-specific regulatory programs, the authors performed DNA motif enrichment analyses on scATAC-seq peak regions specific to oligodendrocytes. They found that SOX9, SOX10, and FOXN2 DNA motifs were significantly enriched in the oligodendrocytes OCRs (<xref rid="vbad104-B7" ref-type="bibr">Corces <italic toggle="yes">et al.</italic> 2020</xref>).</p>
      <p>Aiming to identify the master regulators in oligodendrocytes, we used the cobind package to conduct the collocation analysis between oligodendrocyte-specific OCRs and the binding sites of 1208 TFs (<xref rid="sup1" ref-type="supplementary-material">Supplementary Table S5</xref>). Our methods revealed seven TFs (SOX10, OLIG2, SOX8, SOX2, ZNF654, ZBTB2, and SOX21) that were significantly collocated with oligodendrocyte-specific <italic toggle="yes">cis</italic>-regulatory regions (<xref rid="vbad104-F3" ref-type="fig">Fig. 3A</xref> and <xref rid="sup1" ref-type="supplementary-material">Supplementary Fig. S4</xref>), among which SOX10 and oligodendrocyte TF 2 (OLIG2) had the highest <italic toggle="yes">Z</italic>-scores (<xref rid="vbad104-F3" ref-type="fig">Fig. 3B</xref>), suggesting that they are master regulators of oligodendrocytes. To independently validate these results, we examined the snRNA-seq expression data generated from the human cortex and primary motor cortex region (M1) by the Allen Brain Map project (<ext-link xlink:href="https://portal.brain-map.org/" ext-link-type="uri">https://portal.brain-map.org/</ext-link>). Indeed, we observed that SOX10 and OLIG2 were expressed specifically in oligodendrocytes (<xref rid="vbad104-F3" ref-type="fig">Fig. 3C and D</xref>).</p>
      <fig position="float" id="vbad104-F3">
        <label>Figure 3.</label>
        <caption>
          <p>Evaluation of the collocation metrics implemented in cobind using oligodendrocytes-specific OCRs identified from scATAC-seq data. (A) Venn diagram shows the overlaps of the top 10 master regulators reported by <italic toggle="yes">C</italic>, <italic toggle="yes">J</italic>(SD), SS(PMI), and NPMI. <italic toggle="yes">J</italic> and SD, SS, and PMI were combined since the top 10 master regulators were the same. (B) Barplot shows the <italic toggle="yes">Z</italic>-scores of the seven master regulators reported by all six metrics. Venn diagram shows the overlap between the top three TFs identified by motif analysis (green circle) and the top two TFs identified by collocation analysis (red circle). (C) t-distributed stochastic neighbor embedding (tSNE)-based cell map shows that <italic toggle="yes">SOX10</italic> is specifically expressed in oligodendrocytes. Upper: <italic toggle="yes">SOX10</italic> expression in human primary motor cortex region (M1). Lower: <italic toggle="yes">SOX10</italic> expression in human cortex brain region. (D) tSNE-based cell map shows that <italic toggle="yes">OLIG2</italic> is specifically expressed in oligodendrocytes. Upper: <italic toggle="yes">OLIG2</italic> expression in the human primary motor cortex (M1) region. Lower: <italic toggle="yes">OLIG2</italic> expression in the human cortex brain region. UMI, unique molecular identifiers.</p>
        </caption>
        <graphic xlink:href="vbad104f3" position="float"/>
      </fig>
      <p>Among the three TFs (SOX10, SOX9, and FOXN2) reported by <xref rid="vbad104-B7" ref-type="bibr">Corces <italic toggle="yes">et al.</italic> (2020)</xref> using the motif enrichment method, two (SOX9 and FOXN2) were not detected by our collocation analysis approach; SOX9 was ranked 89th by <italic toggle="yes">Z</italic>-score, while FOXN2 was not included in the ReMap database (<xref rid="sup1" ref-type="supplementary-material">Supplementary Table S5</xref>). snRNA-seq data show that SOX9 and FOXN2 genes were not explicitly expressed in oligodendrocytes, suggesting these two TFs are less likely to be master regulators (<xref rid="sup1" ref-type="supplementary-material">Supplementary Fig. S5</xref>). In contrast, OLIG2, which was missed by the motif enrichment analysis method, is explicitly expressed in both oligodendrocytes and oligodendrocyte progenitor cells (<xref rid="vbad104-F3" ref-type="fig">Fig. 3B and D</xref>) and has proven to play an imperative role in promoting oligodendrocyte differentiation (<xref rid="vbad104-B39" ref-type="bibr">Takebayashi <italic toggle="yes">et al.</italic> 2000</xref>, <xref rid="vbad104-B50" ref-type="bibr">Zhou <italic toggle="yes">et al.</italic> 2001</xref>, <xref rid="vbad104-B47" ref-type="bibr">Yu <italic toggle="yes">et al.</italic> 2013</xref>). These results highlighted that collocation analysis is a more robust approach to revealing key TFs that might be missed by motif analysis.</p>
    </sec>
  </sec>
  <sec>
    <title>4 Summary and discussion</title>
    <p>The metrics implemented in the cobind package (except the collocation coefficient) have been widely utilized in the Natural Language Processing field to determine if two words occur more frequently than expected by chance. However, in the genomics field, only the Jaccard coefficient has been adopted by BEDTools to measure the overlaps between two BED files. It is worth noting that there is a slight difference in the calculation of the Jaccard coefficient between cobind and BEDTools. Cobind considers every input genomic interval, regardless of overlap, while BEDTools only consider intervals that exhibit overlap.</p>
    <p>Motif analysis, a computational approach to identify overrepresented short-nucleotide patterns, has been extensively applied to identify common regulators from a given set of genomic intervals. Although DNA motif analysis can provide valuable insights, it is prone to false positives and false negatives since most TFs only bind less than a few percent of their consensus target sites in the genome (<xref rid="vbad104-B48" ref-type="bibr">Zaret and Carroll 2011</xref>). In our study, we demonstrated that collocation analysis successfully identified a known master regulator in oligodendrocytes, OLIG2, which was not detected by motif analysis. This result highlights the collocation analysis’s potential as a more effective alternative to motif analysis. However, collocation analysis necessitates a comprehensive list of well-annotated <italic toggle="yes">cis</italic>-regulatory sites. Fortunately, public consortia such as ENCODE, modENCODE, Roadmap, and functional genomic repositories like GEO (<ext-link xlink:href="https://www.ncbi.nlm.nih.gov/geo/" ext-link-type="uri">https://www.ncbi.nlm.nih.gov/geo/</ext-link>) offer rich resources encompassing a wide range of TFs from numerous tissues and cell lines.</p>
    <p>The cobind package is the first bioinformatics tool specifically designed for quantitative collocation analysis of genomic intervals. It is efficient in terms of speed and memory usage (<xref rid="sup1" ref-type="supplementary-material">Supplementary Table S6</xref>). This study demonstrated the significant potential of cobind in characterizing the functionalities of noncoding genomic regions, integrating multi-omics data, and gaining new biological insights. This potential is particularly relevant in the context of functional genomics assays such as scATAC-seq, which can reveal cell type-specific regulatory elements.</p>
  </sec>
  <sec sec-type="supplementary-material">
    <title>Supplementary Material</title>
    <supplementary-material id="sup1" position="float" content-type="local-data">
      <label>vbad104_Supplementary_Data</label>
      <media xlink:href="vbad104_supplementary_data.zip">
        <caption>
          <p>Click here for additional data file.</p>
        </caption>
      </media>
    </supplementary-material>
  </sec>
</body>
<back>
  <sec>
    <title>Author contributions</title>
    <p>Tao Ma (Data curation [lead], Formal analysis [lead], Validation [lead], Visualization [equal], Writing—original draft [equal], Writing—review &amp; editing [equal]), Lingyun Guo (Data curation [supporting], Formal analysis [supporting]), HuiHuang Yan (Writing—review &amp; editing [supporting]), and Liguo Wang (Conceptualization [lead], Data curation [lead], Formal analysis [lead], Funding acquisition [lead], Investigation [lead], Methodology [lead], Project administration [lead], Software [lead], Supervision [lead], Validation [lead], Visualization [lead], Writing—original draft [lead], Writing—review &amp; editing [lead])</p>
  </sec>
  <sec>
    <title>Supplementary data</title>
    <p><xref rid="sup1" ref-type="supplementary-material">Supplementary data</xref> are available at <italic toggle="yes">Bioinformatics Advances</italic> online.</p>
  </sec>
  <sec sec-type="COI-statement">
    <title>Conflict of interest</title>
    <p>None declared.</p>
  </sec>
  <sec>
    <title>Funding</title>
    <p>This work is partially supported by the US National Institute of Health [CA180882-07, CA130908-12, CA230712-4, and AA27179] and the epigenomics program of the Center for Individualized Medicine of Mayo Clinic.</p>
  </sec>
  <sec sec-type="data-availability">
    <title>Data availability</title>
    <p>The data underlying this article are available in the article and in its online <xref rid="sup1" ref-type="supplementary-material">supplementary material</xref>.</p>
  </sec>
  <ref-list id="ref1">
    <title>References</title>
    <ref id="vbad104-B1">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Baine</surname><given-names>MK</given-names></string-name>, <string-name><surname>Hsieh</surname><given-names>M-S</given-names></string-name>, <string-name><surname>Lai</surname><given-names>WV</given-names></string-name></person-group><etal>et al</etal><article-title>SCLC subtypes defined by ASCL1, NEUROD1, POU2F3, and YAP1: a comprehensive immunohistochemical and histopathologic characterization</article-title>. <source>J Thorac Oncol</source><year>2020</year>;<volume>15</volume>:<fpage>1823</fpage>–<lpage>35</lpage>.<pub-id pub-id-type="pmid">33011388</pub-id></mixed-citation>
    </ref>
    <ref id="vbad104-B2">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Brett</surname><given-names>JO</given-names></string-name>, <string-name><surname>Spring</surname><given-names>LM</given-names></string-name>, <string-name><surname>Bardia</surname><given-names>A</given-names></string-name></person-group><etal>et al</etal><article-title>ESR1 mutation as an emerging clinical biomarker in metastatic hormone receptor-positive breast cancer</article-title>. <source>Breast Cancer Res</source><year>2021</year>;<volume>23</volume>:<fpage>85</fpage>.<pub-id pub-id-type="pmid">34392831</pub-id></mixed-citation>
    </ref>
    <ref id="vbad104-B3">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Capparelli</surname><given-names>C</given-names></string-name>, <string-name><surname>Purwin</surname><given-names>TJ</given-names></string-name>, <string-name><surname>Glasheen</surname><given-names>M</given-names></string-name></person-group><etal>et al</etal><article-title>Targeting SOX10-deficient cells to reduce the dormant-invasive phenotype state in melanoma</article-title>. <source>Nat Commun</source><year>2022</year>;<volume>13</volume>:<fpage>1381</fpage>.<pub-id pub-id-type="pmid">35296667</pub-id></mixed-citation>
    </ref>
    <ref id="vbad104-B4">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Cattoglio</surname><given-names>C</given-names></string-name>, <string-name><surname>Pustova</surname><given-names>I</given-names></string-name>, <string-name><surname>Walther</surname><given-names>N</given-names></string-name></person-group><etal>et al</etal><article-title>Determining cellular CTCF and cohesin abundances to constrain 3D genome models</article-title>. <source>Elife</source><year>2019</year>;<volume>8</volume>:e40164.</mixed-citation>
    </ref>
    <ref id="vbad104-B5">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Chen</surname><given-names>F</given-names></string-name>, <string-name><surname>Li</surname><given-names>G</given-names></string-name>, <string-name><surname>Zhang</surname><given-names>MQ</given-names></string-name></person-group><etal>et al</etal><article-title>HiCDB: a sensitive and robust method for detecting contact domain boundaries</article-title>. <source>Nucleic Acids Res</source><year>2018</year>;<volume>46</volume>:<fpage>11239</fpage>–<lpage>50</lpage>.<pub-id pub-id-type="pmid">30184171</pub-id></mixed-citation>
    </ref>
    <ref id="vbad104-B6">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Corces</surname><given-names>MR</given-names></string-name>, <string-name><surname>Granja</surname><given-names>JM</given-names></string-name>, <string-name><surname>Shams</surname><given-names>S</given-names></string-name></person-group><etal>et al</etal>; <collab>Cancer Genome Atlas Analysis Network</collab>. <article-title>The chromatin accessibility landscape of primary human cancers</article-title>. <source>Science</source><year>2018</year>;<volume>362</volume>:<fpage>6413</fpage>.</mixed-citation>
    </ref>
    <ref id="vbad104-B7">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Corces</surname><given-names>MR</given-names></string-name>, <string-name><surname>Shcherbina</surname><given-names>A</given-names></string-name>, <string-name><surname>Kundu</surname><given-names>S</given-names></string-name></person-group><etal>et al</etal><article-title>Single-cell epigenomic analyses implicate candidate causal variants at inherited risk loci for Alzheimer’s and Parkinson’s diseases</article-title>. <source>Nat Genet</source><year>2020</year>;<volume>52</volume>:<fpage>1158</fpage>–<lpage>68</lpage>.<pub-id pub-id-type="pmid">33106633</pub-id></mixed-citation>
    </ref>
    <ref id="vbad104-B8">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Crissey</surname><given-names>MAS</given-names></string-name>, <string-name><surname>Guo</surname><given-names>R-J</given-names></string-name>, <string-name><surname>Funakoshi</surname><given-names>S</given-names></string-name></person-group><etal>et al</etal><article-title>Cdx2 levels modulate intestinal epithelium maturity and Paneth cell development</article-title>. <source>Gastroenterology</source><year>2011</year>;<volume>140</volume>:<fpage>517</fpage>–<lpage>28 e518</lpage>.<pub-id pub-id-type="pmid">21081128</pub-id></mixed-citation>
    </ref>
    <ref id="vbad104-B9">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Darst</surname><given-names>BF</given-names></string-name>, <string-name><surname>Hughley</surname><given-names>R</given-names></string-name>, <string-name><surname>Pfennig</surname><given-names>A</given-names></string-name></person-group><etal>et al</etal><article-title>A rare germline HOXB13 variant contributes to risk of prostate cancer in men of African ancestry</article-title>. <source>Eur Urol</source><year>2022</year>;<volume>81</volume>:<fpage>458</fpage>–<lpage>62</lpage>.<pub-id pub-id-type="pmid">35031163</pub-id></mixed-citation>
    </ref>
    <ref id="vbad104-B10">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Di Pierro</surname><given-names>M</given-names></string-name>, <string-name><surname>Cheng</surname><given-names>RR</given-names></string-name>, <string-name><surname>Lieberman Aiden</surname><given-names>E</given-names></string-name></person-group><etal>et al</etal><article-title>De novo prediction of human chromosome structures: epigenetic marking patterns encode genome architecture</article-title>. <source>Proc Natl Acad Sci USA</source><year>2017</year>;<volume>114</volume>:<fpage>12126</fpage>–<lpage>31</lpage>.<pub-id pub-id-type="pmid">29087948</pub-id></mixed-citation>
    </ref>
    <ref id="vbad104-B11">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Dustin</surname><given-names>D</given-names></string-name>, <string-name><surname>Gu</surname><given-names>G</given-names></string-name>, <string-name><surname>Fuqua</surname><given-names>SAW</given-names></string-name></person-group><etal>et al</etal><article-title>ESR1 mutations in breast cancer</article-title>. <source>Cancer</source><year>2019</year>;<volume>125</volume>:<fpage>3714</fpage>–<lpage>28</lpage>.<pub-id pub-id-type="pmid">31318440</pub-id></mixed-citation>
    </ref>
    <ref id="vbad104-B12">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Ferré</surname><given-names>Q</given-names></string-name>, <string-name><surname>Charbonnier</surname><given-names>G</given-names></string-name>, <string-name><surname>Sadouni</surname><given-names>N</given-names></string-name></person-group><etal>et al</etal><article-title>OLOGRAM: determining significance of total overlap length between genomic regions sets</article-title>. <source>Bioinformatics</source><year>2020</year>;<volume>36</volume>:<fpage>1920</fpage>–<lpage>2</lpage>.</mixed-citation>
    </ref>
    <ref id="vbad104-B13">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Flamier</surname><given-names>A</given-names></string-name>, <string-name><surname>Abdouh</surname><given-names>M</given-names></string-name>, <string-name><surname>Hamam</surname><given-names>R</given-names></string-name></person-group><etal>et al</etal><article-title>Off-target effect of the BMI1 inhibitor PTC596 drives epithelial-mesenchymal transition in glioblastoma multiforme</article-title>. <source>NPJ Precis Oncol</source><year>2020</year>;<volume>4</volume>:<fpage>1</fpage>.<pub-id pub-id-type="pmid">31934644</pub-id></mixed-citation>
    </ref>
    <ref id="vbad104-B14">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Freire-Benéitez</surname><given-names>V</given-names></string-name>, <string-name><surname>Pomella</surname><given-names>N</given-names></string-name>, <string-name><surname>Millner</surname><given-names>TO</given-names></string-name></person-group><etal>et al</etal><article-title>Elucidation of the BMI1 interactome identifies novel regulatory roles in glioblastoma</article-title>. <source>NAR Cancer</source><year>2021</year>;<volume>3</volume>:zcab009.</mixed-citation>
    </ref>
    <ref id="vbad104-B15">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Gabriele</surname><given-names>M</given-names></string-name>, <string-name><surname>Brandão</surname><given-names>HB</given-names></string-name>, <string-name><surname>Grosse-Holz</surname><given-names>S</given-names></string-name></person-group><etal>et al</etal><article-title>Dynamics of CTCF- and cohesin-mediated chromatin looping revealed by live-cell imaging</article-title>. <source>Science</source><year>2022</year>;<volume>376</volume>:<fpage>496</fpage>–<lpage>501</lpage>.<pub-id pub-id-type="pmid">35420890</pub-id></mixed-citation>
    </ref>
    <ref id="vbad104-B16">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Haiminen</surname><given-names>N</given-names></string-name>, <string-name><surname>Mannila</surname><given-names>H</given-names></string-name>, <string-name><surname>Terzi</surname><given-names>E</given-names></string-name></person-group><etal>et al</etal><article-title>Determining significance of pairwise co-occurrences of events in bursty sequences</article-title>. <source>BMC Bioinformatics</source><year>2008</year>;<volume>9</volume>:<fpage>336</fpage>.<pub-id pub-id-type="pmid">18691400</pub-id></mixed-citation>
    </ref>
    <ref id="vbad104-B17">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Hammal</surname><given-names>F</given-names></string-name>, <string-name><surname>de Langen</surname><given-names>P</given-names></string-name>, <string-name><surname>Bergon</surname><given-names>A</given-names></string-name></person-group><etal>et al</etal><article-title>ReMap 2022: a database of human, mouse, drosophila and Arabidopsis regulatory regions from an integrative analysis of DNA-binding sequencing experiments</article-title>. <source>Nucleic Acids Res</source><year>2022</year>;<volume>50</volume>:<fpage>D316</fpage>–<lpage>25</lpage>.<pub-id pub-id-type="pmid">34751401</pub-id></mixed-citation>
    </ref>
    <ref id="vbad104-B18">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Hansen</surname><given-names>AS</given-names></string-name>, <string-name><surname>Pustova</surname><given-names>I</given-names></string-name>, <string-name><surname>Cattoglio</surname><given-names>C</given-names></string-name></person-group><etal>et al</etal><article-title>CTCF and cohesin regulate chromatin loop stability with distinct dynamics</article-title>. <source>Elife</source><year>2017</year>;<volume>6</volume>:<fpage>e25776</fpage>.<pub-id pub-id-type="pmid">28467304</pub-id></mixed-citation>
    </ref>
    <ref id="vbad104-B19">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Hänzelmann</surname><given-names>S</given-names></string-name>, <string-name><surname>Castelo</surname><given-names>R</given-names></string-name>, <string-name><surname>Guinney</surname><given-names>J</given-names></string-name></person-group><etal>et al</etal><article-title>GSVA: gene set variation analysis for microarray and RNA-seq data</article-title>. <source>BMC Bioinformatics</source><year>2013</year>;<volume>14</volume>:<fpage>7</fpage>.<pub-id pub-id-type="pmid">23323831</pub-id></mixed-citation>
    </ref>
    <ref id="vbad104-B20">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Heinlein</surname><given-names>CA</given-names></string-name>, <string-name><surname>Chang</surname><given-names>C.</given-names></string-name></person-group><article-title>Androgen receptor in prostate cancer</article-title>. <source>Endocr Rev</source><year>2004</year>;<volume>25</volume>:<fpage>276</fpage>–<lpage>308</lpage>.<pub-id pub-id-type="pmid">15082523</pub-id></mixed-citation>
    </ref>
    <ref id="vbad104-B21">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Herzog</surname><given-names>SK</given-names></string-name>, <string-name><surname>Fuqua</surname><given-names>SAW.</given-names></string-name></person-group><article-title>ESR1 mutations and therapeutic resistance in metastatic breast cancer: progress and remaining challenges</article-title>. <source>Br J Cancer</source><year>2022</year>;<volume>126</volume>:<fpage>174</fpage>–<lpage>86</lpage>.<pub-id pub-id-type="pmid">34621045</pub-id></mixed-citation>
    </ref>
    <ref id="vbad104-B22">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Ingram</surname><given-names>K</given-names></string-name>, <string-name><surname>Samson</surname><given-names>SC</given-names></string-name>, <string-name><surname>Zewdu</surname><given-names>R</given-names></string-name></person-group><etal>et al</etal><article-title>NKX2-1 controls lung cancer progression by inducing DUSP6 to dampen ERK activity</article-title>. <source>Oncogene</source><year>2022</year>;<volume>41</volume>:<fpage>293</fpage>–<lpage>300</lpage>.<pub-id pub-id-type="pmid">34689179</pub-id></mixed-citation>
    </ref>
    <ref id="vbad104-B23">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Jamroze</surname><given-names>A</given-names></string-name>, <string-name><surname>Chatta</surname><given-names>G</given-names></string-name>, <string-name><surname>Tang</surname><given-names>DG</given-names></string-name></person-group><etal>et al</etal><article-title>Androgen receptor (AR) heterogeneity in prostate cancer and therapy resistance</article-title>. <source>Cancer Lett</source><year>2021</year>;<volume>518</volume>:<fpage>1</fpage>–<lpage>9</lpage>.<pub-id pub-id-type="pmid">34118355</pub-id></mixed-citation>
    </ref>
    <ref id="vbad104-B24">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Kosari</surname><given-names>F</given-names></string-name>, <string-name><surname>Ida</surname><given-names>CM</given-names></string-name>, <string-name><surname>Aubry</surname><given-names>M-C</given-names></string-name></person-group><etal>et al</etal><article-title>ASCL1 and RET expression defines a clinically relevant subgroup of lung adenocarcinoma characterized by neuroendocrine differentiation</article-title>. <source>Oncogene</source><year>2014</year>;<volume>33</volume>:<fpage>3776</fpage>–<lpage>83</lpage>.<pub-id pub-id-type="pmid">24037524</pub-id></mixed-citation>
    </ref>
    <ref id="vbad104-B25">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Layer</surname><given-names>RM</given-names></string-name>, <string-name><surname>Pedersen</surname><given-names>BS</given-names></string-name>, <string-name><surname>DiSera</surname><given-names>T</given-names></string-name></person-group><etal>et al</etal><article-title>GIGGLE: a search engine for large-scale integrated genome analysis</article-title>. <source>Nat Methods</source><year>2018</year>;<volume>15</volume>:<fpage>123</fpage>–<lpage>6</lpage>.<pub-id pub-id-type="pmid">29309061</pub-id></mixed-citation>
    </ref>
    <ref id="vbad104-B26">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Li</surname><given-names>Y</given-names></string-name>, <string-name><surname>Haarhuis</surname><given-names>JHI</given-names></string-name>, <string-name><surname>Sedeño Cacciatore</surname><given-names>Á</given-names></string-name></person-group><etal>et al</etal><article-title>The structural basis for cohesin-CTCF-anchored loops</article-title>. <source>Nature</source><year>2020</year>;<volume>578</volume>:<fpage>472</fpage>–<lpage>6</lpage>.<pub-id pub-id-type="pmid">31905366</pub-id></mixed-citation>
    </ref>
    <ref id="vbad104-B27">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Lu</surname><given-names>X</given-names></string-name>, <string-name><surname>Fong</surname><given-names>K-W</given-names></string-name>, <string-name><surname>Gritsina</surname><given-names>G</given-names></string-name></person-group><etal>et al</etal><article-title>HOXB13 suppresses de novo lipogenesis through HDAC3-mediated epigenetic reprogramming in prostate cancer</article-title>. <source>Nat Genet</source><year>2022</year>;<volume>54</volume>:<fpage>670</fpage>–<lpage>83</lpage>.<pub-id pub-id-type="pmid">35468964</pub-id></mixed-citation>
    </ref>
    <ref id="vbad104-B28">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Lupien</surname><given-names>M</given-names></string-name>, <string-name><surname>Eeckhoute</surname><given-names>J</given-names></string-name>, <string-name><surname>Meyer</surname><given-names>CA</given-names></string-name></person-group><etal>et al</etal><article-title>FoxA1 translates epigenetic signatures into enhancer-driven lineage-specific transcription</article-title>. <source>Cell</source><year>2008</year>;<volume>132</volume>:<fpage>958</fpage>–<lpage>70</lpage>.<pub-id pub-id-type="pmid">18358809</pub-id></mixed-citation>
    </ref>
    <ref id="vbad104-B29">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Mach</surname><given-names>P</given-names></string-name>, <string-name><surname>Kos</surname><given-names>PI</given-names></string-name>, <string-name><surname>Zhan</surname><given-names>Y</given-names></string-name></person-group><etal>et al</etal><article-title>Cohesin and CTCF control the dynamics of chromosome folding</article-title>. <source>Nat Genet</source><year>2022</year>;<volume>54</volume>:<fpage>1907</fpage>–<lpage>18</lpage>.<pub-id pub-id-type="pmid">36471076</pub-id></mixed-citation>
    </ref>
    <ref id="vbad104-B30">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Mollaoglu</surname><given-names>G</given-names></string-name>, <string-name><surname>Jones</surname><given-names>A</given-names></string-name>, <string-name><surname>Wait</surname><given-names>SJ</given-names></string-name></person-group><etal>et al</etal><article-title>The lineage-defining transcription factors SOX2 and NKX2-1 determine lung cancer cell fate and shape the tumor immune microenvironment</article-title>. <source>Immunity</source><year>2018</year>;<volume>49</volume>:<fpage>764</fpage>–<lpage>79</lpage> e769.<pub-id pub-id-type="pmid">30332632</pub-id></mixed-citation>
    </ref>
    <ref id="vbad104-B31">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Palit</surname><given-names>SA</given-names></string-name>, <string-name><surname>Vis</surname><given-names>D</given-names></string-name>, <string-name><surname>Stelloo</surname><given-names>S</given-names></string-name></person-group><etal>et al</etal><article-title>TLE3 loss confers AR inhibitor resistance by facilitating GR-mediated human prostate cancer cell growth</article-title>. <source>Elife</source><year>2019</year>;<volume>8</volume>:e47430.</mixed-citation>
    </ref>
    <ref id="vbad104-B32">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Parkinson</surname><given-names>B</given-names></string-name>, <string-name><surname>Chen</surname><given-names>W</given-names></string-name>, <string-name><surname>Shen</surname><given-names>T</given-names></string-name></person-group><etal>et al</etal><article-title>TRPS1 expression in breast carcinomas: focusing on metaplastic breast carcinomas</article-title>. <source>Am J Surg Pathol</source><year>2022</year>;<volume>46</volume>:<fpage>415</fpage>–<lpage>23</lpage>.<pub-id pub-id-type="pmid">35175968</pub-id></mixed-citation>
    </ref>
    <ref id="vbad104-B33">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Phelps</surname><given-names>CA</given-names></string-name>, <string-name><surname>Lai</surname><given-names>SC</given-names></string-name>, <string-name><surname>Mu</surname><given-names>D</given-names></string-name></person-group><etal>et al</etal><article-title>Roles of thyroid transcription factor 1 in lung cancer biology</article-title>. <source>Vitam Horm</source><year>2018</year>;<volume>106</volume>:<fpage>517</fpage>–<lpage>44</lpage>.<pub-id pub-id-type="pmid">29407447</pub-id></mixed-citation>
    </ref>
    <ref id="vbad104-B34">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Pilati</surname><given-names>C</given-names></string-name>, <string-name><surname>Taieb</surname><given-names>J</given-names></string-name>, <string-name><surname>Balogoun</surname><given-names>R</given-names></string-name></person-group><etal>et al</etal><article-title>CDX2 prognostic value in stage II/III resected Colon cancer is related to CMS classification</article-title>. <source>Ann Oncol</source><year>2017</year>;<volume>28</volume>:<fpage>1032</fpage>–<lpage>5</lpage>.<pub-id pub-id-type="pmid">28328000</pub-id></mixed-citation>
    </ref>
    <ref id="vbad104-B35">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Pugacheva</surname><given-names>EM</given-names></string-name>, <string-name><surname>Kubo</surname><given-names>N</given-names></string-name>, <string-name><surname>Loukinov</surname><given-names>D</given-names></string-name></person-group><etal>et al</etal><article-title>CTCF mediates chromatin looping via N-terminal domain-dependent cohesin retention</article-title>. <source>Proc Natl Acad Sci USA</source><year>2020</year>;<volume>117</volume>:<fpage>2020</fpage>–<lpage>31</lpage>.<pub-id pub-id-type="pmid">31937660</pub-id></mixed-citation>
    </ref>
    <ref id="vbad104-B36">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Quinlan</surname><given-names>AR</given-names></string-name>, <string-name><surname>Hall</surname><given-names>IM.</given-names></string-name></person-group><article-title>BEDTools: a flexible suite of utilities for comparing genomic features</article-title>. <source>Bioinformatics</source><year>2010</year>;<volume>26</volume>:<fpage>841</fpage>–<lpage>2</lpage>.<pub-id pub-id-type="pmid">20110278</pub-id></mixed-citation>
    </ref>
    <ref id="vbad104-B37">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Rosenbaum</surname><given-names>SR</given-names></string-name>, <string-name><surname>Tiago</surname><given-names>M</given-names></string-name>, <string-name><surname>Caksa</surname><given-names>S</given-names></string-name></person-group><etal>et al</etal><article-title>SOX10 requirement for melanoma tumor growth is due, in part, to immune-mediated effects</article-title>. <source>Cell Rep</source><year>2021</year>;<volume>37</volume>:<fpage>110085</fpage>.<pub-id pub-id-type="pmid">34879275</pub-id></mixed-citation>
    </ref>
    <ref id="vbad104-B38">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Sheffield</surname><given-names>NC</given-names></string-name>, <string-name><surname>Bock</surname><given-names>C.</given-names></string-name></person-group><article-title>LOLA: enrichment analysis for genomic region sets and regulatory elements in R and bioconductor</article-title>. <source>Bioinformatics</source><year>2016</year>;<volume>32</volume>:<fpage>587</fpage>–<lpage>9</lpage>.<pub-id pub-id-type="pmid">26508757</pub-id></mixed-citation>
    </ref>
    <ref id="vbad104-B39">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Takebayashi</surname><given-names>H</given-names></string-name>, <string-name><surname>Yoshida</surname><given-names>S</given-names></string-name>, <string-name><surname>Sugimori</surname><given-names>M</given-names></string-name></person-group><etal>et al</etal><article-title>Dynamic expression of basic helix–loop–helix olig family members: implication of Olig2 in neuron and oligodendrocyte differentiation and identification of a new member, Olig3</article-title>. <source>Mech Dev</source><year>2000</year>;<volume>99</volume>:<fpage>143</fpage>–<lpage>8</lpage>.<pub-id pub-id-type="pmid">11091082</pub-id></mixed-citation>
    </ref>
    <ref id="vbad104-B40">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Venugopal</surname><given-names>C</given-names></string-name>, <string-name><surname>Li</surname><given-names>N</given-names></string-name>, <string-name><surname>Wang</surname><given-names>X</given-names></string-name></person-group><etal>et al</etal><article-title>Bmi1 marks intermediate precursors during differentiation of human brain tumor initiating cells</article-title>. <source>Stem Cell Res</source><year>2012</year>;<volume>8</volume>:<fpage>141</fpage>–<lpage>53</lpage>.<pub-id pub-id-type="pmid">22265735</pub-id></mixed-citation>
    </ref>
    <ref id="vbad104-B41">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Vora</surname><given-names>P</given-names></string-name>, <string-name><surname>Seyfrid</surname><given-names>M</given-names></string-name>, <string-name><surname>Venugopal</surname><given-names>C</given-names></string-name></person-group><etal>et al</etal><article-title>Bmi1 regulates human glioblastoma stem cells through activation of differential gene networks in CD133+ brain tumor initiating cells</article-title>. <source>J Neurooncol</source><year>2019</year>;<volume>143</volume>:<fpage>417</fpage>–<lpage>28</lpage>.<pub-id pub-id-type="pmid">31115870</pub-id></mixed-citation>
    </ref>
    <ref id="vbad104-B42">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Weintraub</surname><given-names>AS</given-names></string-name>, <string-name><surname>Li</surname><given-names>CH</given-names></string-name>, <string-name><surname>Zamudio</surname><given-names>AV</given-names></string-name></person-group><etal>et al</etal><article-title>YY1 is a structural regulator of enhancer-promoter loops</article-title>. <source>Cell</source><year>2017</year>;<volume>171</volume>:<fpage>1573</fpage>–<lpage>88 e1528</lpage>.<pub-id pub-id-type="pmid">29224777</pub-id></mixed-citation>
    </ref>
    <ref id="vbad104-B43">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Winslow</surname><given-names>MM</given-names></string-name>, <string-name><surname>Dayton</surname><given-names>TL</given-names></string-name>, <string-name><surname>Verhaak</surname><given-names>RGW</given-names></string-name></person-group><etal>et al</etal><article-title>Suppression of lung adenocarcinoma progression by Nkx2-1</article-title>. <source>Nature</source><year>2011</year>;<volume>473</volume>:<fpage>101</fpage>–<lpage>4</lpage>.<pub-id pub-id-type="pmid">21471965</pub-id></mixed-citation>
    </ref>
    <ref id="vbad104-B44">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Witwicki</surname><given-names>RM</given-names></string-name>, <string-name><surname>Ekram</surname><given-names>MB</given-names></string-name>, <string-name><surname>Qiu</surname><given-names>X</given-names></string-name></person-group><etal>et al</etal><article-title>TRPS1 is a lineage-specific transcriptional dependency in breast cancer</article-title>. <source>Cell Rep</source><year>2018</year>;<volume>25</volume>:<fpage>1255</fpage>–<lpage>67 e1255</lpage>.<pub-id pub-id-type="pmid">30380416</pub-id></mixed-citation>
    </ref>
    <ref id="vbad104-B45">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Yoon</surname><given-names>EC</given-names></string-name>, <string-name><surname>Wang</surname><given-names>G</given-names></string-name>, <string-name><surname>Parkinson</surname><given-names>B</given-names></string-name></person-group><etal>et al</etal><article-title>TRPS1, GATA3, and SOX10 expression in triple-negative breast carcinoma</article-title>. <source>Hum Pathol</source><year>2022</year>;<volume>125</volume>:<fpage>97</fpage>–<lpage>107</lpage>.<pub-id pub-id-type="pmid">35413381</pub-id></mixed-citation>
    </ref>
    <ref id="vbad104-B46">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Yu</surname><given-names>J</given-names></string-name>, <string-name><surname>Liu</surname><given-names>D</given-names></string-name>, <string-name><surname>Sun</surname><given-names>X</given-names></string-name></person-group><etal>et al</etal><article-title>CDX2 inhibits the proliferation and tumor formation of Colon cancer cells by suppressing wnt/beta-catenin signaling via transactivation of GSK-3beta and Axin2 expression</article-title>. <source>Cell Death Dis</source><year>2019</year>;<volume>10</volume>:<fpage>26</fpage>.<pub-id pub-id-type="pmid">30631044</pub-id></mixed-citation>
    </ref>
    <ref id="vbad104-B47">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Yu</surname><given-names>Y</given-names></string-name>, <string-name><surname>Chen</surname><given-names>Y</given-names></string-name>, <string-name><surname>Kim</surname><given-names>B</given-names></string-name></person-group><etal>et al</etal><article-title>Olig2 targets chromatin remodelers to enhancers to initiate oligodendrocyte differentiation</article-title>. <source>Cell</source><year>2013</year>;<volume>152</volume>:<fpage>248</fpage>–<lpage>61</lpage>.<pub-id pub-id-type="pmid">23332759</pub-id></mixed-citation>
    </ref>
    <ref id="vbad104-B48">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Zaret</surname><given-names>KS</given-names></string-name>, <string-name><surname>Carroll</surname><given-names>JS.</given-names></string-name></person-group><article-title>Pioneer transcription factors: establishing competence for gene expression</article-title>. <source>Genes Dev</source><year>2011</year>;<volume>25</volume>:<fpage>2227</fpage>–<lpage>41</lpage>.<pub-id pub-id-type="pmid">22056668</pub-id></mixed-citation>
    </ref>
    <ref id="vbad104-B49">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Zhang</surname><given-names>Y</given-names></string-name>, <string-name><surname>Blanchette</surname><given-names>M.</given-names></string-name></person-group><article-title>Reference panel guided topological structure annotation of Hi-C data</article-title>. <source>Nat Commun</source><year>2022</year>;<volume>13</volume>:<fpage>7426</fpage>.<pub-id pub-id-type="pmid">36460680</pub-id></mixed-citation>
    </ref>
    <ref id="vbad104-B50">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Zhou</surname><given-names>Q</given-names></string-name>, <string-name><surname>Choi</surname><given-names>G</given-names></string-name>, <string-name><surname>Anderson</surname><given-names>DJ</given-names></string-name></person-group><etal>et al</etal><article-title>The bHLH transcription factor Olig2 promotes oligodendrocyte differentiation in collaboration with Nkx2.2</article-title>. <source>Neuron</source><year>2001</year>;<volume>31</volume>:<fpage>791</fpage>–<lpage>807</lpage>.<pub-id pub-id-type="pmid">11567617</pub-id></mixed-citation>
    </ref>
  </ref-list>
</back>
